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Introduction 11
Background
Infectious diseases in pregnancy
Preterm birth and low birth weight are considered as important public health concerns 
since both are important causes of perinatal morbidity and mortality (1-3). Furthermore, 
these adverse birth outcomes seem to have long term consequences. Preterm birth 
infants are at risk for neurodevelopmental problems (4). Low birth weight infants are 
at risk for the development of coronary heart disease and diabetes mellitus (5). Several 
determinants of preterm birth and low birth weight have been identifi ed, including bio-
logical, genetic and socio-demographic determinants (6-8). 
Of the biological determinants, Chlamydia trachomatis during pregnancy may lead 
to low birth weight, preterm birth, premature rupture of membranes and other adverse 
pregnancy outcomes (9-11). However, the literature regarding the adverse eff ects of 
these infections yields confl icting results mainly due to diff erences in study design and 
population and microbiological tests employed (12-22). Laboratory testing on C. tra-
chomatis or other urogenital infections during pregnancy is not routinely performed. 
Specifi c antenatal attention for urogenital symptoms, indicating a possible underlying 
urogenital tract infection, may be helpful in identifying women at increased risk for deliv-
ering preterm or low birth weight infants. Not much is known of the eff ects of urogenital 
symptoms in diff erent periods of pregnancy with pregnancy outcomes. This may be rel-
evant for identifying critical periods during pregnancy that could be used for targeting 
preventive strategies.
Infectious diseases in infancy
World wide, respiratory infections and gastrointestinal tract infections are the leading 
cause of morbidity in children (23, 24). In industrialized countries, prospective cohort 
studies in the last decade revealed prevalence’s of 3.4% to 32.1% for respiratory tract dis-
eases and 1.2% to 26.3% for gastrointestinal diseases in the fi rst year of life of infants. The 
wide range in prevalence’s are mainly due to the diff erent defi nitions (25-30). Respiratory 
tract diseases refer to hospitalized or non-hospitalized upper respiratory tract infections, 
lower respiratory tract infections, wheezing or a combination of these diagnoses (25-30). 
Gastrointestinal diseases usually comprises infants with diarrhea including those who 
are hospitalized (27, 30). 
Various risk factors for upper respiratory tract infections (URTI), lower respiratory 
tract infections (LRTI) and gastrointestinal infections (GI) have been identifi ed, includ-
ing gestational age, birth weight, socio-economic status, ethnicity, number of siblings, 
daycare attendance, maternal smoking and breastfeeding (25-46). Of these, maternal 
smoking and breastfeeding seem to be the most modifi able infl uencing factors. The 
disadvantages of maternal smoking and the advantages of breastfeeding on infectious 
Liesbeth BW 16-4.indd   11 24-Apr-08   12:05:09 PM
12
Ch
ap
te
r 1
diseases in infants seem to depend on the dose and duration of these factors at which 
infants are exposed. The independent eff ects of maternal smoking of diff erent duration 
in pregnancy and in the postnatal period on the risk or respiratory tract infections are not 
yet clear. This may be relevant for identifying critical periods for the eff ect of exposure 
of maternal smoking on airway and lung development and respiratory tract infections in 
infants. Breastfeeding is assumed to protect infants from respiratory and gastrointestinal 
infections. The World Health Organization (WHO) recommended in 2001 to exclusively 
breastfeed all children for 6 months instead of 4 months. However, they called for more 
research regarding the benefi ts of 6 versus 4 months of exclusive breastfeeding (47).
Respiratory tract illnesses and gastrointestinal illnesses in infancy are mostly caused 
by various viruses and to a lesser extent by bacteria or parasites. Streptococcus pneu-
moniae is one of most important bacterial pathogens that causes respiratory tract ill-
nesses with serious morbidity in infants, including sinusitis, otitis media, bronchitis and 
pneumonia (4). Nasopharyngeal carriage of S. pneumoniae is common and is mostly 
asymptomatic. However, nasopharyngeal carriage of S. pneumoniae might lead to seri-
ous pneumococcal disease when the host-pathogen balance is disturbed (48-51). Several 
risk factors of nasopharyngeal carriage of S. pneumoniae have been identifi ed, including 
age, day care attendance, smoking exposure, and large households (52, 53). However, 
population-based prospective cohort studies in infants regarding environmental factors, 
dynamics and interference of S. pneumoniae with other pathogens are lacking.
Immune system in infancy
Major reasons for the high rates of recurrent infections in infants are excessive exposure 
to infectious agents in group settings, such as day care attendance, but also their rela-
tive immature immune system. In the nineties, the fi rst immunophenotyping studies on 
lymphocytes in healthy neonates, infants and children were performed (54-65). Various 
lymphocyte subsets were identifi ed with the use of fl ow cytometry immunophenotyp-
ing. Compared with adults, several technical problems had to be managed, including the 
limited available amount of blood, the presence of normoblasts and the lysis-resistant 
erythrocytes in neonatal cord blood and the variability in staining patterns of some fl uo-
rochrome-conjugated antibodies combinations in neonates (61, 62, 66). After addressing 
the technical diffi  culties, it was found that neonates and infants had higher absolute lym-
phocyte counts than adults, which made comparative studies between neonates, infants 
and adults less informative when using relative lymphocyte counts (61). Furthermore, 
it seemed that at birth a large poole of naïve, untriggered, lymphocytes are stand-by 
for primary immune responses. In the fi rst two years of life, absolute numbers of the 
various lymphocyte subsets change as result from maturation processes. After birth, sev-
eral studies observed an increase of absolute numbers of CD3+ T lymphocytes until the 
age of 6 months and a decrease from that age onwards until adult ranges are attained 
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(62, 63, 65). Within the T lymphocyte population, absolute numbers of CD4+ CD3+ helper 
T lymphocytes followed the same pattern as the total CD3+ T lymphocytes. CD8+ CD3+ 
cytotoxic T lymphocytes remain stable after birth up to 2 years of age, followed by a grad-
ual decrease towards adult levels. Absolute numbers of CD19+ B lymphocytes increase 
immediately after birth and gradually decline after the age of 6 months. In the fi rst 2 
months of life, absolute numbers of CD16.56+ NK lymphocytes decrease and remain 
stable thereafter. In infancy, the maturation process of the various lymphocyte subsets 
is suggested to be triggered by infectious diseases, nutrition and vaccinations. However, 
before assessing how and to what extent these parameters aff ect the maturation of the 
various lymphocyte subsets, the diff erent maturation phases of the lymphocyte subsets 
themselves need to be established in more detail.
At birth, the large poole of naïve, untriggered, lymphocytes found in neonates 
seemed smaller in preterm than in term born neonates (61). These fi ndings suggest a 
prenatal development of the immune system. Since not only preterm birth but also fetal 
growth restriction or low birth weight represents suboptimal fetal growth and develop-
ment, an adverse development of lymphocytes in those infants might be present. It is not 
well known whether other perinatal factors associated with fetal well-being, stress and 
hypoxia, including mode of delivery, Apgar scores or umbilical cord blood pH, infl uence 
the various lymphocyte subset counts at birth (67-76). Since insulin-like growth factor 
(IGF-I) seem to stimulate growth, development and function of lymphocytes (9, 77-85), 
it is of interest to study whether functional variants of the IGF-I gene are associated with 
absolute lymphocyte subset counts in neonates. Large population-based studies assess-
ing the associations of infl uencing pre-and perinatal factors with absolute numbers of 
lymphocyte subsets are lacking.
Aims
The overall aims of this thesis are to study the risk factors and consequences of infec-
tious diseases in pregnancy and infancy and to study the developing immune system in 
infancy in a population-based prospective cohort study. The specifi c aims are to assess:
The associations of 1. C. trachomatis infection and symptoms of subclinical urogenital 
infections in pregnancy with preterm birth and low birth weight.
The protective eff ect of breastfeeding in industrialized countries against infectious 2. 
diseases in infancy in a review, the associations of duration and exclusiveness of 
breastfeeding and maternal smoking habits with respiratory tract or gastrointestinal 
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infections in infancy, and the prevalence and determinants of pneumococcal car-
riage during the fi rst 14 months of life. 
The diff erent maturation phases of the lymphocyte subsets during the fi rst 24 months 3. 
of life, and the associations of fetal growth and development, stress-related perinatal 
factors and an IGF-1 promoter polymorphism with absolute numbers of T, B and NK 
lymphocytes and T lymphocyte subsets (helper, cytotoxic, naïve and memory) in 
cord blood of neonates.
Outline thesis
In chapter 2 of this thesis, consequences of infectious diseases in pregnancy are 
described. Prevalence and risk factors of C. trachomatis infection in pregnant women are 
presented (chapter 2.1). Additionally, associations of C. trachomatis infection and uro-
genital symptoms in diff erent periods of pregnancy with adverse pregnancy outcomes 
are shown (chapter 2.2).
Risk factors for infectious diseases in infancy are presented in chapter 3. The protec-
tive eff ect of breastfeeding on infectious diseases in infants is explored in a systematic 
review of studies published in the last two decades (chapter 3.1). The associations of 
the duration of exclusive breastfeeding and the risk of respiratory infections and gas-
trointestinal tract infections in infants in the fi rst year of life are examined (chapter 3.2). 
Special interest was in the benefi cial protective eff ects of 3 and 6 months of exclusive 
breastfeeding, compared with infants who were never breastfed. In chapter 3.3, the 
independent eff ects of maternal smoking in diff erent periods of pregnancy and in early 
postnatal life on respiratory tract infections at the age of 6 months are assessed. Chapter 
3.4 describes the prevalence of nasopharyngeal carriage of Streptococcus pneumoniae in 
infants, prospectively followed until the age of 14 months. Furthermore, risk factors for 
nasopharyngeal carriage of S. pneumoniae at diff erent ages (6 weeks, 6 months and 14 
months) are examined.
Chapter 4 presents the development of absolute numbers of lymphocytes in infants 
and its infl uencing factors. Maturation of lymphocytes (T, B and NK) and T lymphocyte 
subsets (helper, cytotoxic, naïve and memory) at birth and at the age of 6, 14 and 24 
months are explored (chapter 4.1). In chapter 4.2, the associations of gestational age, 
fetal growth and birth weight with absolute numbers of lymphocytes (T, B and NK) and 
T lymphocyte subsets (helper, cytotoxic, naïve and memory) in cord blood of neonates 
are assessed. Associations of stress-related perinatal factors, including mode of delivery, 
1- and 5-minute Apgar scores and umbilical cord blood pH, with the various types of 
lymphocytes are described in chapter 4.3. In chapter 4.4, we studied the hypothesis 
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whether variants of the IGFI gene promotor region are related to changes in absolute 
numbers of lymphocyte subsets.
In chapter 5, the main fi ndings, methodological considerations and future perspec-
tives of the studies described in this thesis are discussed. 
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Abstract
Context: Chlamydia trachomatis infection is the most prevalent sexually transmitted 
infection and may infl uence pregnancy outcome.
Objective: To assess the eff ect of C. trachomatis infection during pregnancy on pregnancy 
outcomes. 
Design and Setting: A population-based prospective cohort study of women present-
ing for antenatal care to the midwifery practices and antenatal clinics in Rotterdam, 
the Netherlands. Women completed a self-administered questionnaire and submitted 
a urine sample. C. trachomatis was detected by PCR. Pregnancy outcomes were obtained 
from midwives and hospital registries. 
Participants: This study was embedded in the Generation R Study. Women, who attended 
one of the participating centres between February 2003 and January 2005 and who were 
expected to deliver in Rotterdam, were eligible for the study. In total 5,167 pregnant 
women were enrolled. From 4,055 women urine samples and questionnaires were avail-
able for analysis. 
Main outcome measures: Unfavourable pregnancy outcomes including abortion, still-
birth, perinatal death, prematurity and low birth weight.
Results: The prevalence of C. trachomatis infection was 3.9% and was highest in women 
with young age, Antillean, Cape Verdian or Surinamese ethnicity, single marital status, 
multiple sexual partners or a history of a sexually transmitted infection, and with part-
ners with similar risk factors. C. trachomatis infection was associated with preterm deliv-
ery, especially with early prematurity before 32 weeks gestation (OR 6.14 [95% CI 1.69, 
22.30]), but not with low birth weight. Of all preterm deliveries before 32 weeks gestation 
in this region 15.8 % was attributable to C. trachomatis infection.
Conclusion: C. trachomatis infection in pregnant women is an important risk factor for 
early premature delivery. C. trachomatis infection in pregnancy should be considered a 
public health problem, especially for young women in certain socio-economic groups at 
increased risk of C. trachomatis infection. 
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Introduction 
Chlamydia trachomatis is an important cause of sexually transmitted infections (STIs) in 
women, which may lead to tubal infertility, ectopic pregnancy, pelvic infl ammatory dis-
ease, and chronic abdominal pain. (1-3) Screening for C. trachomatis in pregnant women 
has revealed prevalence rates varying from 0% to 37%. (4-6) In the Netherlands, a C. tra-
chomatis prevalence of 2.5% was reported in women, (7) but data on pregnant women 
are lacking. Various risk factors have been associated with chlamydial infection including 
in particular age and socio-economic status. (6, 8) 
C. trachomatis infection during pregnancy may infl uence pregnancy outcomes lead-
ing to prematurity, premature rupture of membranes, low birth weight and perinatal 
mortality. The literature regarding these latter detrimental eff ects of C. trachomatis infec-
tion yields confl icting results that seem primarily due to diff erences in study design, 
population and microbiological tests employed. (9-19) The objective of this study was to 
assess the prevalence of C. trachomatis infection in pregnant women and to investigate 
the association of chlamydial infection with pregnancy outcomes in a large population-
based prospective study in Rotterdam, the Netherlands. 
Methods
Design 
This C. trachomatis study was embedded in the Generation R Study, which is a population-
based prospective cohort study designed to identify early environmental and genetic 
determinants of growth, development and health of children, starting from foetal life 
until adolescence, as previously described. (20, 21) Pregnant women, who attended one 
of the participating midwifery practices or antenatal clinics and who were expected to 
deliver in Rotterdam, were eligible for the study. Regular health care workers (midwives, 
obstetricians) informed the women about the study. Most women spoke Dutch, oth-
erwise the study was explained and questionnaires provided in their native language. 
Enrolment was scheduled in early pregnancy (gestational age < 18 weeks) at the fi rst 
routine foetal ultrasound examination, but was allowed until delivery. Women who were 
scheduled for an induced abortion and women with a pregnancy resulting in foetal 
death or miscarriage prior to or at the fi rst ultrasound were not included in the study. All 
children were born between April 2002 and January 2006. (21) Inclusion for the current 
C. trachomatis sub-study was between February 2003 and January 2005.
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Risk factors
Data were obtained using confi dentially administered standardized questionnaires at the 
time of inclusion. Maternal age was defi ned as age at enrolment of the study. Ethnicity 
has been associated with chlamydial infection and was self-classifi ed in this study. Most 
women were Dutch (49%), Surinamese (9%), Turkish (9%) or Moroccan (7%). Educational 
levels of participating women were defi ned in groups by highest attained education (pri-
mary school, secondary school, higher education). Marital status was defi ned as married 
if formally married or living together in partnership. Further information was obtained 
regarding gravidity, number of sexual partners in the year prior to pregnancy, history 
of an STI, and the use of cigarettes, alcohol and drugs. Information about partners was 
collected indirectly via maternal questionnaires and included age, ethnicity, number of 
sexual partners in the year prior to pregnancy, history of an STI and the use of cigarettes, 
alcohol and drugs. The partner was defi ned as the biological father of the current preg-
nancy.
Microbiological diagnosis
Women provided a fi rst-void urine specimen to test for C. trachomatis at enrolment. 
Urines were stored at 4°C, transported the same or following working day, and processed 
within 24 hours of receipt by the laboratory. DNA was isolated from pooled urine speci-
mens using the MagNA Pure LC Bacterial DNA isolation Kit III (Roche Molecular Systems, 
Inc, Alameda, CA, USA) and amplifi ed by polymerase chain reaction (PCR) (Cobas Ampli-
cor, Roche Molecular Diagnostics, Branchburg USA) as previously described. (22) In brief, 
pools were made of fi ve individual urines by adding 200 μl of each of the urines into 
one tube. From each pool the full 1000 μl were taken, and centrifuged for 10 minutes. 
Subsequently 900 μl were removed and the pellet was resuspended in 100 μl of the 
remaining supernatant, mixed with 130 μl lysis buff er and 20 μl proteinase K, incubated 
for 10 minutes and thereafter denatured for 10 minutes. Finally, DNA was isolated in the 
automated MagNA Pure LC using a sample volume of 250 μl and an elution volume of 
100 μl. Then, 25 μl was used for PCR. Urines from positive pools were individually re-
tested and reported as negative or positive.
Pregnancy outcomes
Information about pregnancy outcomes (abortion, stillbirth, perinatal death, gestational 
age, birth weight) was obtained postnatally from midwives and hospital registries. Gesta-
tional age was established by foetal ultrasound examination. Preterm birth was defi ned 
as delivery at a gestational age of less than 37 weeks with subgroups that had gestational 
ages of less than 32 weeks and less than 35 weeks. Birth weight measurements were 
converted into gestational age adjusted standard deviation scores (SDSs). (23) 
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Ethical aspects
Within the framework of the Generation R Study several sub-studies are embedded, 
as was our C. trachomatis study. Both studies were approved by the Medical Ethical 
Committee for Research on Human Subjects of the Erasmus University Medical Centre, 
Rotterdam. Written informed consent was obtained from all participants. Generation R 
provided data anonymously to protect the privacy of participants; we had no access to 
names or addresses. (20, 21) We did not treat C. trachomatis positive women nor refer 
women to regular health care providers. The study did not interfere with current Dutch 
standard medical practice. Standard medical practice was, and still is at the time, not to 
screen for C. trachomatis antenatally and only to treat Chlamydia in pregnancy if women 
are identifi ed as being at risk of infection due to clinical signs or via contact tracing from 
a Chlamydia-positive partner.
Data analysis
The associations of C. trachomatis infection during pregnancy with socio-economic 
and life style risk factors of women and partners were assessed using multiple logistic 
regression models. Unequivocal confounders were selected based on previous studies. 
In addition, we included variables that, in our study cohort, were associated both with 
Chlamydia infection and adverse pregnancy outcomes as possible confounders. Associa-
tions were studied for each risk factor while adjusting for all other risk factors. Associa-
tions of socio-economic and life style risk factors of partners with C. trachomatis infection 
of women were additionally adjusted for maternal risk factors (maternal age, ethnicity, 
multiple partners the year prior to pregnancy, history of an STI). 
For the analysis of birth weight as a continuous variable, multiple linear regression 
models were used. For the analysis of low birth weight and preterm birth multiple logis-
tic regression models were employed. The latter regressions were adjusted for known 
determinants of low birth weight and preterm birth (maternal age, ethnicity, gravidity) 
and for socio-economic status and life style related variables (education, smoking). Mea-
sures of association are presented with 95% confi dence intervals (CI). The Kaplan-Meier 
procedure was used to illustrate the proportion of women who delivered at given ges-
tational ages. 
The proportion of preterm delivery attributable to C. trachomatis infection in women 
in the total population was assessed using the population attributable risk (PAR). (24) 
The PAR was calculated on the basis of the observed relative risk (RR) and the population 
fraction with chlamydial infection (PF), using the formula: 
PAR = [(RR – 1)PF] / [1 + (RR – 1)PF].
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Statistical analysis was performed using the Statistical Package of Social Sciences version 
11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Population for analysis 
In total 5,167 pregnant women were enrolled in the study (Figure 1). Women with 
incomplete data sets (N = 1,112) were excluded: from 491 women no urine sample was 
obtained or urine was lost during transport to the laboratory, and from 621 women the 
urines could not be matched to their respective questionnaires in the data base. From 
Figure 1. Profi le of the Generation R sub-study on Chlamydia trachomatis.
 
Enrolment in the C. trachomatis sub-study 
From February 2003 to January 2005 
n=5,167 women 
Enrolment in the Generation R Study  
From April 2002 to January 2006 
n=9,788 women 
n=1,112 women excluded due to: 
Urine samples missing (n=491)  
Urine samples mismatch to questionnaires (n=621)  
n=4,055 women included  
with C. trachomatis test results and  
matching questionnaires 
n=147 women excluded due to: 
Twin pregnancies (n=37)  
Abortion (n=12) 
Perinatal death (n=50) 
Lost to follow-up (n=48)
n=3,908 women included  
with complete data on C. trachomatis infection and 
pregnancy outcomes 
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4,055 (78%) women urine samples and data on socio-economic and life style risk factors 
were available, which were used for the analyses of the prevalence and risk factors for 
Table 1. Socio-economic and life style risk factors of Chlamydia trachomatis infection in pregnant women.
Chlamydia trachomatis infection
No 
n=3898
Yes 
n=157
Adjusted
OR (95% CI)#
Age groups
< 21 217 34 3.89 (1.85, 8.21)**
21-25 741 53 2.93 (1.54, 5.56)**
26-30 1194 41 2.04 (1.13, 3.69)**
> 30 1746 29 1.00
Ethnicity
Dutch 1701 33 1.00
Cape Verdian 137 15 1.56 (0.70, 3.50)
Antillean 105 19 2.74 (1.28, 5.85)**
Surinamese 298 30 2.06 (1.10, 3.84)*
Moroccan/Turkish 563 14 0.71 (0.30, (1.67)
Other (non-) western 630 19 0.98 (0.51, 1.89)
Education
Primary school 396 27 1.29 (0.61, 2.73)
Secondary school 1421 69 1.09 (0.62, 1.92)
Higher education 1474 27 1.00
Marital status
Not married 452 64 3.55 (2.13, 5.91)**
Married 2846 65 1.00
Gravidity ≥ 1
No 1652 73 1.00
Yes 2083 73 0.78 (0.51, 1.19)
Multiple sexual partners in year prior to 
pregnancy
No 2918 99 1.00 
Yes 251 21 1.19 (0.67, 2.11)
History of STI
No 2778 100 1.00
Yes 370 25 1.06 (0.59, 1.88)
Do not know 38 2 1.06 (0.24, 4.78)
Values are frequencies and odds ratios (95% CI) 
*P-value < 0.05, **p-value < 0.01
$Data missing for ethnicity (n=491), education (n=641), marital status (n=628), gravidity (n=174), number of sexual partners 
(n=766), STI (n=742)
#Adjusted for all other risk factors, drug use, alcohol use and smoking
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chlamydial infection. Half the women were included within the fi rst 14 weeks of their 
pregnancy, 95% within 22 weeks.
Prevalence 
C. trachomatis infection was detected in 157 of 4,055 (3.9%) women. Age-specifi c preva-
lences were 13.5% in women age 20 years or less, 6.7% between 21 and 25 years, 3.3% 
between 26 and 30 years and 1.6% in women over 30 years. The prevalence was highest 
in Antillean (15.3%), Cape Verdian (9.8%) or Surinamese (9.1%) women, and in women 
with low education (6.4%), single marital status (12.4%), fi rst pregnancies (4.2%), multiple 
sexual partners in the past year (7.7%) or a history of an STI (6.3%) (Table 1). Chlamydia 
prevalence was also high in women whose partner was less than 21 years (18.8%), or 
between 21 and 25 years of age (7.3%), Antillean (17.1%), Cape Verdian (13.4%), or Suri-
namese (9.5%), or who had more than two partners in the past year (9.8%). C. trachomatis 
prevalence rates were also high among women who did not know whether their partner 
had multiple sexual contacts in the past year or a history of an STI (data on partners not 
shown in Table 1).
Women with missing data on marital status, gravidity, multiple sexual partners or a 
history of an STI had similar rates of C. trachomatis infection when compared to women 
with these data recorded. Women with missing data on ethnicity and education had 
somewhat higher rates of C. trachomatis infection, 5.5 % and 5.3%, respectively, (p=0.05 
and p=0.04).
Risk factors 
In the adjusted analysis age below 21 years, or between 21-25 years, and between 26-30 
years remained risk factors for C. trachomatis infection, as did Antillean or Surinamese 
ethnicity and single marital status. Other maternal factors were not independently asso-
ciated with C. trachomatis infection. 
Adjusted risk factors of partners showed that if partners were Cape Verdian, Suri-
namese or Moroccan/Turkish, the risk of C. trachomatis infection for women was higher. 
If the partner had multiple sexual partners the year prior to pregnancy or the woman 
did not know whether her partner had had multiple sexual contacts, women also had a 
signifi cantly higher risk of C. trachomatis infection. Drugs use by women or their partners 
were, in the adjusted analysis, not associated with C. trachomatis infection of women nor 
were alcohol use and smoking (data not shown).
Pregnancy outcomes
Of the 4,055 pregnancies 3,908 resulted in live singleton births and 37 in the birth of live 
twins. Women who gave birth to twins were more often Chlamydia positive than women 
who had singletons, which diff erence was borderline signifi cant (Table 2). Adverse preg-
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nancy outcomes leading to loss of fetal or neonatal live, including abortion, stillbirth and 
perinatal death, occurred in 62 (1.5%) of the pregnancies. These adverse events were 
not associated with Chlamydia infection during pregnancy. Preterm delivery occurred 
in 191 women (4.9%) of which prematurity before gestational ages of 32 weeks and of 
35 weeks was signifi cantly associated with Chlamydia infection during pregnancy (Table 
2). Regarding birth weights, no signifi cant association was observed between low birth 
weight and Chlamydia infection during pregnancy. The eff ect of Chlamydia infection on 
gestational age and birth weight were further analysed. For these analyses women who 
were lost to follow up, who had twin pregnancies, or who had an abortion, stillbirth or 
perinatal death were excluded. Thus, 3908 women and neonates remained to analyse the 
eff ect of Chlamydia infection on gestational age and birth weight.
Gestational age. The distribution of gestational ages of neonates according to the 
chlamydial status of women is shown in a Kaplan-Meier plot (Figure 2). C. trachomatis 
Table 2. Pregnancy outcomes of women and their association with Chlamydia trachomatis infection.
Chlamydia trachomatis infection
Outcomes No Yes Percentage positive (95% CI) P-value *
All outcomes
all women enrolled 3898 157 3.9
Live pregnancy outcomes
live singleton birth 3758 150 3.8
live twin birth 33 4 10.8 (4.2 – 25.1) 0.05
lost to follow up 45 3 6.3 (2.1 – 17.1) 0.43
Fetal death
abortion 12 0 0 (0 – 24.4) 1.00
stillbirth 33 0 0 (0 – 10.5) 0.64
perinatal death 17 0 0 (0 – 18.6) 1.00
Gestational age**
term, ≥ 37 weeks 3577 140 3.8
prematurity,  < 37 weeks 181 10 5.2 (2.8 – 9.6) 0.33
prematurity,  < 35 weeks 56 7 11.1 (5.4 – 21.7) 0.01
prematurity,  < 32 weeks 17 4 19.0 (7.6 – 40.8) 0.01
Birth weight**
≥ 2500 gram 3585 140 3.8
< 2500 gram 173 10 5.5 (2.9 – 10.0) 0.24
* P-value (Fishers exact test) for comparison of Chlamydia prevalence with respective outcome categories of live singleton 
birth, gestational age ≥ 37 weeks, and birth weight ≥ 2500 gram
** Including live singleton birth outcomes only
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infected women had a signifi cantly higher rate of delivery at 35 weeks gestation or ear-
lier. 
Unadjusted analysis (Table 3) showed that C. trachomatis infected women had a sig-
nifi cantly higher risk of preterm delivery before 32 weeks compared to delivery at term 
(OR 6.01 [95% CI 2.00, 18.10]). This six-fold increased risk (OR 6.14 [95% CI 1.69, 22.30]) 
remained after adjustment for gestational age and the potential confounders maternal 
age, ethnicity, education, gravidity, and smoking. C trachomatis infected women also had 
a signifi cantly higher risk of preterm delivery before 35 weeks compared to delivery at 
term (OR 3.19 [95% CI 1.43, 7.13]). Although this risk increase was half of that observed 
for preterm delivery at 32 weeks, it also remained signifi cant after adjustment for the 
confounders stated above (OR 2.82 [95% CI 1.10, 7.22]). C. trachomatis infected women 
did not have an increased risk of preterm delivery before 37 weeks. Alcohol, drug use 
and marital status did not meet our criteria of potential confounders. Indeed, including 
alcohol and/or drug use in our regression model did not have a signifi cant eff ect on the 
calculated ORs. Adjustment for marital status somewhat reduced the calculated ORs (4.46 
[95% CI 1.33, 14.97] for preterm delivery before 32 weeks, and 2.72 [95% CI 1.15, 6.40] for 
preterm delivery before 35 weeks), but the risk remained signifi cantly elevated.The frac-
Figure 2. Kaplan-Meier analysis of duration of gestation at delivery in women with and without Chlamydia 
trachomatis infection
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Table 3. Risk for preterm delivery among women with Chlamydia trachomatis infection.
Risk for preterm delivery
< 32 weeks
n=21
< 35 weeks
n=63
< 37 weeks
n=191
Unadjusted odds ratio
C. trachomatis infection
6.01 
(2.00,18.10)**
3.19
 (1.43, 7.13)**
1.41 
(0.73, 2.73)
Adjusted odds ratio#
C. trachomatis infection
6.14 
(1.69, 22.30) #**
2.82
 (1.10, 7.22) #*
1.00
 (0.44, 2.26) #
aValues are odds ratios (95% confi dence interval) 
Analyses are done versus delivery ≥ 37 weeks (n=3717)
#Adjusted for maternal age, ethnicity, education, gravidity and smoking
*P-value < 0.05, **p-value < 0.01
Figure 3. Birth weight standard deviation scores (SDS) versus gestational ages of neonates born to women with and 
without Chlamydia trachomatis infection
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tion of all premature deliveries before 32 weeks gestation attributable to C. trachomatis 
infection in women was 15.8% (95% CI 4.9, 41.0) in this study cohort. The population 
attributable risk of C. trachomatis infection for preterm delivery before 35 weeks gesta-
tion was 7.5% (95% CI 2.5, 20.4).
Birth weight. Crude analysis of the diff erence in birth weight (in grams) between neo-
nates born to Chlamydia positive and Chlamydia negative women showed a signifi cant 
diff erence (-113 grams [95% CI -204, -22]), which disappeared after adjustment for the 
potential confounders gestational age, maternal age, ethnicity, education, gravidity and 
smoking (-24 grams [95% CI -107, 59]). A comparison of the presence of low birth weight 
(n=183), defi ned as birth weight below 2500 grams, among neonates born to Chlamydia 
positive and Chlamydia negative women also showed no signifi cant diff erence, neither in 
the unadjusted analysis (OR 1.48 [ 95% CI 0.77, 2.86]) nor in the adjusted analysis (OR 0.52, 
[0.12, 2.23]). Analysis of the correlation between birth weights of neonates, expressed in 
SDSs, and their gestational ages according to the Chlamydia status of the women during 
pregnancy is demonstrated in Figure 3. This fi gure suggests that neonates born to C. 
trachomatis infected women had, on average, a lower birth weight SDS, especially when 
prematurely born. However, this diff erence in birth weight SDSs between neonates born 
to Chlamydia positive women and Chlamydia negative women did not reach statistical 
signifi cance, also not after stratifi cation by gestational ages (Table 4). 
Table 4. Diff erences in birth weight between neonates born to women with and without Chlamydia trachomatis 
infection. 
Number (%)
Mean birth 
weight SDS 
Diff erence in birth weight SDS *
Unadjusted Adjusted #
Gestational age 
< 32 weeks (n=21)
C. trachomatis – 17 (81) 0.83 
C. trachomatis + 4 (19) –0.72 –1.54 (–3.56, 0.47) –2.66 (–6.93, 1.61)
< 35 weeks (n=63)
C. trachomatis – 56 (89) 0.13 
C. trachomatis + 7 (11) –0.87 –0.99 (–2.20, 0.22) –1.18 (–2.69, 0.33)
< 37 weeks (n=191)
C. trachomatis – 181 (95) –0.27 
C. trachomatis + 10 (5) –0.85 –0.59 (–1.34, 0.17) –0.43 (–1.38, 0.52)
≥ 37 weeks (n=3717)
C. trachomatis – 3577 (96) –0.08 
C. trachomatis + 140 (4) –0.19 –0.10 (–0.27, 0.07) –0.04 (–0.23, 0.16)
* SDS, standard deviation score. Diff erence and 95% confi dence interval calculated with linear regression analysis
# Adjusted for maternal age, ethnicity, education, gravidity and smoking
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Discussion
This population-based prospective cohort study provides strong evidence that C. tra-
chomatis infection is associated with preterm delivery, but not with low birth weight. 
In this study region young age, Antillean and Surinamese ethnicity and single marital 
status were independent risk factors for C. trachomatis infection in pregnant women as 
were Cape Verdian, Surinamese and Moroccan/Turkish ethnicity and promiscuity of their 
partners.
The strength of this study is its population-based, non-interventional and prospec-
tive design with a large number of well-described participants, adjustments for many 
potential confounders, use of a highly sensitive microbiological test method and near 
perfect follow-up until delivery (97%). 
However, several potential weaknesses should be mentioned. The Generation R Study 
cohort is slightly skewed towards a relatively affl  uent and healthy study population (21). 
We do not expect this to aff ect our results since the present study was designed to assess 
the eff ects of C. trachomatis infection on pregnancy outcomes in a non-hospital based, 
low risk population. A weakness could be that 21% of initially enrolled women could not 
be tested for C. trachomatis. However, all risk factors were similarly distributed among 
tested and untested women and no diff erences were found in the median gestational 
age and mean birth weight (40.1 weeks versus 40.1 weeks; p=0.33, 3419 grams versus 
3418 grams; p=0.99). Also, no diff erences were found in the proportion of C. trachomatis 
infection between women included and not included in the analyses of gestational age 
and birth weight (3.6% versus 4.5%); p=0.57). These selection mechanisms might lead to 
bias if the associations of C. trachomatis infection with gestational age and birth weight 
would diff er between the women included and not included in the present analyses. 
This seems unlikely. One more limitation could have been the missing information on 
risk factors (on average 16%; range 4.3 – 18.9%), but the distribution of C. trachomatis 
infection was similar in women with and without information about risk factors. Finally 
our numbers were too small to properly assess the association of C. trachomatis infec-
tion with abortion, stillbirth or perinatal death. Of all women enrolled in the study and 
with information about C. trachomatis infection, 62 (1.5%) had an abortion, stillbirth or 
perinatal death. Data on gestational age and birth weight were not available for women 
with the latter adverse pregnancy outcomes, but it is likely that these women delivered 
prematurely relatively more frequently. None of these women had a C. trachomatis infec-
tion. Theoretically, our eff ect estimates for the associations of chlamydial infection with 
gestational age and birth weight could be biased and exaggerated when these associa-
tions would diff er between all fetuses and fetal `survivors`. This would be the case when 
C. trachomatis infection has a `protective` eff ect on early fetal death. However, this is 
most unlikely. (9,17) 
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Previous studies of associations between maternal chlamydial infection and subse-
quent spontaneous preterm delivery produced mixed results. Early studies were often 
based on serology, which does not reliably distinguish current from past infection. (10, 
12, 16, 25) One case-control study found an association between the presence of IgM 
anti-chlamydial antibody, but not IgG antibody, and preterm delivery. (12) Studies using 
cervical culture for C. trachomatis at that time also yielded confl icting results. (10, 11, 
15, 25) More recently, sensitive DNA amplifi cation techniques have been used to screen 
pregnant women for C. trachomatis. One case-control study, nested in a large USA study 
among 2,929 pregnant women, used this methodology and reported a two- to three-
fold increased risk of preterm delivery before 35 weeks gestation. (18) Interestingly, the 
same study group reported more recently that C. trachomatis infection in midterm preg-
nancy was not associated with an increased risk of preterm delivery among 2,470 women 
enrolled in an antibiotic treatment trial for bacterial vaginosis or Trichomonas vaginalis 
infection. (19) Since all women were infected and bacterial vaginosis itself may induce 
preterm delivery, (11, 13) the fi ndings of the latter study cannot be extrapolated to the 
population at large. Another population-based retrospective cohort study in the USA 
recently found that Chlamydia infected pregnant women (cases, n=851) had a relative 
risk of preterm delivery before 37 weeks gestation of only 1.50 compared to non-infected 
women (controls, n=3,404). (26) However, the true eff ect of Chlamydia infection on preg-
nancy outcomes cannot be ascertained from that study since all women were screened 
for Chlamydia in the fi rst trimester of their pregnancy, and, when positive, treated. In 
contrast, our study is prospective non-interventional and population-based (n = 4,055), 
which makes that our fi ndings better estimate the eff ect of Chlamydia on pregnancy and 
are more predictive for the population as a whole. 
Preterm birth represents a major problem for obstetrics and neonatology due to its 
increasing frequency and accompanying socio-economic impact. We found C. trachoma-
tis infection to be associated with preterm delivery before 32 weeks as well as before 
35 weeks gestation. The association was much stronger for 32 weeks than for 35 weeks 
gestation indicating that C. trachomatis infection contributes relatively more to early pre-
maturity compared to late prematurity. 
For such an important issue, a six-fold increased risk of preterm delivery before 32 
weeks gestation implies that a considerable proportion (15.8% in our cohort) of preterm 
deliveries before 32 weeks gestation is attributable to chlamydial infection in pregnancy. 
Although there is a considerable confi dence interval around this estimate this would 
classify C. trachomatis among the important infective risk factors of early prematurity. 
For preterm delivery before 35 weeks the attributable fraction remains signifi cant (7.5%). 
It should be kept in mind, however, that the number and proportion of early and late 
premature deliveries attributable to chlamydial infection highly depends upon the C. 
trachomatis prevalence in a given population, and that some confounding as a result of 
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co-infection by other genital pathogens cannot be excluded. We also did not correct for 
a previous history of induced abortion in these women since this potential confounder 
was only recently established (27). Finally, we did not screen the women for the use of 
macrolide antibiotics during pregnancy, but suggest that such use would mitigate the 
observed eff ect of Chlamydia infection of pregnancy outcome rather than exaggerate 
it. 
Extrapolation of our fi ndings to the Netherlands, where approximately 3,000 neo-
nates are born before 32 weeks gestation annually, (28) showed that C. trachomatis 
infection in pregnancy contributes approximately 475 cases to this burden; for deliveries 
before 35 weeks gestation these numbers are 7,100 and 530, respectively.
Interestingly, Chlamydia infection during pregnancy was more prevalent among 
women who had twins compared to women who had singletons, a fi nding not reported 
before. This observation warrants further study into the medical histories of women with 
twins versus women with singletons as pregnancy outcomes. 
Our fi nding of an association between C. trachomatis infection with premature deliv-
ery may be useful in a cost-benefi t analysis of screening for C. trachomatis infection dur-
ing pregnancy, especially among women with increased risk for infection. 
The major risk factors we found are amongst the many previously described includ-
ing young age, urban residence, low socio-economic class, specifi c ethnic groups, single 
marital status and recent changes in sexual partnerships or sexual promiscuity. (6, 9, 10, 
29) Young age is one of the most infl uential risk factors. (8) Adolescent women are at 
highest risk, which was also observed in this study. Urban residence has been described 
to be of importance, which eff ect we could not evaluate since all participating women 
resided in Rotterdam. The risk factors we describe are similar to those reported in another 
recent Dutch community-based study. (7, 30) Importantly, on global scale C. trachoma-
tis prevalences vary widely, (6) which will directly aff ect the incidence of complications 
attributable to this infection, including preterm delivery.
In conclusion, C. trachomatis urogenital infection in pregnant women increases the 
risk of preterm delivery, especially early prematurity, such that a signifi cant proportion 
of preterm deliveries can be attributed to this infection. Therefore, C. trachomatis infec-
tion in pregnancy should be regarded as a serious public health problem, especially for 
young women belonging to socio-economic groups at increased risk for C. trachomatis 
infection.
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Abstract
Objective: The aim of this study was to assess the association of urogenital symptoms in 
diff erent periods of pregnancy with birth weight and gestational age.
Study Design: This study was embedded in the Generation R Study, a population-based 
prospective cohort study from early fetal life. Urogenital symptoms, including vaginal 
bleeding, other vaginal symptoms (vaginal discharge, itching vagina) and urinary tract 
symptoms (frequent need to urinate, pain or burning feeling during urination), were 
assessed by questionnaires in early, mid- and late pregnancy. Pregnancy outcomes were 
obtained from midwife and hospital registries. The present analyses were based on 8,169 
pregnant women with complete records.
Results: Vaginal bleeding in late pregnancy was associated with preterm birth (adjusted 
odds ratio (aOR) 1.94 (95% confi dence interval: 1.05, 3.59), but not with birth weight. 
Associations of other vaginal symptoms with adverse pregnancy outcomes were not 
found. Urinary tract symptoms in early or in multiple periods of pregnancy were associ-
ated with an increased risk of low birth weight, adjusted for gestational age (aOR 2.39 
(1.21, 4.72) and 1.71 (1.02, 2.88)), not of preterm birth. 
Conclusions: Vaginal bleeding in late pregnancy is associated with an increased risk of 
preterm birth and urinary tract symptoms in early or present in multiple periods of preg-
nancy with an increased risk of low birth weight.
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Introduction
The incidence of low birth weight and premature birth varies from 4% to 25% and 5 
to15%, respectively, depending on geographical and demographical features of the 
population studied [1-3]. Delivery of low birth weight and premature infants is recog-
nized as a major public health problem, accounting for the majority of neonatal death 
and morbidity in developed countries. In the last decades, there seems to be an upward 
trend in the incidence of premature births in Western societies [4-6].
Presence of urogenital tract infections during pregnancy are associated with low 
birth weight, preterm delivery, premature rupture of membranes and other adverse 
pregnancy outcomes [7-9]. Laboratory testing on urogenital infections during preg-
nancy is not routinely performed. Specifi c antenatal attention for urogenital symptoms, 
indicating a possible underlying urogenital tract infection, may be helpful in identifying 
women at increased risk of delivering low birth weight or preterm infants. Symptoms 
mostly associated with common urogenital infections include vaginal bleeding, change 
in vaginal discharge, frequent need to urinate or lower abdominal pain [10]. These symp-
toms result from ascending reproductive tract infections leading to (sub)clinical cervi-
citis, endometritis, deciduitis or chorioamnionitis which can adversely eff ect implanta-
tion, placental development, fetal growth and gestational duration [11, 12]. Not much 
is known of the eff ects of urogenital symptoms in diff erent periods of pregnancy with 
pregnancy outcomes. This may be relevant for identifying critical time-periods that could 
be used for preventive strategies. 
Therefore, we examined in a population-based cohort study of pregnant women and 
their children the associations of urogenital symptoms in diff erent periods of pregnancy 
with the risk of low birth weight and preterm birth. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. The Generation R Study was designed 
to identify early environmental and genetic determinants of growth, development and 
health and has been described previously in detail [13, 14]. Briefl y, the cohort includes 
9,778 mothers and their children living in Rotterdam, the Netherlands. Enrolment of 
mothers was aimed in early pregnancy (gestational age < 18 weeks) but was possible 
until birth of the child. All children were born between April 2002 and January 2006 and 
form a prenatally enrolled birth-cohort that is currently followed until young adulthood. 
Of all eligible children in the study area, 61% participated at birth in the study [14]. The 
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Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, has approved the 
study. Written informed consent was obtained from all participants.
Urogenital symptoms
Information about urogenital symptoms was prospectively obtained by postal question-
naires in early (gestational age < 18 weeks), mid- (gestational age18 - 25 weeks) and late 
(gestational age ≥ 25 weeks) pregnancy. Response rates for the questionnaires were 91% 
(early pregnancy), 81% (mid- pregnancy) and 77% (late pregnancy). Women were asked 
whether they experienced the following symptoms in the previous two or three months 
(no, yes): vaginal bleeding, postcoital bleeding, frequent need to urinate, pain during uri-
nation, burning feeling or itching on urethra, vaginal discharge, burning feeling or itch-
ing vagina. These urogenital symptoms were subsequently categorized in three groups: 
1. vaginal bleeding (vaginal bleeding, postcoital bleeding); 2. other vaginal symptoms 
(vaginal discharge, burning feeling or itching vagina) and 3. urinary tract symptoms (fre-
quent need to urinate, pain or burning feeling during urination or itching on urethra).
Pregnancy outcomes
Gestational age was established by the fi rst fetal ultrasound examination at enrolment 
[15]. Crown-rump length was used for pregnancy dating during the fi rst 12 weeks of 
gestational age and the biparietal diameter for pregnancy dating thereafter. Informa-
tion about date of birth and birth weight was obtained from community midwives and 
hospital registries. Preterm birth was defi ned as a gestational age of less than 37 weeks 
at birth. Birth weight measurements were converted into gestational age adjusted stan-
dard deviation scores (sds) [16]. Low birth weight was defi ned as birth weight below the 
10th percentile (< -1.39 sds) in the study cohort.
Covariates
Maternal age was recorded at enrolment. Information about educational level, ethnicity, 
smoking and parity was obtained by the fi rst questionnaire at enrolment in the study. 
Ethnicity and educational level of the mother were defi ned according to the classifi cation 
of Statistics Netherlands [17, 18]. Maternal smoking was categorized into ‘non-smoking’, 
‘stopped smoking when pregnancy was known’ and ‘continued smoking during preg-
nancy’ groups. Parity was defi ned as nulliparity and multiparity.
Population for analysis 
Of the total of 9,778 mothers, 8,880 (91%) and 898 (9%) were enrolled in pregnancy and 
at delivery of their child, respectively [14]. The present analysis was restricted to mothers 
who were enrolled in pregnancy (n=8,880). Mothers with no information about urogeni-
tal symptoms in any period of pregnancy were excluded (n=434) (Figure 1). Furthermore, 
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those with twin pregnancies (n=92), miscarriage (n=17), perinatal mortality (n=97) or 
missing pregnancy outcomes (n=71) were excluded. Of the remaining 8,169 mothers, 
6.0% was registered with a second (n=479) or third (n=8) pregnancy within the same 
study period [14]. Since there were no diff erences in results after exclusion of these 
subjects, they were included in the analyses presented. Complete data about urogenital 
symptoms and pregnancy outcomes were available on 7,411 mothers (early pregnancy), 
6,910 mothers (mid-pregnancy) and 6,642 mothers (late pregnancy).
Figure 1. Flow chart participants
n=8,880  
Participants enrolled during pregnancy 
 
n=9,778  
Generation R cohort 
n=711 
− Missing data on urogenital symptoms during 
pregnancy (n=434) 
− Excluded: twins (n=92), miscarriage (n=17), 
perinatal mortality (n=97) and lost to follow 
up (n=71) 
 
n=898  
Consent at birth 
n=8,169 
Eligible study cohort  
Complete data on urogenital symptoms and 
pregnancy outcomes in early pregnancy 
n=7,411 
n=6,910 
n=6,642 
n=5,554 
Complete data on urogenital symptoms and 
pregnancy outcomes in mid- pregnancy 
Complete data on urogenital symptoms and 
pregnancy outcomes in late pregnancy 
Complete data on urogenital symptoms and 
pregnancy outcomes in all periods of pregnancy 
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Data analysis
The associations between urogenital symptoms and birth weight were analyzed using 
multiple linear regression analysis. For the associations with low birth weight or preterm 
birth as the outcome, logistic regression analysis was used. After the crude analyses, 
potential confounders, including maternal age, education, ethnicity, smoking and parity, 
were added to the model. First, the associations of urogenital symptoms with pregnancy 
outcomes were analyzed in each period of pregnancy, not taking urogenital symptoms 
in the other periods of pregnancy into account. Secondly, urogenital symptoms were 
reclassifi ed in having symptoms in only early, only mid-, only late or in multiple periods 
of pregnancy. This was performed to examine whether associations with pregnancy out-
comes are explained by having urogenital symptoms in one period only or in multiple 
periods during pregnancy. These analyses were assessed in mothers of whom data on 
urogenital symptoms was available in all three periods of pregnancy (n=5,554). The sta-
Table 1. Maternal and infant characteristics.
Single live births*
Boys 
(n=4120)
Girls 
(n=4049)
Age (years) 29.8 (5.3) 29.7 (5.2)
Ethnicity (%)
Dutch 50.0 50.7
Capeverdean 3.7 4.3
Antillean 3.4 3.5
Surinamese 9.3 8.6
Moroccan 6.8 6.4
Turkish 9.2 8.8
Other western 11.6 11.6
Other (non-) western 6.0 6.3
Education (%)
Primary school 12.3 13.2
Secondary school 45.1 44.7
Higher education 42.7 42.1
Smoking (%)
Never 74.3 76.4
Until pregnancy was known 7.2 7.7
Continued 18.6 15.9
Nulliparae (%) 55.9 57.6
Birth weight (grams) 3476 (635) 3353 (538)
Gestational age (weeks)† 40.1 (36.9-42.1) 40.1 (37.0-42.0)
Values are means (standard deviation) or percentages. †Median (5-95% range). 
*Data were missing on ethnicity (n=589), education (n=830), smoking (n=44) and parity (n=226).
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tistical analyses were performed using the Statistical Package of Social Sciences version 
11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Subject characteristics
Characteristics of the mothers and their infants are presented in Table 1. The age of 
mothers at enrolment ranged from 15.3 to 46.3 years (mean 29.7 years). Of all mothers, 
those of Dutch, Surinamese, Moroccan and Turkish origin and those with a secondary or 
higher education were most present. Of the mothers, 17.3% continued smoking during 
pregnancy and 56.7% were nulliparae. Mean birth weight was higher in boys than girls 
(3476 versus 3353 grams). No diff erences in gestational age between boys and girls were 
observed.
Vaginal bleeding during pregnancy was present varying from 15.8% in early preg-
nancy to 6.1% in late pregnancy (Table 2). Other vaginal and urinary tract symptoms 
ranged from 64% to 73.5% and 75.5% to 80.2% in early and late pregnancy, respectively. 
Maternal and infant characteristics and prevalence of urogenital symptoms did not 
diff er between mothers with data in early pregnancy (n=7,411), mid-pregnancy (n=6,910), 
late pregnancy (n=6,642) and mothers of whom data were available in all three periods 
of pregnancy (n=5,554). 
Urogenital symptoms and pregnancy outcomes
Mothers with vaginal bleeding, other vaginal or urinary tract symptoms in early pregnan-
cy, did not show a diff erence in continuously measured birth weight or low birth weight, 
compared to mothers who did not had these symptoms (Table 3). However, mothers 
with vaginal bleeding in early pregnancy showed a higher risk of preterm birth, adjusted 
for age, education, ethnicity, smoking and parity (aOR 1.38 (95% confi dence interval 
(95% CI) 1.06, 1.81)). In mid- pregnancy, vaginal bleeding was associated with low birth 
Table 2. Prevalences of urogenital symptoms in early, mid- and late pregnancy.
Urogenital symptoms (%)*
Vaginal bleeding Other vaginal symptoms Urinary tract symptoms
Early pregnancy (n=7,411) 15.8 64.0 75.5
Mid- pregnancy (n=6,910) 7.5 68.4 77.6
Late pregnancy (n=6,642) 6.1 73.5 80.2
Values are percentages. 
*Data on symptoms were missing in:
Early pregnancy: vaginal bleeding (n=33), other vaginal symptoms (n=121) and urinary tract symptoms (n=82). 
Mid- pregnancy: vaginal bleeding (n=19), other vaginal symptoms (n=109) and urinary tract symptoms (n=86).Late 
pregnancy: vaginal bleeding (n=11), other vaginal symptoms (n=42) and urinary tract symptoms (n=18). 
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weight (aOR 1.41 (95% CI: 1.05, 1.91)). No other urogenital symptoms in mid-pregnancy 
were associated with adverse pregnancy outcomes. In late pregnancy, trends were found 
for vaginal bleeding, other vaginal and urinary tract symptoms with preterm birth with 
an aOR 1.49 (95% CI: 0.96, 2.33), 1.24 (95% CI: 0.92, 1.69) and 1.42 (95% CI: 0.99, 2.04), 
respectively. No associations of urogenital symptoms in late pregnancy with a diff erence 
in continuously measured birth weight or low birth weight were found. 
As for urogenital symptoms in only one period of pregnancy, mothers with urinary 
tract symptoms in only early pregnancy showed an association with low birth weight 
(aOR 2.39 (95% CI: 1.21, 4.72)) (Table 4). Mothers with vaginal bleeding only in mid-
pregnancy were associated with continuously measured birth weight (-93 grams (95% 
CI: -172, -14)). Vaginal bleeding only in late pregnancy increased the risk of preterm birth 
(aOR 1.94 (95% CI: 1.05, 3.59)). Other associations of urogenital symptoms in only one 
period of pregnancy with adverse pregnancy outcomes were not observed.
As for mothers with urogenital symptoms in multiple periods of pregnancy, vaginal 
bleeding or other vaginal symptoms in ≥ 2 periods of pregnancy were not related to 
adverse pregnancy outcomes. Mothers with urinary tract symptoms in ≥ 2 periods of 
pregnancy had a higher risk of low birth weight infants compared to mothers without 
urinary tract symptoms in ≥ 2 periods of pregnancy (aOR 1.71 (95% CI: 1.02, 2.88)). 
Table 3. Urogenital symptoms in early, mid- and late pregnancy and pregnancy outcomes.
Pregnancy outcomes
Diff erence in birth weight 
(grams (95% CI))
Low birth weight
(aOR (95% CI))
Preterm birth
(aOR (95% CI))
Early pregnancy
Vaginal bleeding -2 (-30, 26) 1.10 (0.89, 1.36) 1.38 (1.06, 1.81)*
Other vaginal symptoms 12 (-10, 33) 0.90 (0.76, 1.07) 0.84 (0.67, 1.05)
Urinary tract symptoms -5 (-29, 19) 1.09 (0.89, 1.33) 1.00 (0.76, 1.29)
Mid- pregnancy
Vaginal bleeding -27 (-70, 15) 1.41 (1.05, 1.91)* 1.36 (0.90, 2.05)
Other vaginal symptoms 15 (-9, 39) 0.90 (0.74, 1.09) 0.92 (0.71, 1.20)
Urinary tract symptoms -5 (-32, 22) 1.06 (0.84, 1.33) 1.28 (0.92, 1.77)
Late pregnancy
Vaginal bleeding -38 (-85, 9) 1.19 (0.82, 1.69) 1.49 (0.96, 2.33)
Other vaginal symptoms -4 (-32, 25) 0.92 (0.75, 1.14) 1.24 (0.92, 1.69)
Urinary tract symptoms 16 (-10, 41) 1.06 (0.83, 1.36) 1.42 (0.99, 2.04)
Reference for each type of symptom is the group of pregnant women without that specifi c symptom.
Values are regression coeffi  cients (95% confi dence interval (CI)) or odds ratio’s (OR (95% CI)), adjusted for maternal age, 
education, ethnicity, smoking and parity. Birth weight was additionally adjusted for gestational age.
*p-value <0.05.
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Discussion
This prenatally enrolled birth-cohort study showed that mothers with vaginal bleeding 
in late pregnancy have an increased risk of preterm birth. Other vaginal symptoms of 
mother in any period of pregnancy did not aff ect birth weight or gestational age of the 
infants. Mothers with urinary tract symptoms in early or in multiple periods of pregnancy 
had an increased risk of delivering a low birth weight infant. Having urinary tract symp-
toms in mid- or late pregnancy was weakly associated with low birth weight. 
The strength of this study is the population-based cohort with a large number of 
subjects with data on urogenital symptoms in diff erent periods of pregnancy, informa-
tion about a large number of potential confounders and a high follow-rate until birth 
(97%). Because of the large sample size and the high prevalence of the diverse urogenital 
symptoms, we were able to study the association of these symptoms with pregnancy 
outcomes in single or multiple periods of pregnancy separately. 
Accounting for having vaginal bleeding in multiple periods of pregnancy, the overall 
prevalence of vaginal bleeding during pregnancy in our study (21.8%) was similar to that 
Table 4. Urogenital symptoms present in only one period or in multiple periods of pregnancy and pregnancy 
outcomes.
Pregnancy outcomes
Diff erence in birth weight 
(grams (95% CI))
Low birth weight
(aOR (95% CI))
Preterm birth
(aOR (95% CI))
Early pregnancy only
Vaginal bleeding 4 (-33, 41) 0.92 (0.68, 1.26) 1.10 (0.73, 1.65)
Other vaginal symptoms 3 (-65, 70) 1.12 (0.67, 1.89) 0.63 (0.26, 1.52)
Urinary tract symptoms -70 (-142, 3) 2.39 (1.21, 4.72)* 0.81 (0.32, 2.05)
Mid- pregnancy only
Vaginal bleeding -93 (-172, -14)* 1.64 (0.96, 2.81) 0.96 (0.38, 2.38)
Other vaginal symptoms 12 (-69, 92) 0.89 (0.45, 1.75) 0.67 (0.23, 1.93)
Urinary tract symptoms -27 (-111, 58) 1.86 (0.85, 4.09) 1.05 (0.39, 2.81)
Late pregnancy only
Vaginal bleeding -55 (-127, 16) 0.93 (0.53, 1.65) 1.94 (1.05, 3.59)*
Other vaginal symptoms 33 (-24, 89) 1.05 (0.67, 1.17) 1.43 (0.81, 2.51)
Urinary tract symptoms -46 (-114, 21) 1.69 (0.86, 3.33) 0.62 (0.25, 1.56)
≥ 2 periods of pregnancy 
Vaginal bleeding -10 (-61, 42) 1.15 (0.77, 1.73) 1.25 (0.73, 2.16)
Other vaginal symptoms 25 (-9, 59) 0.99 (0.67, 1.17) 0.95 (0.6, 1.40)
Urinary tract symptoms -29 (-75, 17) 1.71 (1.02, 2.88)* 1.07 (0.61, 1.88)
Reference for each type of symptom is the group of pregnant women without that specifi c symptom.
Values are regression coeffi  cients (95% confi dence interval (CI)) or odds ratio’s (OR (95% CI)), adjusted for maternal age, 
education, ethnicity, smoking and parity. Birth weight was additionally adjusted for gestational age.
*p-value <0.05.
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found in other cohort studies (15-24.4%) [19-21]. According to the association of vaginal 
bleeding and adverse pregnancy outcomes, former studies found relative risk estimates 
between 0.3 to 6.4 for vaginal bleeding and preterm birth and risk estimates between 1.6 
to 3.0 for vaginal bleeding and low birth weight [22-26]. However, in these studies neither 
diff erent periods of bleeding in pregnancy independent from each other nor low birth 
weight adjusted for gestational age were studied. One similar study assessed the sepa-
rate eff ects of vaginal bleeding in diff erent trimesters and showed that vaginal bleeding 
in fi rst trimester only led to a higher risk of 1.6 for preterm birth < 34 weeks, but not of 
preterm birth <37 weeks [19]. Our study replicated the latter conclusion and addition-
ally, we found that vaginal bleeding in only late pregnancy was associated with preterm 
birth. Risk estimates of vaginal bleeding and low birth weight found in earlier studies 
probably refl ect the underlying eff ect of gestational age, since in our study no eff ect of 
vaginal bleeding in any period of pregnancy was seen for gestational age adjusted low 
birth weight.
Not fi nding an association of other vaginal symptoms with adverse pregnancy out-
comes could be accounted to the fact that not all of the assessed symptoms are specifi c 
enough for infections like vaginal candidiasis, bacterial vaginosis or vaginal trichomonia-
sis which increase the risk of preterm birth or low birth weight [27]. Furthermore, vaginal 
symptoms could also imply normal, physiological pregnancy induced changes of the 
vagina. 
Studies that examined urinary tract infections or asymptomatic bacteriuria in preg-
nancy, showed a high rate of low birth weight and preterm birth [28, 29]. Screening and 
treating of bacteruria in early pregnancy has been recommended to prevent adverse 
pregnancy outcomes [30, 31]. Our lack of associations between urinary tract symptoms, 
a proxy for urinary tract infection, with preterm birth may be explained by treatment 
of underlying tract infections. However, associations of urinary tract symptoms in only 
early pregnancy and present in multiple periods of pregnancy with low birth weight 
were observed. A pathophysiological mechanism could be that urinary tract infections 
lead to irreversible placental changes leading to inadequate supply of nutrients to the 
fetus. This would subsequently lead to fetal growth retardation and low birth weight. This 
hypothesis is supported by animal models that demonstrated that urinary tract infected 
mice (E. Coli Dr+) had a reduction of fetal birth weight and massive bacterial infi ltration of 
the placenta, causing increased infl ammation with a reduction of the placental villi [32]. 
This implies a diff erent mechanism than that leading to preterm birth, including cytokine 
induced prostaglandin synthesis leading to uterine contractions, cervical dilatation and 
greater entry of microbes into the uterine cavity [33]. 
Some methodological issues ought to be considered. Data on urogenital symptoms 
in any period during pregnancy was missing in 5% of the participating mothers. No dif-
ference in prevalence of low birth weight or preterm birth was present between those 
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with and without data on urogenital symptoms during pregnancy (low birth weight 
10.1% and 11.7% (χ2-test, p-value 0.317); preterm birth 5.1% and 6.2% (χ2-test, p-value 
0.316), respectively). Furthermore, infants of whom data on birth weight and gestational 
age was missing were as much from mothers who had urogenital symptoms as from 
mothers who had no urogenital symptoms (3.2% and 4% (χ2-test, p-value 0.390), respec-
tively). Therefore it is unlikely that the observed association of urogenital symptoms and 
pregnancy outcomes were a result of selection bias. 
Information about urogenital symptoms of mother in diff erent periods of pregnancy 
was prospectively collected by questionnaires without reference to the pregnancy out-
comes. Using self-reported urogenital symptoms may have introduced misclassifi cation 
because of over- or underreporting of urogenital symptoms in pregnancy. Previous stud-
ies suggested for example that early vaginal bleeding could be unintentionally reported 
as last menstrual period bleeding, consequently leading to a lower estimated gestational 
age and an increased association of vaginal bleeding and preterm birth [20, 26]. Since in 
our study gestational age in all women was established by ultrasound examination at 
enrolment, misclassifi cation of preterm birth seems unlikely. In late pregnancy, vaginal 
bleeding might be caused as well by infections as by structural placental abnormalities 
which are also associated with preterm birth [34]. Therefore, the reported association 
between vaginal bleeding in late pregnancy and preterm birth could probably partly be 
explained by pregnancies complicated with these placental abnormalities. 
Our fi ndings suggest that vaginal bleeding in late pregnancy increases the risk of 
preterm birth and urinary tract symptoms in early or present in multiple periods of preg-
nancy increase the risk of low birth weight. The exact underlying pathogens or other 
non-infectious causes regarding the association of vaginal bleeding and urinary tract 
symptoms with adverse pregnancy outcomes need to be explored. Screening on these 
urogenital symptoms might contribute to primary prevention of these adverse preg-
nancy outcomes.
References
1. Steer P. The epidemiology of preterm labor--a global perspective. J Perinat Med. 2005;33(4):273-6.
2. Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002 Nov 9;360(9344):1489-97.
3. Kramer MS. The epidemiology of adverse pregnancy outcomes: an overview. J Nutr. 2003 May;133(5 
Suppl 2):1592S-6S.
4. Langhoff -Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm deliv-
ery in primiparous women at low risk in Denmark: population based study. Bmj. 2006 Apr 
22;332(7547):937-9.
5. Stoelhorst GM, Rijken M, Martens SE, Brand R, den Ouden AL, Wit JM, et al. Changes in neonatol-
ogy: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On 
Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 
1996-1997. Pediatrics. 2005 Feb;115(2):396-405.
Liesbeth BW 16-4.indd   51 24-Apr-08   12:05:19 PM
52
Ch
ap
te
r 2
.2
6. Davidoff  MJ, Dias T, Damus K, Russell R, Bettegowda VR, Dolan S, et al. Changes in the gestational age 
distribution among U.S. singleton births: impact on rates of late preterm birth, 1992 to 2002. Semin 
Perinatol. 2006 Feb;30(1):8-15.
7. Goldenberg RL, Culhane JF, Johnson DC. Maternal infection and adverse fetal and neonatal out-
comes. Clin Perinatol. 2005 Sep;32(3):523-59.
8. Pararas MV, Skevaki CL, Kafetzis DA. Preterm birth due to maternal infection: Causative pathogens 
and modes of prevention. Eur J Clin Microbiol Infect Dis. 2006 Sep;25(9):562-9.
9. Nelson DB, Macones G. Bacterial vaginosis in pregnancy: current fi ndings and future directions. Epi-
demiol Rev. 2002;24(2):102-8.
10. French JI, McGregor JA, Draper D, Parker R, McFee J. Gestational bleeding, bacterial vaginosis, and 
common reproductive tract infections: risk for preterm birth and benefi t of treatment. Obstet Gyne-
col. 1999 May;93(5 Pt 1):715-24.
11. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 
2000 May 18;342(20):1500-7.
12. Witkin S, McGregor JA. Infection-induced activation of cell-mediated immunity: possible mechanism 
for preterm birth. Clin Obstet Gynecol. 1991 Mar;34(1):112-21.
13. Hofman A, Jaddoe VW, Mackenbach JP, Moll HA, Snijders RF, Steegers EA, et al. Growth, develop-
ment and health from early fetal life until young adulthood: the Generation R Study. Paediatr Perinat 
Epidemiol. 2004 Jan;18(1):61-72.
14. Jaddoe VW, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Verhulst FC, et al. The Generation R 
Study: Design and cohort profi le. Eur J Epidemiol. 2006;21(6):475-84.
15. Tunon K, Eik-Nes SH, Grottum P. A comparison between ultrasound and a reliable last menstrual 
period as predictors of the day of delivery in 15,000 examinations. Ultrasound Obstet Gynecol. 1996 
Sep;8(3):178-85.
16. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P. An update of the Swedish 
reference standards for weight, length and head circumference at birth for given gestational age 
(1977-1981). Acta Paediatr Scand. 1991 Aug-Sep;80(8-9):756-62.
17. Standaard onderwijsindeling 2003. Voorburg/Heerlen: Statistics Netherlands; 2004.
18. Allochtonen in Nederland 2004. Voorburg/Heerlen: Statistics Netherlands; 2004.
19. Yang J, Hartmann KE, Savitz DA, Herring AH, Dole N, Olshan AF, et al. Vaginal bleeding during preg-
nancy and preterm birth. Am J Epidemiol. 2004 Jul 15;160(2):118-25.
20. Axelsen SM, Henriksen TB, Hedegaard M, Secher NJ. Characteristics of vaginal bleeding during preg-
nancy. Eur J Obstet Gynecol Reprod Biol. 1995 Dec;63(2):131-4.
21. Ananth CV, Savitz DA. Vaginal bleeding and adverse reproductive outcomes: a meta-analysis. Pae-
diatr Perinat Epidemiol. 1994 Jan;8(1):62-78.
22. Funderburk SJ, Guthrie D, Meldrum D. Outcome of pregnancies complicated by early vaginal bleed-
ing. Br J Obstet Gynaecol. 1980 Feb;87(2):100-5.
23. Berkowitz GS, Harlap S, Beck GJ, Freeman DH, Baras M. Early gestational bleeding and pregnancy 
outcome: a multivariable analysis. Int J Epidemiol. 1983 Jun;12(2):165-73.
24. Strobino B, Pantel-Silverman J. Gestational vaginal bleeding and pregnancy outcome. Am J Epide-
miol. 1989 Apr;129(4):806-15.
25. Harger JH, Hsing AW, Tuomala RE, Gibbs RS, Mead PB, Eschenbach DA, et al. Risk factors for preterm 
premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol. 1990 
Jul;163(1 Pt 1):130-7.
26. Yang J, Savitz DA. The eff ect of vaginal bleeding during pregnancy on preterm and small-for-gesta-
tional-age births: US National Maternal and Infant Health Survey, 1988. Paediatr Perinat Epidemiol. 
2001 Jan;15(1):34-9.
27. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. Jama. 2004 Mar 
17;291(11):1368-79.
Liesbeth BW 16-4.indd   52 24-Apr-08   12:05:19 PM
53Urogenital symptoms in diff erent periods of pregnancy and adverse birth outcomes
28. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship 
between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol. 1989 
Apr;73(4):576-82.
29. McGrady GA, Daling JR, Peterson DR. Maternal urinary tract infection and adverse fetal outcomes. 
Am J Epidemiol. 1985 Mar;121(3):377-81.
30. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 
2001(2):CD000490.
31. Vazquez JC, Villar J. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane 
Database Syst Rev. 2003(4):CD002256.
32. Kaul AK, Khan S, Martens MG, Crosson JT, Lupo VR, Kaul R. Experimental gestational pyelo-
nephritis induces preterm births and low birth weights in C3H/HeJ mice. Infect Immun. 1999 
Nov;67(11):5958-66.
33. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, et al. Infection and labor. V. Prevalence, 
microbiology, and clinical signifi cance of intraamniotic infection in women with preterm labor and 
intact membranes. Am J Obstet Gynecol. 1989 Sep;161(3):817-24.
34. Salafi a CM, Lopez-Zeno JA, Sherer DM, Whittington SS, Minior VK, Vintzileos AM. Histologic evi-
dence of old intrauterine bleeding is more frequent in prematurity. Am J Obstet Gynecol. 1995 
Oct;173(4):1065-70.
Liesbeth BW 16-4.indd   53 24-Apr-08   12:05:19 PM
Liesbeth BW 16-4.indd   54 24-Apr-08   12:05:19 PM
Infectious diseases in infancy
3
Liesbeth BW 16-4.indd   55 24-Apr-08   12:05:19 PM
Liesbeth BW 16-4.indd   56 24-Apr-08   12:05:20 PM
Breastfeeding protects against infectious 
diseases during infancy in industrialized 
countries. A systematic review.
3.1
Liesbeth BW 16-4.indd   57 24-Apr-08   12:05:20 PM
58
Ch
ap
te
r 3
.1
 Abstract 
Objective: This review was performed to assess the eff ect of breastfeeding against infec-
tious diseases during infancy in industrialized countries. Secondly, the eff ect of duration 
and exclusiveness of breastfeeding were explored.
Method: Studies were identifi ed using Medline, Cochrane Library, Science Citation Index, 
and by a manual search from bibliographies of articles from August 1986 until January 
2008. Follow-up and case control studies performed in an industrialized country, pub-
lished in English, with overall infections, gastrointestinal or respiratory tract infections as 
a major outcome, and at least 40 subjects in the study were included. Using Bauchner’s 
criteria published in a review in 1986, two reviewers and a peer reviewer assessed the 
internal validity of those studies. 
Results: Twenty-one studies that met the inclusion and internal validity criteria were 
included. These included fi ve case controls and sixteen follow-up studies. Four out of fi ve 
studies observed decreased eff ects on overall infections in breastfed infants. With regard 
to gastrointestinal infections, fi ve out of seven studies suggested that breastfeeding had 
a protective eff ect. Thirteen out of fi fteen studies concluded that breastfeeding protects 
infants against respiratory tract infections. Five studies combined duration and exclusive-
ness of breastfeeding. All studies observed a protective dose/duration-response eff ect 
on gastrointestinal or respiratory tract infections.
Conclusions: These studies strongly suggest that breastfeeding protects infants against 
overall infections, gastrointestinal and respiratory tract infections in industrialized coun-
tries. The optimal duration of exclusive breastfeeding for protection against infectious 
diseases needs to be studied in more detail.
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Introduction
The World Health Organization recommends mothers to breastfeed their infants, due 
to an accumulating evidence of the breastfeeding’s benefi ts in growth, development 
and health (2). There are several mechanisms explaining how human milk can protect 
infants from infectious diseases. Human milk has secretory IgA antibodies which react 
on microbes in the infant’s mucosa by inducing an infl ammatory response consequently 
preventing infection, tissue engagement and energy loss (3, 4). Human milk also con-
tains other protective factors like lactoferrin and oligosaccharides, functioning as the 
analogues for microbial receptors and thus preventing from mucosa attachment (3-5). 
Furthermore, the transfer of numerous cytokines and growth factors via milk may add 
to an active stimulation of the infant’s immune system (3). Consequently, the risks of 
infections like gastrointestinal infections, otitis media, other respiratory tract infections, 
and infection-induced wheezing may be reduced for several years after the termination 
of breastfeeding (3). 
In developing or low income countries, it has been repeatedly shown that breast-
feeding has a protective eff ect especially against two major infectious diseases in infancy, 
gastrointestinal and respiratory tract infections (1). On the contrary, research results were 
often confl icting in developed or industrialized countries, where overall sanitation and 
health care are better (6, 7). These confl icting result may be due to methodological fl aws 
suggested by Bauchner et al. in 1986 and include failure to prevent from detection bias, 
failure to control for confounding variables, non-blind assessment, failure to control for 
reverse causality, small samples sizes, and lack of precision in specifying the categories 
of feeding and health outcomes (7). In Europe and the United States, the incidences of 
breastfeeding showed an increasing trend after the eighties (8-10). However, more than 
half of the mothers who initially start breastfeeding stop before the infants reach the age 
of six months (9-12). 
This review was performed to assess the eff ect of breastfeeding on the risks of overall 
infections, gastrointestinal and respiratory tract infections during infancy in industrial-
ized countries, using studies started after the publication of the article of Bauchner et al. 
Secondly, the duration and exclusiveness of breastfeeding were taken into account.
Methods
Articles were searched using medical databases, namely Medline, Cochrane Library, and 
Science Citation Index. Secondary references were scanned from the bibliographies of 
each article on breastfeeding and infection and relevant studies were obtained. The key-
words used were: breastfeeding, breast milk; infant; gastrointestinal infection, respira-
Liesbeth BW 16-4.indd   59 24-Apr-08   12:05:20 PM
60
Ch
ap
te
r 3
.1
tory tract infection, infectious diseases; developed, western or industrialized countries; 
and combinations of those terms. The last search was performed in January 2008. 
Inclusion criteria were as follows: the article had to be written in English and pub-
lished after 1986, the year in which the review of Bauchner et al was published; the study 
design had to be case control or follow-up study and the study had to be performed in 
an industrialized country. An industrialized country was defi ned as a country that the 
World Bank considered to have a high income. In January 2008 this income applied to 
60 countries, mostly in Western and Northern Europe, Northern America, Australia, and 
some Asian countries (www.worldbank.org/data/countryclass/classgroups.htm#High_
income). Furthermore, breastfeeding had to be at least one of the determinants and 
overall infections, gastrointestinal or respiratory tract infections had to be one of the 
major outcomes. The study also had to have a total of at least 40 subjects, since studies 
with smaller sample sizes are likely to have inadequate statistical power (7). Two review-
ers screened the abstracts on the above criteria. For further analysis, both reviewers inde-
pendently read the articles obtained by all methods. Diff erences in opinion between the 
reviewers were proposed to a third reviewer and discussed to get consensus. 
Based on the search, twenty-six studies met the inclusion criteria for further analysis. 
After inclusion, the internal validity of those studies were assessed using Bauchner’s cri-
teria (7): (1) avoidance of detection bias, (2) adjustment for confounding variables, such 
as socioeconomic status, size of the family, smoking by the mother, and the mother’s 
level of education, (3) a defi nition of outcome events, and (4) a defi nition of infant feed-
ing (7). Studies that met at least three criteria were included and twenty-one articles 
matched those pre-specifi ed criteria. From those valid studies, fi ve were case control and 
sixteen were follow-up studies. We categorized those studies according to the outcome 
measured (Table 1). There were eleven studies which met four criteria, and ten studies 
which met three of the internal validity criteria.
Results
Breastfeeding and overall infections 
A limited number of articles that studied overall infectious morbidity as the outcome 
was found.
Leventhal et al (13) found that breastfeeding protects infants from hospitalization 
rather than from infections (Table 1). The protective eff ect of breastfeeding in their study 
was substantially diminished when the data were stratifi ed according to the severity of 
infections, in order to minimize the potential surveillance bias. They ended up with an 
odds ratio of 0.79 (95% confi dence interval: 0.47 to 1.32) for infants with serious infec-
tions and an odds ratio 0.17 (0.03, 0.44) for infants with mild infections. Another study 
Liesbeth BW 16-4.indd   60 24-Apr-08   12:05:20 PM
61Breastfeeding protects against infectious diseases during infancy in industrialized countries. A systematic review
came from Beaudry et al (14) which found that the Incidence Density Ratio (IDR) for all 
infections in infants from 0-6 months of age was 0.67 (0.54,0.82). However, they did not 
control for potential confounders for this relation. 
Recent studies that adjusted for confounders showed that infants with a shorter 
breastfeeding duration had higher risks of infections or illnesses that required a doctor 
or hospital admission (15-17).
Breastfeeding and gastrointestinal infections
Seven studies had gastrointestinal infections (e.g. gastroenteritis, diarrhea, vomiting) as 
the outcome measured (Table 1). From those studies, fi ve studies suggested a protec-
tive eff ect of breastfeeding, which varied according to the duration and exclusiveness 
of breastfeeding. Howie et al (18) found that babies breastfed for 13 weeks or more had 
signifi cantly less gastrointestinal infections at the age of 0 to 13 weeks (p<0.01; reduction 
in incidence 6.6%-16.8%), at 14 to 26 weeks (p<0.05), at 27 to 39 weeks (p<0.05) and at 
40 to 52 weeks (p<0.05), than those who were bottle fed from birth. Infants who were 
breastfed less than 13 weeks had a similar rate of gastrointestinal infections as bottle fed 
infants. Dewey et al (19) found that during the fi rst year of life, the incidence of gastroin-
testinal infections among formula fed infants was approximately twice that of breastfed 
infants, even after controlling for day care use and number of siblings. Scariati et al (20) 
concluded that, after adjusting for potential confounders, the risk of gastrointestinal 
infections remained signifi cant between infants who received no breast milk compared 
with those who received only breast milk (OR 1.8, p<0,05). Compared with infants exclu-
sively breastfed for 3 months, Kramer et al (21) showed a reduced risk for gastrointestinal 
infections at age 3 to 6 months in infants exclusively breastfed for 6 months (IDR 0.35 
(0.13, 0.96). This reduced risk was not observed for gastrointestinal infections at the age 
of 6 to 12 months. Quigley et al (22) found a protective eff ect for diarrhea in the fi rst 8 
months of life in infants exclusively breastfed (OR 0.37 (0.18, 0.78)). 
Two studies did not observe a protective eff ect of breastfeeding were from Beaudry 
et al and Rubin et al (14, 23). The fi rst study concluded that breastfeeding was protective 
against gastrointestinal infections during the fi rst 6 months of life (Incidence Density 
Ratio (IDR) 0.53 (95% CI 0.27-1.04). However, after adjusting per potential confounders 
(socioeconomic status, infant’s age, mother’s age or maternal cigarette consumption) the 
IDR’s mostly became non signifi cant. The latter study observed no substantial protective 
eff ect of breastfeeding against gastrointestinal infections, with an adjusted IDR of 1.07 
(0.98, 1.23).
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Breastfeeding and respiratory tract infections
Fifteen studies were included with respiratory tract infections or illnesses, including 
upper respiratory tract infections, lower respiratory tract infections and otitis media, as 
the outcomes (Table 1).
Howie et al (18) discovered a signifi cant reduction of respiratory tract infections at 
ages 0 to 13 weeks and 40 to 52 weeks if the infants were breastfed for 13 weeks or more, 
compared to infants never breastfed. In this study, they did not diff erentiate between 
upper or lower respiratory tract infection. Holberg et al (24) studied 1,179 infants in the 
US. They observed that the relative risk of having Respiratory Syncytial Virus-lower respi-
ratory tract infections (RSV) between 1 and 3 months old infants increased from 5.6 (2.00, 
15.30) to 8.0 (2.80, 22.80). The increase was observed when minimal breastfeeding and 
other confounders (≥ 2 people sharing the same room with the child, maternal education 
≤ 12 years) were included in the model. At older ages, breastfeeding did not signifi cantly 
aff ect the relative risk for RSV infections. Furthermore in the US, Duncan et al (25), con-
cluded that exclusive breastfeeding of 4 or more months protected infants from single 
and recurrent episodes of otitis media. In their studies, infants exclusively breastfed for 4 
or more months had half of the mean number of acute otitis media episodes than those 
who were not breastfed at all. Furthermore, those infants had 40% less acute otitis media 
than those infants whose diets were supplemented with other foods before 4 months. 
Aniansson et al (26) studied 448 children and observed that the frequency of acute otitis 
media was signifi cantly lower in breastfed infants than in non-breastfed infants in each 
age group. The fi rst acute otitis media episode occurred signifi cantly earlier in children 
who were weaned before 6 months of age than in the remaining groups. 
In Italy, Pisacane et al (27) studied 74 cases and 88 controls and found that infants 
with a pneumonia or bronchiolitis were less likely to have been breastfed until admission 
(OR 0,22 (0.09, 0.55)). Severely ill infants were less breastfed than those with mild illness-
es. Nevertheless, in the pertussis group, they found no protective eff ect of breastfeeding. 
They concluded that breastfeeding has a strong protective eff ect against acute lower 
respiratory tract infections in industrialized countries. As one of the outcome in their 
study, Beaudry et al (14) studied respiratory tract infections (including upper respiratory 
tract infections, lower respiratory tract infections and otitis media) and found that after 
adjustment for age of the infant, socioeconomic status, maternal age, and cigarette con-
sumption, the incidence density ratio was 0.78 (0.61, 1.00). It is borderline signifi cant, but 
we may suggest that there is a protective eff ect of breastfeeding against respiratory tract 
infections. In the USA, Dewey et al (19) concluded that in the fi rst year of life, the percent-
age of otitis media was 19% lower and the prolonged episodes of otitis media (>10 days) 
was 80% lower in breastfed compared with formula fed infants. Except for otitis media, 
there were no signifi cant diff erences in rates of respiratory tract infections. In their study, 
Cushing et al (28) found that, after adjustment for important confounders, breastfeeding 
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did not have a signifi cant eff ect on the risk of total respiratory tract infections or upper 
respiratory tract infections. Full breastfeeding was associated with a signifi cant reduction 
in risk of lower respiratory tract infections, OR 0.79 (0.67, 0.91). In addition, breastfeeding 
signifi cantly reduced the duration of respiratory tract infections. 
In Greenland, Koch et al (29), studied several risk factors for respiratory tract infec-
tions in children less than 2 years of age. Compared with children who were exclusively 
breastfed, partly or never breastfed children had a higher risk of lower respiratory tract 
infections, OR 2.98 (0.91, 9.71) and 3.66 (1.06, 12.6), respectively. Although a tendency 
of protective eff ect for lower respiratory tract infections was seen, the association for 
partly breastfeeding was not signifi cant in the fi nal model. Oddy et al (30) concluded 
that predominant breastfeeding for at least 6 months and partial breastfeeding for up 
to one year might reduce the prevalence and subsequent morbidity of respiratory tract 
infections in infancy. They found that hospital, doctor, or clinic visits for four or more 
upper respiratory tract infections were signifi cantly higher if predominant breastfeeding 
was stopped before 2 months or partial breastfeeding was stopped before 6 months. 
Compared with neonates only fed with formula, Sinha et al (31) observed that exclusive 
breastfeeding was inversely associated with neonatal respiratory tract infections among 
neonatal girls (OR 0.5, 95% CI 0.29-0.79) but not among neonatal boys (OR 1.1, 95% CI 
0.64-2.00), after adjustment for confounders. Mixed feeding also showed a protective 
eff ect on neonatal respiratory tract infections, again only in neonatal girls (OR 0.6, 95% 
CI 0.34-0.93). Infants fully breastfed for 4 to 6 months had higher risks for pneumonia or 
recurrent OM, compared with infants fully breastfed ≥ 6 months (OR 4.27 (1.27, 14.35) 
and OR 1.95 (1.06, 3.59)), according to Chantry et al (32). Associations of breastfeeding 
with recurrent upper respiratory tract infections or wheezing were not found. Quigley 
et al (22) found a protective eff ect of exclusive breastfeeding on lower respiratory tract 
infections (OR 0.66 (0.47, 0.91). Furthermore, per month shorter breastfeeding, an OR of 
1.46 (1.19, 1.80) was observed for lower respiratory tract infections at the age of 1 to 4 
months, and an OR of 1.12 (1.00, 1.27) for lower respiratory tract infections at the age of 
5 to 7 months.
In line with the other fi ndings in their study, Rubin et al (23) did not fi nd any signifi -
cant relation between breastfeeding and upper respiratory tract illnesses. The adjusted 
incidence density ratio was 0.98 (95% CI 0.88-1.10). Kramer et al found (21) no associa-
tions between episodes of respiratory tract infections, upper respiratory tract infections, 
hospitalisation for respiratory tract infections or otitis media and duration of exclusive 
breastfeeding (< 3 months versus ≥ 6 months).
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Duration and exclusiveness of breastfeeding and infections 
Of all studies included in our study, several assessed the eff ects of exclusiveness, others 
the duration and some the combination of duration and exclusiveness of breastfeeding 
on infectious diseases (Table 1).
Compared with exclusive breastfeeding, Holberg and Koch observed higher risks 
of RSV-lower respiratory tract infections and respiratory tract infections, respectively, if 
infants who were not breastfed (24, 29). They found no diff erence in these outcomes in 
infants who were partially breastfed. Scariati et al (20) found a dose-response eff ect when 
each feeding group (breast milk only, high mixed, middle mixed, low mixed) was com-
pared with infants who received breast milk only (reference group), even after adjusting 
for confounders. There was a small, but steady increase in the risk of developing gas-
trointestinal infections as the amount of breast milk that an infant received decreased. 
They also observed the similar phenomenon when assessing the eff ect of feeding on 
otitis media. Compared with never breastfed infants, exclusively breastfed infants had 
lower risks of lower respiratory tract infections (28), neonatal respiratory tract infections 
(only girls (31)), respiratory tract infections and gastrointestinal infections (22). Except in 
the study of Sinha et al (31), no protective eff ects of partial breastfeeding on the major 
infectious diseases were seen. 
According to the duration of breastfeeding, Pettigrew et al (16) observed a 4% 
increase of illnesses requiring a health care provider, per week longer breastfeeding of 
fi rst born children. Infants admitted for all sort of causes or for fever of unknown origin 
had been breastfed for a shorter period, as shown by a study of Pardo-Crespo et al (15). 
Howie et al (18) found a signifi cant protective eff ect against gastrointestinal and respira-
tory tract infections if the infants were breastfed for more than 13 months (full or partial) 
compared to those who were bottle fed since birth. Per month shorter breastfeeding, 
the risk of diarrhea and lower respiratory tract infections at the age of 1 to 4 months 
increased, as did the risk of lower respiratory tract infections at the age of 5 to 7 months, 
observed by Quigley et al (22).
Some studies combined the exclusiveness and duration of breastfeeding, like Dun-
can et al (25), who used the categories of no breastfeeding, less than 4 months, 4 to 
6 months, and longer than 6 months. From both birth to 6 months of age and from 6 
months to 12 months, the mean number of episodes of acute otitis media decreased 
signifi cantly with increasing duration and exclusivity of breastfeeding. Oddy et al found 
that predominantly breastfeeding less than 2 months increased the risk of upper respira-
tory tract infections with 1.43 (1.02, 2.01), compared with infants predominantly breast-
fed for > 2 months. If infants were exclusively breastfed less than 4 months, they had 
an increased risk of hospitalization for an infections, compared with infants exclusively 
breastfed for ≥ 4 months, according to Paricio-Talayero et al (17). Compared with infants 
exclusively or fully breastfed for ≥ 6 months, risks for respiratory tract infections were 
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not diff erent (Kramer et al (21)) or increased (Chantry et al (32)) in infants exclusively 
breastfed for 3 months or fully breastfed for 4 to 6 months, respectively. 
Discussion
With the improvement of the general quality of recent studies on breastfeeding and infec-
tious diseases in industrialized countries, the positive protective eff ects of breastfeed-
ing seem to be clear. It is has been consistently shown that breastfeeding is protective 
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Figure 1. Associations of diff erent types of feeding with overall, gastrointestinal or respiratory tract infections in 
industrialized countries.
Odds ratio (OR ♦), Incidence Density Ratio (IDR {), Hazard Ratio (HR ), or Relative Risk (RR ◊) with their 95% 
confi dence intervals (95% CI). 
If breastfeeding was de reference group, 1/OR, 1/RR or 1/HR was used. Studies using diff erences in means or 
frequencies as eff ect estimates are not presented.
*No 95% confi dence interval was given. ** Mixed feeding versus bottle feeding.
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against infections, gastrointestinal and respiratory tract infections, even in industrialized 
countries (Figure 1).
Important reviews about the methodological fl aws in studies on breastfeeding were 
done by Kovar et al and Bauchner et al (7, 33). Their criteria are adequate for assessing 
validity, even though there are more aspects for assessing internal validity such as the 
presence of reverse causality, selection bias, and other types of information bias like non-
blind assessment (33). They concluded in their article that studies with important meth-
odological standards and controlling for confounding variables suggest that breastfeed-
ing has at least a minimal protective eff ect in industrialized countries (7). Our review, of 
studies taking their criteria into account, confi rms this suggestion, and are in line with 
former reviews around that time (6, 8, 30, 33-35)
The methods used for the study collection in this review led to a selection of only 
the high quality studies with minimal methodological imperfections. The use of Bauch-
ner’s criteria, to assess the study quality, limited the numbers of studies, but assured the 
high quality of all studies included. However, there are some limitations, including no 
representation of industrialized Asian countries in this review. One study from Asia was 
found, but did not meet our inclusion criteria for the validity of the study design (34). The 
use of only English literature also limited the range of studies included, and allowed for 
publication bias. In their review, Bauchner et al (7) found two studies that met all four of 
their criteria and four that met three criteria. In our review, eleven studies that met all 
four criteria and ten that met three criteria were found. All 15 studies controlled for at 
least one major confounder, such as socioeconomic status. From all twenty-one studies 
included, fi ve did not meet the fi rst criterion for active surveillance because they used 
mailed questionnaires that were only once being fi lled in (14, 16, 22, 30, 32). But, as oth-
ers stated in their article (14, 32), detection bias, which would modify their results, would 
probably underestimate the protective eff ect of breastfeeding. One study validated the 
questionnaires with hospital case notes in a subsample and concluded that 99% of the 
parental recall was valid (30). Furthermore, assessing infectious diseases by question-
naires is currently widely accepted in epidemiological studies, and reliably refl ect the 
true incidence of those infections (35). The outcomes of several studies included, used 
terminology that compose a mix of causes of the disease, such as gastrointestinal or 
respiratory illnesses that can consist of infectious or non-infectious etiology. This could 
dilute or exaggerate the real protective eff ect of breastfeeding against infections and 
should be prevented. 
The protection of human breast milk against gastrointestinal infections or illnesses 
was fi rst established in developing countries (36). It was suggested that the minimal 
morbidity due to gastrointestinal infectious diseases in infants in industrialized countries 
was not caused by the breastfeeding itself, but mostly because of the overall better qual-
ity of water, infant feeding, sanitation, and health care system (6, 37). From the studies 
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with gastrointestinal infections as the outcome fi ve out of seven studies suggested that 
breastfeeding had a protective eff ect against gastrointestinal infections. The qualities of 
those studies had a similar quality, carefully designed to avoid biases and consequently 
leading to inappropriate conclusions. One of the studies that did not support the oth-
ers had an extensive defi nition of doctor diagnosed-gastroenteritis, but relatively small 
number of subjects (23). Another study did observe an association of breastfeeding and 
gastrointestinal infections in the unadjusted, but not in the adjusted analyses (14). Over-
all, based on these studies we may conclude that human breast milk protects infants 
from gastrointestinal infections. 
Thirteen out of fi fteen studies concluded that breastfeeding protected infants 
against respiratory tract infections. However, not all studies separated infectious from 
non-infectious respiratory tract illnesses as their outcome since it is diffi  cult to distin-
guish between the infectious and non-infectious origin of respiratory tract illnesses 
during infancy. The protection seems to be diff erent against upper respiratory tract 
infections and lower respiratory tract infections. Therefore, it is necessary to diff erentiate 
between upper respiratory tract infections, lower respiratory tract infections and acute 
otitis media, instead of analyzing them under one entity (respiratory tract infections). 
Our fi ndings are in line with a meta-analysis, which observed on overall protective eff ect 
of breastfeeding and lower respiratory disease hospitalization in the fi rst two years of life 
(RR 0.28 (0.14, 0.54)), adjusted for smoking and socio-economic status (12). They did not 
diff erentiate between lower respiratory tract infections and asthma.
For the association between dose and duration of breastfeeding and its protec-
tion against infections, a positive correlation of the duration, the exclusiveness and 
the combination of duration and exclusiveness of breastfeeding with gastrointestinal 
and respiratory diseases were observed. This suggests a dose-response eff ect whereby 
a longer and more exclusive breastfeeding period leads to a better protection against 
infection diseases. However, the exact minimal duration of exclusive breastfeeding that 
still protects infants in industrialized countries against infectious diseases need to be 
further explored (8, 38, 39). The benefi ts and general applicability of 4 versus 6 months 
of exclusively breastfeeding are not completely clarifi ed, although the World Health 
Organization recommended in 2001 to exclusively breastfeed infants for 6 months in all 
countries (40).
We found an established protective association of breastfeeding with gastrointesti-
nal and respiratory tract infections. These fi ndings might be used to support the health 
policy in industrialized countries in order to promote breastfeeding as well for increasing 
the incidence and the duration of exclusive breastfeeding. However, the optimal dura-
tion of exclusive breastfeeding (4 or 6 months) for protection against infectious diseases 
needs to be further studied.
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Abstract
Objective: To examine the associations of duration of exclusive breastfeeding with upper 
respiratory tract infections (URTI), lower respiratory tract infections (LRTI) and gastroin-
testinal tract infections (GI) in infancy.
Methods: This study was embedded in the Generation R Study, a population-based pro-
spective cohort study from fetal life onwards in the Netherlands. Breastfeeding during 
the fi rst 6 months (never; partial < 4 months, not thereafter; partial 4-6 months; exclusive 
4 months, not thereafter; exclusive 4 months, partial thereafter; exclusive 6 months) and 
the occurrence of doctor-attended URTI, LRTI and GI until the age was 12 months were 
assessed by questionnaires and available in 4,164 subjects.
Results: Prolonged and exclusively breastfed infants had lower risks of URTI, LRTI and GI 
during the fi rst 6 months, and a lower risk of LRTI between the ages of 7 and 12 months 
(p-values for trend < 0.01). Compared to never breastfed infants, those who were breast-
fed exclusively until 4 months and partially thereafter, had lower risks of URTI, LRTI and GI 
until the age of 6 months (adjusted odds ratio (aOR) 0.65 (95% confi dence interval: 0.51 
to 0.83), aOR 0.50 (0.32, 0.79) and aOR 0.41 (0.26, 0.64), respectively) and of LRTI between 
7 and 12 months (aOR 0.46 (0.31, 0.69)). Similar tendencies were observed for infants 
exclusively breastfed ≥ 6 months. 
Conclusions: Prolonged duration of exclusiveness of breastfeeding is associated with low-
er risks of common infectious diseases in the fi rst 6 months life. These fi ndings support 
current health policy strategies to promote breastfeeding in industrialized countries. 
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Introduction
Respiratory and gastrointestinal tract infections are the leading cause of morbidity in 
children (1, 2). Prospective cohort studies in industrialized countries, revealed preva-
lences of 3.4% to 32.1% for respiratory tract infectious diseases and 1.2% to 26.3% for 
gastrointestinal infectious diseases in infancy (3-8). The risks of these infectious diseases 
are aff ected by several factors including birth weight, gestational age, socio-economic 
status, ethnicity, number of siblings, daycare attendance and parental smoking (3, 5, 6, 
8-20). 
Breastfeeding has been suggested as a modifi able infl uencing factor. When given 
exclusively, breastfeeding reduces the risk of infectious diseases in infants in develop-
ing countries (21, 22). In industrialized countries, exclusive breastfeeding during the fi rst 
6 months seems to decrease the risk of gastrointestinal tract infections, compared to 
exclusive breastfeeding during only the fi rst 3 to 4 months (23, 24). Based on these and 
other reports, the World Health Organization (WHO) recommended in 2001 to exclusively 
breastfeed all children for 6 months instead of 4 months. However, they also called for 
more research regarding the benefi ts of 6 versus 4 months of exclusive breastfeeding 
(25). Thus far, several studies in industrialized countries showed that a shorter duration 
of breastfeeding increases the risk of common infectious diseases, such as respiratory 
and gastrointestinal tract infections (8, 19, 24, 26-32). However, in these studies various 
defi nitions of the ‘relative amount’ of breastfeeding were used (24, 27, 28, 30) or the com-
bination of duration and exclusiveness of breastfeeding was not taken into account (8, 
31). 
We examined in a population-based prospective cohort study in the city of Rotter-
dam, the Netherlands, the associations of the duration of exclusive breastfeeding with 
upper and lower respiratory and gastrointestinal tract infections during the fi rst year of 
life. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood, in the city of Rotterdam, the Nether-
lands. The Generation R Study was designed to identify early environmental and genetic 
determinants of growth, development and health and has been described previously in 
detail (33, 34). Enrolment of mothers was aimed in early pregnancy (gestational age < 18 
weeks) but was possible until birth of the child. All children were born between April 2002 
and January 2006 and form a prenatally enrolled birth-cohort that is currently followed 
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until young adulthood. Response rate for the Generation R Study is 61%. In total, 7893 
parents gave informed consent for participation of their infants in the postnatal phase of 
the study (33). The Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, 
has approved the study. Written informed consent was obtained from all participants. 
Duration and exclusiveness of breastfeeding
Information about breastfeeding was obtained by postal questionnaires at the ages of 
6 and 12 months (33). Mothers were asked whether they ever breastfed their infant (no, 
yes). Duration of breastfeeding was assessed by asking at what age (months) the infant 
received breast milk for the last time. Breastfeeding was categorized into three groups of 
infants who received breastfeeding for less than 4 months, 4 to 6 months or 6 months or 
longer. Duration of exclusive breastfeeding was defi ned using information about at what 
age other types of milk and/or solids were introduced in the fi rst 6 months of life. The 
information about duration and exclusiveness of breastfeeding was combined and cat-
egorized into the following six breastfeeding categories: 1) never; 2) partial < 4 months, 
not thereafter; 3) partial 4-6 months; 4) exclusive 4 months, not thereafter; 5) exclusive 4 
months, partial thereafter; 6) exclusive 6 months. Never indicates infants who have never 
been breastfed. Partial indicates infants receiving both breastfeeding and formula feed-
ing or solids in this period. Exclusive indicates infants who have been breastfed, without 
any other milk, solids or fl uids. After the age of 6 months, all infants received other milk, 
fl uids and/or solids.
Infectious diseases
Information about infectious diseases was obtained by questionnaires at the ages of 6 
and 12 months. Parents were asked whether their infant has had a serious cold, ear or 
throat infection, pneumonia, bronchitis, bronchiolitis or gastrointestinal tract infection 
(‘no or yes, not visited a doctor’; ‘yes, visited a doctor’). The respiratory tract infections 
were combined into doctor-attended and no doctor-attended upper (serious cold, ear 
infection, throat infection) and lower respiratory tract infections (pneumonia, bronchitis 
and bronchiolitis). 
Covariates
Information about ethnicity and educational level of the mother was obtained at enrol-
ment in the study. Ethnicity and educational level of the mother were defi ned according 
to the classifi cation of Statistics Netherlands (35). Birth weight and date of birth were 
obtained from midwife and hospital registries. Gestational age was established by fetal 
ultrasound examination (37). Information about siblings, day-care attendance and 
maternal smoking (no, yes) was obtained by questionnaire at the age of 6 months of the 
infant. 
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Cohort for analysis 
Of the 7,893 participants of the postnatal cohort, 7,295 (92%) gave consent for receiv-
ing questionnaires. Twins (n=179) were excluded from the present analyses, since 
these were correlated with each other. Of the remaining 7,116 infants, 60% and 69% 
responded to the 6 months- and 12 months questionnaire, respectively. Information 
about breastfeeding in infancy was available in 4,618 infants (65%). Of those, informa-
tion about infectious diseases at the ages of 6 and 12 months was available in 4,164 
and 3,962 infants, respectively.
Data analysis
First, the associations of duration of breastfeeding with upper and lower respiratory 
and gastrointestinal tract infections in infants at the ages of 6 and 12 months were 
analyzed using multiple logistic regression analysis. Second, to examine whether the 
effects of duration of breastfeeding were due to exclusive breastfeeding, the associa-
tions of duration of exclusive breastfeeding with upper and lower respiratory and gas-
trointestinal tract infections were examined. All models were adjusted for potential 
confounders including maternal education, ethnicity, smoking, gestational age, birth 
weight, siblings and day-care attendance. Tests for trend were performed by includ-
ing the breastfeeding categories as continuous variables in the regression models. The 
statistical analyses were performed using the Statistical Package of Social Sciences ver-
sion 11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
The median infant’s ages at which parents filled in the 6 and 12 months questionnaire 
were 6.3 (90% range 5.7 to 8.8) months and 11.9 (90% range 11.6 to 13.6) months, 
respectively. Most mothers were high educated (55%) and of Dutch ethnicity (61%) 
(Table 1). Median gestational age at birth was 40.1 weeks (90% range 37.1 to 42.1 
weeks) and mean birth weight was 3456 grams (SD 547 grams). Of all mothers, 88% ini-
tiated breastfeeding. Of all infants, 29% received breastfeeding for less than 4 months, 
25% for 4 to 6 months and 34% for 6 months or more. When duration of breastfeeding 
was taken into account, most mothers partially breastfed their infants for less than 
4 months or for 4 to 6 months (29% and 29%) or breastfed their infants exclusively 
until the age of 4 months and partially thereafter (26%). Exclusive breastfeeding for 
6 months was given to only 1.4% of all infants. In the first 6 months of life, 40% of all 
infants had an upper respiratory tract infection and 8% had a lower respiratory tract 
infection and a gastrointestinal tract infection (Table 1). Between 7 and 12 months of 
life, upper and lower respiratory and gastrointestinal tract infections were present in 
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27%, 10% and 9% of all infants. Table 2 shows that mothers who were older than 30 
years, higher educated and non-smoking tended to breastfed their infants longer and 
more exclusively.
Duration of breastfeeding
Infants who were breastfed for 4 months or 4 to 6 months did not have lower risks of upper 
and lower respiratory or gastrointestinal tract infections in the fi rst 6 months compared 
to never breastfed infants (all p-values > 0.05) (Figure 1). Compared to never breastfed 
infants, those who were breastfed for 6 months or more had lower risks of upper respira-
tory tract infections (adjusted odds ratio (aOR) 0.62 (95% confi dence interval (CI): 0.49, 
0.78)), lower respiratory tract infections (aOR 0.60 (95% CI: 0.40, 0.91)) and gastrointesti-
nal tract infections (aOR 0.46. (95% CI: 0.30, 0.70)). Between 7 and 12 months, the risks of 
upper and lower respiratory and gastrointestinal tract infections were similar in infants 
who were breastfed until 4 months and who were never breastfed. Infants breastfed for 
4 to 6 months or 6 months or more had lower risks of lower respiratory tract infections 
(aOR 0.54 (95% CI: 0.37, 0.81) and aOR 0.54 (95% CI: 0.37, 0.78), respectively). No associa-
tions were found with upper respiratory and gastrointestinal tract infections.
Duration and exclusiveness of breastfeeding
Compared to never breastfed infants, infants who were breastfed partially until 4 months 
or for 4 to 6 months and infants who were breastfed exclusively until 4 months but not 
thereafter, did not have lower risks of upper and lower respiratory and gastrointestinal 
tract infections until the age of 6 months (all p-values > 0.05) (Table 3). Infants who were 
breastfed exclusively until 4 months and partially thereafter, had lower risks of upper 
and lower respiratory and gastrointestinal tract infections in the fi rst 6 months after 
birth (aOR 0.65 (95% CI: 0.51, 0.83), 0.50 (95% CI: 0.32, 0.79) and 0.41 (95% CI: 0.26, 0.67), 
respectively). Infants who were breastfed exclusively for 6 months had a lower risk of 
upper respiratory tract infections (aOR 0.37 (95% CI: 0.18, 0.74)), but no associations were 
found with lower respiratory tract or gastrointestinal tract infections. Between 7 and 12 
months, lower respiratory tract infections were less present in infants who were breast-
fed partially until 4 to 6 months and exclusively until 4 months and partially thereafter, 
compared to never breastfed infants (aOR 0.68 (95% CI: 0.47, 0.99) and aOR 0.46 (95% CI: 
0.31, 0.69)). No other associations of the various breastfeeding categories with upper and 
lower respiratory and gastrointestinal tract infections between the age of 7 to 12 months 
were observed. All tests for trend for the associations of prolonged exclusive breastfeed-
ing with upper and lower respiratory and gastrointestinal tract infections until the age of 
6 months, and lower respiratory tract infections between the age of 7 to 12 months were 
signifi cant (p-values for trend < 0.01). 
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Table 1. Maternal and infant characteristics of the study population.
Infants 
(n=4,164)
Mother
Maternal age (years) 31.1 (4.8)
Education (%)
Low 6.2 (246)
Intermediate 38.7 (1,538)
High 55.2 (2,195)
Non-Dutch ethnicity (%) 38.9 (1,574)
Smoking (%) 16.2 (647)
Infant
Girl 50.6 (2,107)
Gestational age (weeks)* 40.1 (37.1-42.1)
Birth weight (grams) 3,456 (547)
Siblings ≥ 1 (%) 40.2 (1,604)
Daycare attendance (%) 49.7 (1,949)
Duration of breastfeeding (%) 
Never 12.5 (519)
< 4 months 29.1 (1,203)
4-6 months 24.5 (1,1012)
≥ 6 months 33.9 (1,404)
Duration of exclusive breastfeeding (%)
Never 12.8 (519)
Partial < 4 months, not thereafter 29.2 (1,182)
Partial 4-6 months 28.8 (1,166)
Exclusive 4 months, not thereafter 2.0 (80)
Exclusive 4 months, partial thereafter 25.7 (1,037)
Exclusive 6 months 1.4 (58)
Doctor-attended infectious diseases ≤ 6 months (%)
Upper respiratory tract infection (URTI) 39.5 (1,644)
Lower respiratory tract infection (LRTI) 7.8 (323)
Gastrointestinal tract infection (GI) 7.6 (309)
Doctor-attended infectious diseases 7-12 months (%)
Upper respiratory tract infection (URTI) 26.6 (912)
Lower respiratory tract infection (LRTI) 10.2 (360)
Gastrointestinal tract infection (GI) 8.7 (295)
Values are means (standard deviation) or percentages (absolute numbers). 
*Median (95% range). 
Data were missing on education (n=185), ethnicity (n=121), smoking (n=170), birth weight (n=3), siblings (n=171), 
daycare attendance (n=240), duration of breastfeeding (n=26), duration of exclusive breastfeeding (n=122); at age 6 
months: URTI (n=2), LRTI (n=36) and GI (n=92); at age 12 months: URTI (n=737), LRTI (n=644) and GI (n=772).
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Discussion
The main fi ndings of this population-based prospective cohort study were that breast-
feeding for 6 months seems to have protective eff ects for development of respiratory 
and gastrointestinal tract infections during the fi rst 6 months, and lower respiratory tract 
infections between the age of 7 and 12 months. When taking the exclusiveness of breast-
feeding into account, infants who were breastfed exclusively until 4 months and partially 
thereafter, had lower risks of respiratory and gastrointestinal tract infections until the age 
of 6 months and lower respiratory tract infections between the age of 7 and 12 months. 
Several studies showed that a shorter period of breastfeeding increases the risks of 
physician visits for illness, lower respiratory tract infections and gastrointestinal symp-
toms (8, 28, 32). Studies that were able to take the ‘relative amount ’ of breastfeeding 
into account, showed that exclusive, followed by partial breastfeeding, or predominantly 
breastfeeding during 6 months or more was associated with a lower risk of gastrointesti-
nal tract infection compared to less than 3 months breastfeeding (24). Infants who were 
breastfed for less than 4 months, showed a higher risk of hospitalization for infectious 
diseases (hazard ratio 2.45 (95% CI 1.28, 4.66)) compared to those who were breastfed for 
more than 4 months. Furthermore, infants who were breastfed for 4 to 6 months showed 
Table 2. Maternal characteristics and breastfeeding habits.
Duration of exclusive breastfeeding
Never
Partial < 4 
months,
not thereafter
Partial 4-6 
months
Exclusive 4 
months, not 
thereafter
Exclusive 4 
months, partial 
thereafter
Exclusive 6 
months
P-value
Maternal age
< 26 76 (12.8) 264 (44.4) 151 (25.4) 6 (1.0) 95 (16.0) 3 (0.5)
26-30 184 (14.9) 369 (29.8) 360 (29.1) 21 (1.7) 289 (23.1) 17 (1.4)
>30 256 (11.6) 549 (24.9) 655 (29.7) 53 (2.4) 656 (29.7) 38 (1.7) < 0.01
Education
Low 32 (13.9) 80 (34.8) 74 (32.2) 3 (1.3) 39 (17.0) 2 (0.9)
Intermediate 272 (18.2) 555 (37.2) 366 (24.5) 29 (1.9) 263 (17.6) 8 (0.5)
High 183 (8.6) 490 (22.9) 672 (31.4) 45 (2.1) 704 (32.9) 46 (2.1) < 0.01
Ethnicity
Dutch 342 (14.1) 668 (27.6) 647 (26.8) 51 (2.1) 666 (27.6) 43 (1.8)
Non-Dutch 155 (10.3) 474 (31.4) 490 (32.5) 26 (1.7) 350 (23.2) 13 (0.9) < 0.01
Smoking
No 360 (11.1) 882 (27.1) 985 (30.3) 68 (2.1) 906 (27.9) 52 (1.6)
Yes 127 (20.4) 249 (39.9) 140 (22.4) 9 (1.4) 95 (15.2) 4 (0.6) < 0.01
Values are absolute numbers (percentages). 
Data were missing on education (n=185), ethnicity (n=121), smoking (n=170), siblings (n=171), daycare attendance 
(n=240), duration of breastfeeding (n=26) and duration of exclusive breastfeeding (n=122). Diff erences between 
groups were tested by Chi-square. **P-value < 0.01.
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higher risks of both pneumonia (OR 4.27 (95% CI 1.27, 14.35) and recurrent otitis media 
(OR 1.95 (95% CI 1.06, 3.59) compared to those who were breastfed 6 or more months 
(29, 30). One study observed a protective eff ect of predominant breastfeeding for at least 
6 months on doctor visits for ≥ 4 upper respiratory tract infections or ≥ 2 wheezing epi-
sodes, compared to breastfeeding for less than 6 months (27). Our results are diffi  cult to 
compare with these studies, since diff erent breastfeeding categories and various defi -
nitions of the breastfeeding categories (predominantly or exclusive) and the outcomes 
(self-reported or doctor-diagnosed infections) were used. 
We observed protective eff ects of breastfeeding on infectious diseases mainly in 
the fi rst 6 months of life. Most studies reported protective eff ects of breastfeeding on 
common infections in the fi rst 8 to12 months of life (8, 27, 29, 30). One study, that distin-
guished between infectious diseases until and from the age of 6 months, found similar 
results as in our study (24). Although they used exclusive breastfeeding for 3 months as 
the reference group, exclusive breastfeeding for 6 months reduced the risk of gastroin-
testinal tract infections between the age of 3 to 6 months, but not between the age of 6 
to 12 months (24). Breastfeeding might have prolonged protective eff ect eff ects by infl u-
encing the severity (hospital admission) and frequency of common infectious diseases 
between the age of 6 and 12 months. However, immunological evidence of prolonged 
protective eff ect of increased dose and duration of breastfeeding is not well established. 
Short-term protective eff ects are due to several factors in human breast milk. Epidermal 
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Figure 1. Duration of breastfeeding and risk of infectious diseases in the fi rst year of life.
URTI = upper respiratory tract infections, LRTI = lower respiratory tract infections and GI = gastrointestinal tract 
infections.
Values are odds ratios (95% confi dence interval), adjusted for maternal education, ethnicity, smoking, gestational 
age, birth weight, siblings and daycare attendance. *P-value < 0.05, ** p-value < 0.01.
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growth factor helps to induce maturation of the intestinal epithelium, IgA and oligo-
saccharides prevent attachment of pathogens and lactoferrin has broad antimicrobial 
properties, including disruption of the bacterial outer membrane (38, 39).
The strength of this study is its prospective population-based cohort design with 
a large number of subjects and the possibility to adjust for all major confounders. Fur-
thermore, we were able to categorize the various breastfeeding habits in combination 
with the duration of breastfeeding. Some methodological considerations need to be 
considered. Of all postnatal eligible participants of the Generation R Study, question-
naires with breastfeeding data were available in 65%. Infectious diseases until the age of 
6 months were more present in those without information (50%) than those with infor-
mation about breastfeeding (44%). This diff erence might have led to an underestimation 
of our eff ect estimates of infectious diseases. There were no diff erences in prevalences of 
infectious diseases from the age of 7 through 12 months between those with (35%) and 
without (36%) breastfeeding data. Of all participants with breastfeeding data, 10% and 
14% had missing data on infectious diseases at the ages of 6 and 12 months, respectively. 
Among those infants without data on infectious diseases, on average 28% were exclusive 
breastfed for 4 months and 1.7% were exclusively breastfed for 6 months. Since these 
frequencies did not diff er from the frequencies in our cohort for analysis (27% and 1.4%, 
respectively), biased estimates due to selective loss to follow-up seems unlikely. 
Table 3. Duration of exclusive breastfeeding and risk of infectious diseases in the fi rst year of life.
≤ 6 months 7-12 months
URTI LRTI GI URTI LRTI GI
Duration of exclusive 
breastfeeding
Never 1.00 1.00 1.00 1.00 1.00 1.00
Partial < 4 months,
not thereafter
0,96 
(0.76, 1.21)
1.01 
(0.68, 1.50)
0.77 
(0.52, 1.15)
1.02 
(0.78, 1.34)
0.81 
(0.57, 1.17)
0.95 
(0.68, 1.31)
Partial 4-6 months
0,85 
(0.67, 1.07
0.89 
(0.60, 1.34)
0.72 
(0.48, 1.09)
0.96 
(0.73, 1.27)
0.68 
(0.47, 0.99)*
0.97 
(0.70, 1.35)
Exclusive 4 months,
not thereafter 
0.70 
(0.41, 1.20)
0.39 
(0.12, 0.31)
1.01 
(0.44, 2.38)
1.75 
(0.99, 3.14)
0.45 
(0.17, 1.19)
1.16 
(0.60, 2.27)
Exclusive 4 months,
partial thereafter
0.65 
(0.51, 0.83)**
0.50 
(0.32, 0.79)**
0.41 
(0.26, 0.64)**
0.88 
(0.66, 1.16)
0.46
(0.31, 0.69)**
1.07 
(0.77, 1.49)
Exclusive breastfeeding 6 
months 
0.37 
(0.18, 0.74)**
0.33 
(0.08, 1.40)
0.46 
(0.14, 1.59)
0.63 
(0.30, 1.33)
0.54 
(0.18, 1.58)
0.93 
(0.42, 2.06)
Ptrend < 0.01 < 0.01 < 0.01 NS < 0.01 NS
URTI = upper respiratory tract infections, LRTI = lower respiratory tract infections and GI = gastrointestinal tract 
infections. 
Values are odds ratios (95% confi dence interval), adjusted for maternal education, ethnicity, smoking, gestational 
age, birth weight, siblings and daycare attendance. *P-value < 0.05, ** p-value < 0.01.
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Information about breastfeeding was prospectively collected by questionnaires 
without direct reference to upper and lower respiratory and gastrointestinal tract infec-
tions. Although assessing breastfeeding by questionnaires seems to be a valid method, 
misclassifi cation may occur. A recent review of studies performed between 1966 and 
2003 showed that maternal report of breastfeeding is reliable through the age of 3 years 
(40). The main outcomes in our study were self-reported upper and lower respiratory 
and gastrointestinal tract infections. This method is widely accepted in epidemiological 
studies and reliably refl ect the true incidence of those infections (41).
Our fi ndings support previous studies suggesting that prolonged and exclusive 
breastfeeding protects against respiratory and gastrointestinal tract infections in the 
fi rst year of life. Exclusive breastfeeding until 4 months followed by partial breastfeeding, 
lead to a signifi cant reduction of respiratory and gastrointestinal morbidity in infants. 
These fi ndings support current health policy strategies to promote breastfeeding in 
industrialized countries. Biological, cultural and social constraints related to breastfeed-
ing habits need to be studied more extensively. The eff ects of prolonged and exclusive 
breastfeeding on infectious diseases at older ages in industrialized countries remains to 
be studied. 
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Abstract
Objective: To assess the associations of maternal smoking during pregnancy and in the 
postnatal period with respiratory tract infections in young infants. 
Methods: This study was embedded in the Generation R Study, a population-based pro-
spective cohort study from fetal life onwards. All data were assessed by questionnaires. 
Maternal smoking was assessed in pregnancy (no, stopped when pregnancy was known, 
continued during pregnancy) and at 6 months postnatally. Doctor-attended respiratory 
tract infections were recorded at the age of 6 months. The present analyses were based 
on 3,418 subjects.
Results: Continued maternal smoking during pregnancy was not associated with respira-
tory tract infections in young infants. Maternal smoking in the postnatal period showed 
a tendency for an increased risk of lower respiratory tract infections in infants (adjusted 
odds ratio (aOR) 1.61 (95% confi dence interval: 0.99, 2.63)). Dose-response eff ects for 
maternal smoking during pregnancy or in the postnatal period on the risk of respiratory 
tract infections were not observed. In infants of mothers who smoked neither during 
pregnancy nor in the postnatal period, environmental smoking during pregnancy and 
in the postnatal period together was associated with upper respiratory tract infections 
(aOR 1.58 (95% CI: 1.07, 2.35)).
Conclusions: No eff ect of maternal smoking during pregnancy with respiratory tract 
infections was observed. Weak evidence for the association between maternal smoking 
in the postnatal period and lower respiratory tract infections were found. Exposure to 
non-maternal environmental smoking during pregnancy and in the postnatal period 
together increases the risk of upper respiratory tract infections in young infants.
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Introduction
Upper and lower respiratory tract infections are the most common cause of morbidity and 
mortality in infancy (1-3). On average an infant has 3-12 respiratory tract infections per 
year (4). The risk of respiratory morbidity is infl uenced by several factors including birth 
weight, gestational age, socio-economic status, ethnicity, number of siblings, attending 
a daycare centre and breastfeeding (4-20). Exposure to maternal smoking during preg-
nancy and in the postnatal period has been proposed as an additional and modifi able 
risk factor in early life (21-28). Most of these studies were not able to assess the separate 
eff ects of the timing of smoking since most mothers who smoked during pregnancy also 
smoked in the postnatal period. 
During pregnancy, maternal smoking and fetal exposure to nicotine cause growth 
retardation and a reduction in fetal breathing movements, which can lead to abnormal 
growth and maturation of the airways and lungs (29). In the postnatal period, exposure 
to smoke may increase the susceptibility to pathogens due to impaired defence mecha-
nisms of the airways and bronchial tree, such as mucociliary clearance (30). The indepen-
dent eff ects of maternal smoking of diff erent duration in pregnancy and in the postnatal 
period on the risk of respiratory tract infections in young infants are not yet clear, and 
may be relevant for identifying critical periods for the eff ect of exposure to maternal 
smoking on airway and lung development and respiratory tract infections in infants.
We examined in a population-based prospective cohort study the associations of 
maternal smoking habits of diff erent duration in pregnancy and in the postnatal period 
with respiratory tract infections in the infants. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. The Generation R Study was designed 
to identify early environmental and genetic determinants of growth, development and 
health and has been described previously in detail (31, 32). Briefl y, the cohort includes 
9,778 mothers and their children living in Rotterdam, the Netherlands. Enrolment of 
mothers was aimed in early pregnancy (gestational age < 18 weeks) but was possible 
until birth of the child. All children were born between April 2002 and January 2006 and 
form a prenatally enrolled birth-cohort that is currently followed until young adulthood. 
Of all eligible children in the study area, 61% participated at birth in the study (32). The 
Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, has approved the 
study. Written informed consent was obtained from all participants. 
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Exposure to maternal smoking in pregnancy and the postnatal period
Information about maternal smoking was obtained by postal questionnaires in early 
(gestational age < 18 weeks), mid- (gestational age 18 - 25 weeks) and late (gestational 
age ≥ 25 weeks) pregnancy and in the postnatal period at the age of 6 months (32). 
Maternal smoking at enrolment was assessed in the fi rst questionnaire by asking whether 
the mother smoked in pregnancy (no, yes-but stopped when pregnancy was known, yes-
continued during pregnancy). This questionnaire was send to all mothers, independent 
of their gestational age at enrolment. In the second and third questionnaire, the mothers 
were asked whether they smoked in the past 2 months in mid- and late pregnancy (no, 
yes), respectively. Because of our interest in duration of exposure to maternal smoking 
in prenatal life, the 3 smoking categories in the fi rst questionnaire were combined with 
the smoking categories in mid- and late pregnancy: mothers who reported in the fi rst 
questionnaire to have stopped smoking when pregnancy was known but still reported 
to smoke in the second or third questionnaire (n=92), were reclassifi ed into the ‘contin-
ued smoking during pregnancy’ category. The same strategy was used for mothers who 
reported not to smoke in the fi rst questionnaire but smoked in the second or third ques-
tionnaire (n=31). In the fourth questionnaire used for this study, mothers were asked 
whether they smoked (no, yes) when their child was 6 months old. These categories were 
used for exposure to maternal smoking in early postnatal life.
Among the smoking mothers, the number of cigarettes was asked for in the follow-
ing categories: less than 1 per day; 1-2 per day; 3-4 per day; 5-9 per day; 10-19 per day; 
and 20 or more per day. To increase the exposure groups, these categories were com-
bined and reclassifi ed into the following categories: non-smoking; less than 5 cigarettes 
per day; 5-9 cigarettes per day and 10 or more cigarettes per day. 
Non-maternal environmental smoking during pregnancy was obtained in early, 
mid- and late pregnancy as the number of hours per day that mothers were exposed to 
environmental smoke at home and at work. For both exposure to smoke at home and at 
work, categories were combined and reclassifi ed into the following categories: non- or 
occasionally exposed; and exposed (less than one hour per day, one to three hours per 
day or more than three hours per day). If mothers reported in the fi rst questionnaire to 
be non-exposed to smoke at home or at work, but reported to be exposed in the second 
or third questionnaire, they were reclassifi ed into the exposed category (n=87). Environ-
mental smoking in the postnatal period was obtained by the fourth questionnaire at the 
infants’ age of 6 months. Parents were asked whether their infants were exposed to envi-
ronmental smoke at home or at other places (no, yes). These questions were combined 
and reclassifi ed into the categories ‘non-exposed’ and ‘exposed’.
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Respiratory tract infections
Information about respiratory tract infections was obtained by a postal questionnaire at 
the age of 6 months. Parents were asked whether their infant has had an upper respira-
tory tract infection (serious cold, ear infection, throat infection) and/or a lower respira-
tory tract infection (pneumonia, bronchitis or bronchiolitis) for which they attended a 
doctor in the previous 6 months.
Covariates
Information about ethnicity and educational level of the mother was obtained by the fi rst 
questionnaire at enrolment in the study. Ethnicity and educational level of the mother 
was defi ned according to the classifi cation of Statistics Netherlands (33, 34). Gestational 
age was established by fetal ultrasound examination (32). Birth weight and date of birth 
were obtained from midwife and hospital registries. Information about siblings, daycare 
Figure 1. Flow chart of participants in the study on exposure to maternal smoking during pregnancy and in the 
postnatal period and the risk of respiratory tract infections in infancy. 
n=5,189 
Infants eligible for present study 
n=3,574 
Response questionnaires at 6 months 
Complete data on maternal smoking during 
pregnancy and respiratory tract infections 
Complete data on maternal smoking in the 
postnatal period and respiratory tract 
infections 
 
n=3,264 
 
n=3,418 
n=6,880  
Consent infants postnatal phase  
 
n=1,691 
Excluded: twins (n=144), 2nd or 3rd 
participating infants from same mother 
(n=465) and infants without receiving a 6 
months questionnaire (n=1,082) 
n=1,615  
Non-responders 
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centre and breastfeeding for at least one month (no, yes) was asked in the fourth ques-
tionnaire at the age of 6 months.
Cohort for analysis 
Of the total of 9,778 mothers, 8,880 (91%) were enrolled in pregnancy (32). Of these 8,880 
mothers, 6,880 gave informed consent for participation in the postnatal phase of the 
study (32) (Figure 1). Second or third participating infants of the same mother (n=465) 
and twins (n=144) were excluded from the present analyses to prevent potential bias due 
to correlation. Of the remaining 6,271 infants, a 6 months-questionnaire was not send 
to 1,082 parents since part of the parents did not give informed consent for postnatal 
participation of their children before the age of 6 months and because this questionnaire 
was started to sent out from a later stage in the study (June 2003). Of the 5,189 parents 
the questionnaire was sent to, 3,574 (69%) responded. Complete data for the analyses on 
the associations of maternal smoking during pregnancy and in the postnatal period were 
available in 3,418 and 3,264 mothers and infants, respectively. 
Data analysis
The associations of maternal smoking of diff erent duration in pregnancy and in the post-
natal period with reported respiratory tract infections in the infants were analyzed using 
multiple logistic regression analysis. After the crude analysis (model A), potential con-
founders including birth weight, gestational age, education, ethnicity, siblings, daycare 
centre and breastfeeding were added to the model (model B). In the third model (model 
C), maternal smoking in the postnatal period was added as a confounder to the models 
focused on the associations of maternal smoking during pregnancy with respiratory tract 
infections. Maternal smoking during pregnancy was added as a confounder to the models 
focused on the association between maternal smoking in the postnatal period and respi-
ratory tract infections. The associations of the reported number of cigarettes smoked by 
mother with the risk of respiratory tract infections were analyzed using multiple logistic 
regression models. These models were adjusted for all potential confounders mentioned 
above and the exposure to maternal smoking habits in other periods. Furthermore, tests 
for trends were performed by treating each categorized variable as a continuous term and 
entering the variable in to the fully adjusted logistic regression model. Adjusted analyses 
of exposure to environmental smoking were performed in mothers who neither smoked 
during pregnancy nor in the postnatal period. Four strata of exposure to environmental 
smoking were used: non-exposed; during pregnancy but not in the postnatal period; 
not during pregnancy but in the postnatal period; and both during pregnancy as in the 
postnatal period. The statistical analyses were performed using the Statistical Package of 
Social Sciences version 11.0 for Windows (SPSS Inc, Chicago, IL, USA).
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Results
Characteristics of the mothers and their infants according to maternal smoking habits 
during pregnancy are presented in Table 1. Of all mothers, 8.5% stopped smoking when 
pregnancy was known and 13.7% continued smoking during pregnancy. Of mothers 
who smoked until pregnancy was known, 30.9% started smoking again in the postnatal 
period and of mothers who continued smoking in pregnancy, 76.1% still smoked in the 
postnatal period. Of mothers who did not smoke during pregnancy, 19.7% were exposed 
Table 1. Maternal and infant characteristics according to smoking habits of mother during pregnancy.
Maternal smoking during pregnancy
Non-smoking 
(n=2,659)
Stopped when pregnancy 
was known 
(n=291)
Continued during pregnancy 
(n=468)
Mothers
Age (years) 31.0 (4.6) 30.3 (4.9) 29.8 (5.5)
Education (%)
Primary school 5.5 (132) 4.9 (14) 10.9 (44)
Secondary school 35.4 (852) 49.9 (115) 62.9 (254)
Higher education 59.1 (1,420) 55.2 (159) 26.2 (106)
Non-Dutch ethnicity (%) 38.8 (964) 38.5 (112) 45.6 (193)
Smoking in the postnatal period (%)
Non-smoking 92.0 (2,445) 66.3 (193) 19.7 (92)
Smoking 3.3 (88) 30.9 (90) 76.1 (356)
Unknown 4.7 (126) 2.7 (8) 4.3 (20)
Non-maternal environmental 
smoking during pregnancy (%)
19.7 (523) 33.7 (98) 72.2 (338)
Non-maternal environmental 
smoking in the postnatal period (%)
15.0 (380) 18.6 (52) 32.1 (143)
Infants
Siblings ≥ 1 (%) 32.6 (828) 27.0 (76) 39.1 (174)
Daycare centre (%) 80.7 (2,145) 75.9 (221) 74.8 (350)
Breastfeeding ≥ 1 month (%) 80.3 (2,114) 81.2 (233) 63.7 (295)
Birth weight (grams) 3463 (540) 3512 (512) 3256 (540)
Gestational age (weeks)* 40.1 (37.1-42.1) 40.1 (37.4-42.1) 40.0 (36.7-42.1)
Upper respiratory tract infection (%) 37.9 (1006) 39.5 (115) 44.2 (207)
Lower respiratory tract infection (%) 7.3 (194) 6.9 (20) 8.5 (40)
Values are means (standard deviation) or percentages (absolute numbers). *Median (95% range). 
Data were missing on education (n=322), ethnicity (n=224), environmental smoking during pregnancy (n=2), environmental 
smoking in the postnatal period (n=160), siblings (n=153), breastfeeding (n=34) and birth weight (n=2).
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to environmental smoke during pregnancy and 15.0% were exposed to environmental 
smoke in the postnatal period.
At 6 months, upper and lower respiratory tract infections were reported for 38.8% 
and 7.4% of all infants, respectively. Infants whose mother stopped smoking when preg-
nancy was known did not have more upper and lower respiratory infections than infants 
with non-smoking mothers (Table 2). In the unadjusted analyses (model A), continued 
smoking during pregnancy was associated with more upper respiratory tract infections 
Table 2. Exposure to maternal smoking during pregnancy and the risk of respiratory tract infections in infants.
Upper respiratory tract infections 
OR (95%CI)
Maternal smoking Model A Model B Model C
Non-smoking (n=2,659) Reference Reference Reference
Stopped when pregnancy was known (n=291) 1.07 (0.84, 1.37) 1.09 (0.84, 1.41) 1.06 (0.81, 1.40)
Continued during pregnancy (n=468) 1.30 (1.07, 1.59)** 1.25 (0.99, 1.57) 1.18 (0.86, 1.61)
Lower respiratory tract infections 
OR (95%CI)
Maternal smoking Model A Model B Model C
Non-smoking (n=2,659) Reference Reference Reference
Stopped when pregnancy was known (n=291) 0.94 (0.58, 1.51) 0.97 (0.58, 1.61) 0.84 (0.49, 1.44)
Continued during pregnancy (n=468) 1.19 (0.83, 1.69) 1.16 (0.77, 1.75) 0.81 (0.45, 1.45)
Values are odds ratios (95% confi dence interval), *P-value < 0.05.
Model A: unadjusted.
Model B: adjusted for birth weight, gestational age, education and ethnicity mother, siblings, daycare centre and 
breastfeeding. 
Model C: model B + adjusted for maternal smoking in the postnatal period. 
Table 3. Exposure to maternal smoking in the postnatal period and the risk of respiratory tract infections in infants.
Upper respiratory tract infections 
OR (95%CI)
Maternal smoking Model A Model B Model C
Non-smoking (n=2,730) Reference Reference Reference
Postnatal (n=534) 1.23 (1.02, 1.49)* 1.21 (0.98, 1.50) 1.13 (0.86, 1.47)
Lower respiratory tract infections 
OR (95%CI)
Maternal smoking Model A Model B Model C
Non-smoking (n=2,730) Reference Reference Reference
Postnatal (n=534) 1.34 (0.97, 1.87) 1.41 (0.98, 2.04) 1.61 (0.99, 2.63)
Values are odds ratios (95% confi dence interval), *P-value < 0.05. 
Data were missing on maternal smoking in the postnatal period (n=154).
Model A: unadjusted.
Model B: adjusted for birth weight, gestational age, education and ethnicity mother, siblings, daycare centre and 
breastfeeding. 
Model C: model B + adjusted for maternal smoking ‘stopped when pregnancy was known’ or ‘continued during pregnancy’.
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but not with lower respiratory tract infections (OR 1.30 (95% CI: 1.07, 1.59) and OR 1.19 
(95% CI: 0.83, 1.69)). After adjusting for potential confounders and maternal smoking in 
the postnatal period the eff ect of continued smoking during pregnancy on upper respi-
ratory tract infections decreased (aOR 1.18 (95% CI: 0.86, 1.61)). Maternal smoking in the 
postnatal period was associated with more upper respiratory tract infections in the unad-
justed but not in the adjusted analysis (OR 1.23 (95% CI: 1.02, 1.49) and aOR 1.13 (95% 
CI: 0.86, 1.47)) (Table 3). The aOR for lower respiratory tract infection in infants exposed 
to maternal smoking in the postnatal period was 1.61 (95% CI: 0.99, 2.63). Table 4 shows 
that there were no signifi cant trends for the associations of number of cigarettes smoked 
by mother during pregnancy or in the postnatal period with upper or lower respiratory 
tract infections in infancy (all p-values for trend > 0.05).
Table 4. Number of cigarettes smoked by mother and the risk of respiratory tract infections in infants.
Upper respiratory tract infections 
aOR (95%CI)
Lower respiratory tract infections 
aOR (95% CI)Smoking stopped when pregnancy was 
known 
Non-smoking (n=2,659) Reference Reference
< 5 cigarettes per day (n=171) 0.77 (0.54, 1.11) 0.75 (0.36, 1.53)
5-9 cigarettes per day (n=56) 1.88 (1.07, 3.32)* 1.02 (0.35, 2.95)
≥ 10 cigarettes per day (n=57) 1.29 (0.74, 2.24) 1.14 (0.40, 3.26)
P-value for trend 0.23 0.93
Upper respiratory tract infections 
aOR (95%CI)
Lower respiratory tract infections 
aOR (95% CI)Continued smoking during pregnancy
Non-smoking (n=2,659) Reference Reference
< 5 cigarettes per day (n=184) 1.39 (0.93, 2.09) 1.10 (0.53, 2.29)
5-9 cigarettes per day (n=112) 1.29 (0.76, 2.18) 1.04 (0.42, 2.59)
≥ 10 cigarettes per day (n=71) 1.42 (0.78, 2.57) 0.65 (0.20, 2.10)
P-value for trend 0.21 0.59
Upper respiratory tract infections 
aOR (95%CI)
Lower respiratory tract infections 
aOR (95% CI)Postnatal smoking 
Non-smoking (n=2,730) Reference Reference
< 5 cigarettes per day (n=210) 1.11 (0.79, 1.56) 1.92 (1.09, 3.39)*
5-9 cigarettes per day (n=163) 1.01 (0.68, 1.51) 1.26 (0.58, 2.71)
≥ 10 cigarettes per day (n=149) 1.12 (0.73, 1.70) 1.55 (0.73, 3.28)
P-value for trend 0.65 0.22
Values are odds ratios (95% confi dence interval). *P-value < 0.05. 
Data were missing on numbers of cigarettes smoked by mother during pregnancy (n=108) and numbers of cigarettes smoked 
by mother in the postnatal period (n=12).
Values are adjusted for birth weight, gestational age, education and ethnicity mother, siblings, daycare centre and 
breastfeeding. Also adjusted for maternal smoking in the postnatal period (in analyses on maternal smoking ‘stopped when 
pregnancy was known’ or ‘continued during pregnancy’ and respiratory tract infections) or for maternal smoking ‘stopped 
when pregnancy was known’ or ‘continued during pregnancy’ (in analysis on maternal smoking in the postnatal period and 
respiratory tract infections).
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Of the mothers who neither smoked during pregnancy nor in the postnatal period 
(n=2,445), exposure to environmental smoking during pregnancy and in the postnatal 
period together was associated with upper respiratory tract infections (aOR 1.58 (95% CI: 
1.07, 2.35) but not with lower respiratory tract infections (aOR 0.92 (95% CI: 0.41, 2.04)). 
Associations of the other strata of exposure to non-maternal environmental smoking 
with respiratory tract infections were not observed (Table 5).
Discussion
This prenatally enrolled birth-cohort study showed weak evidence for an association of 
maternal smoking in the early postnatal period with lower respiratory tract infections in 
infants in the fi rst 6 months of life. No eff ect of maternal smoking of diff erent duration in 
pregnancy on respiratory tract infections in infants was found. We did not observe dose-
response eff ects for maternal smoking in diff erent periods on respiratory tract infections. 
Exposure to non-maternal environmental smoking both during pregnancy as in the post-
natal period was associated with upper respiratory tract infections.
No previous large population-based prospective cohort study has assessed the 
separate eff ects of diff erent duration of maternal smoking exposure in pregnancy and in 
Table 5. Exposure to environmental smoking and the risk of respiratory tract infections in infants of mothers who 
smoked neither during pregnancy nor in the postnatal period.
Upper respiratory tract infections 
OR (95%CI)
Environmental smoking Model A Model B
Non-exposed (n=1,735) Reference Reference
During pregnancy +, in postnatal period - (n=231) 0.87 (0.65, 1.16) 0.80 (0.58, 1.09)
During pregnancy -, in postnatal period + (n=329) 0.99 (0.78, 1.26) 0.92 (0.71, 1.20)
During pregnancy +, in postnatal period + (n=133) 1.65 (1.16, 2.36)** 1.58 (1.07, 2.35)*
Lower respiratory tract infections 
OR (95%CI)
Environmental smoking Model A Model B
Non-exposed (n=1,735) Reference Reference
During pregnancy +, in postnatal period - (n=231) 0.59 (0.31, 1.10) 0.59 (0.29, 1.18)
During pregnancy -, in postnatal period + (n=329) 0.76 (0.47, 1.24) 0.82 (0.48, 1.41)
During pregnancy +, in postnatal period + (n=133) 0.65 (0.30, 1.43) 0.92 (0.41, 2.04)
Values are odds ratios (95% confi dence interval), *P-value < 0.05. 
Analyses were performed in mothers who neither smoked during pregnancy nor in the postnatal period (n=2,445). 
Data were missing on environmental smoking during pregnancy and/or in the postnatal period (n=17).
Model A: unadjusted.
Model B: adjusted for birth weight, gestational age, education and ethnicity mother, siblings, daycare centre and 
breastfeeding. 
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the postnatal period on both upper and lower respiratory tract infections, until recently. 
Håberg et al observed that maternal smoking during pregnancy and postnatal paternal 
smoking were independent risk factors for lower respiratory tract infections until the 
age of 18 months (35). Other previous studies found risk estimates of 0.77 and 1.23 for 
the associations of prenatal maternal smoking and upper respiratory tract infections 
and lower respiratory tract symptoms, respectively (21, 24). Risk estimates between 1.25 
and 1.74 were found for the associations of maternal smoking in the postnatal period 
and upper and acute respiratory tract infections (24-26, 28). These studies were not per-
formed independent of the timing of smoking relative to pregnancy since most mothers 
who smoked during pregnancy also smoked in the postnatal period. Two previous stud-
ies showed an enhancing eff ect of prenatal maternal smoking in the associations of post-
natal smoke exposure with acute respiratory tract infection and bronchitis, respectively 
(25, 28). One similar study assessed the separate eff ects of prenatal and postnatal smoke 
exposure and showed that maternal smoking at the time of the fi rst antenatal care clinic 
visit in pregnancy led to a higher risk of at least 1.6 for acute ear infections in children 
at the age of 5 years whereas maternal smoking in the third trimester of pregnancy or 
in the postnatal period did not (27). In our study, we report follow up for respiratory 
tract infections until the age of 6 months. This limited time span may underestimate the 
total eff ect of smoke exposure, since assessing respiratory tract infections at older ages 
might show stronger eff ects. After 6 months, there will be less protection of circulating 
maternal antibodies and higher pathogen exposure. The lack of association of maternal 
smoking until early pregnancy with respiratory tract infections might be explained by 
the short fetal exposure time of smoking since it is likely that most women were aware of 
their pregnancy in an early stage. Thus, our fi ndings suggest that exposure to maternal 
smoking limited to early pregnancy has no important infl uence on postnatal risk of respi-
ratory tract infections in the fi rst 6 months. 
The initial response in the Generation R Study is 61%. In our study, non-participation 
would lead to selection bias if the associations of maternal smoking with respiratory tract 
infections diff er between those with and without complete data. This seems unlikely as 
far as non-response on maternal smoking questions in pregnancy is concerned. Informa-
tion about smoking in pregnancy at enrolment was missing in 2.9% of all mothers and 
no diff erence in prevalence of upper and lower respiratory tract infections was present 
between those with and without data on maternal smoking habits during pregnancy 
(upper respiratory tract infections 34.5% and 39.3%; lower respiratory tract infections 
7.4% and 7.4%, respectively). Selection bias due to loss to follow-up could be present 
in our study since infants lost to follow-up more often had smoking mothers than non-
smoking mothers (48.4% and 41.9%, respectively). As a result of this selective loss to fol-
low up, a truly existing eff ect of maternal smoking with respiratory tract infection could 
be missed in our study, subsequently leading to an underestimation of the tendencies 
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we found. The odds ratio’s for the associations of the numbers of cigarettes continuously 
smoked by mother during pregnancy with upper respiratory tract infections (Table 4; 
aOR 1.39, aOR 1.29 and aOR 1.42) all exceeds that of the odds ratio of continued smoking 
with upper respiratory tract infections (Table 2; aOR 1.18). Of the mothers who contin-
ued smoking during pregnancy (n=468), 101 did not report the numbers of cigarettes 
smoked. Infants of these mothers had less upper respiratory tract infections than infants 
of mothers with reported number of cigarettes (41.6% vs. 45%). Bias might have occurred 
leading to overestimated tendencies of the associations of numbers of cigarettes smoked 
by mother during pregnancy with upper respiratory tract infections.
Information about maternal smoking in pregnancy and in the postnatal period was 
prospectively collected by questionnaires without direct reference to respiratory tract 
infections. Although assessing smoking habits by questionnaires seem to be a valid 
method, misclassifi cation may occur, with underreporting of maternal smoking during 
pregnancy and in the postnatal period (36, 37). This could lead to underestimating the 
risk of respiratory tract infections in infants of smoking mothers, especially if smoking 
mothers also tend to underreport respiratory symptoms of their infants. To overcome 
the limitation of underreporting, other studies have used biomarkers of tobacco expo-
sure including cotinine in maternal urine, saliva or blood samples or nicotine in indoor 
air (37-40). However, so far these studies have demonstrated that these biomarkers are 
not superior to self-report when studying the eff ect of maternal smoking on respira-
tory tract infections of their off spring (36, 40-44). The main outcomes in our study were 
self-reported upper and lower respiratory tract infections, and it could be argued that 
self-report may be inaccurate. However, assessing these diagnoses by questionnaires 
is widely accepted in epidemiological studies and reliably refl ect the true incidence of 
respiratory infections (45).
Respiratory tract infections are a major cause of hospitalizations for infants and mater-
nal smoking seems to be a risk factor that can be modifi ed. According to the tendencies 
found in this study, prevention strategies for maternal smoking should be focused on 
early postnatal life. Exposure to environmental smoking during pregnancy and in the 
postnatal period should be limited. Furthermore, studies on respiratory tract infections 
in infants at a later age are necessary to examine the long-term eff ects of maternal smok-
ing during and after pregnancy. 
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Abstract
Objective: To study the prevalence, risk factors and dynamics of pneumococcal carriage 
in infancy.
Study design: In a population-based prospective cohort study in Rotterdam, the Nether-
lands (June 2003 - November 2006), nasopharyngeal swabs were obtained at the age of 
1.5, 6 and 14 months. Data on risk factors were obtained by midwives, hospital registries 
and by postal questionnaires.
Results: Prevalence of pneumococcal carriage increased from 8.3% to 31.3% to 44.5% at 
the ages of 1.5 (n=627), 6 (n=832) and 14 months (n=757), respectively. The prevalence 
of serotypes covered by the 7-valent conjugate increased from 3.0% to 16.2% and 27.7%, 
at the diff erent ages. Having siblings (aOR 4.33, CI 1.22-15.35) and day care attendance 
(aOR 3.05, CI 1.88-4.95 at 6 months and aOR 2.78, CI 1.70-4.55 at 14 months) were associ-
ated with pneumococcal carriage. Pneumococcal carriage at 6 months was associated 
with pneumococcal carriage at 14 months (aOR 2.43, CI 1.50-3.94). Pneumococcal car-
riage was not associated with gender, maternal smoking, educational level mother and 
breastfeeding.
Conclusions: The prevalence of serotypes covered by the 7-valent conjugate vaccine 
increases in the fi rst year of life. Siblings, day care attendance and previous pneumococ-
cal carriage are independent risk factors for pneumococcal carriage.
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Introduction
Streptococcus pneumoniae (pneumococcus) is one of the major causes of bacterial infec-
tions worldwide. Pneumococal infections range from otitis media to life threatening 
invasive infections like sepsis, meningitis and pneumonia (1-3). Young children, elderly 
people, and patients with immunodefi ciencies have an increased risk for pneumococ-
cal infections (4). Pneumococci are frequently carried in the nasopharynx, especially in 
children. Although usually asymptomatic, pneumococcal colonization is the fi rst step 
in the pathogenic route towards an invasive disease. Besides, carriage is the source for 
horizontal spread in the community (5).
Numerous studies have shown that acquisition of pneumococci in the nasopharynx 
occurs early in life (6). Prevalence of pneumococcal carriage increases in the fi rst years of 
life. Crowding, defi ned by family size and day care attendance, is a well-established risk 
factor for pneumococcal carriage (7, 8). For other risk factors like gender, socioeconomic 
status, smoking and breastfeeding the association with pneumococcal carriage is incon-
clusive. Coles et al. (9) found an association between pneumococcal carriage and gender 
and passive smoking. Other could not confi rm this association (10, 11). Greenberg et 
al.(12) found an association between passive smoking and pneumococal carriage in 
infants, in contrast to other studies (9,13). Breastfeeding is protective against respiratory 
tract infections(14-16) and invasive pneumococcal disease (17). However, the associa-
tion between breastfeeding and pneumococcal carriage in human and in vitro studies is 
largely inconclusive (18-22).
Large longitudinal studies on dynamics and risk factors of pneumococcal carriage in 
the fi rst year of life are lacking. Our aim was to study in a population-based prospective 
cohort the prevalence, dynamics and risk factors for pneumococcal carriage during the 
fi rst 14 months of life.
Material and methods
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood (23, 24). Detailed assessments of fetal 
and postnatal growth and development were conducted 1,232 Dutch pregnant women 
and their children, referred to as the Generation R Focus Study (23, 24). The study was 
conducted in Rotterdam, the Netherlands from June 2003 till November 2006. The chil-
dren were planned to visit the research centre at the ages of 1.5 month, 6 months and 14 
months. The Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, has 
approved the study. Written informed consent was obtained from all participants.
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To detect pneumococcal carriage, trained research assistants obtained a single 
nasopharyngeal swab at each visit. Nasopharyngeal samples were taken with rayon 
tipped dacron pernasal swabs. The fl exible swab was inserted into the anterior nares, 
gently rubbed on the posterior nasopharyngeal wall, removed, and stored in Amies 
transport medium at room temperature. Swabs were plated within 6 hours of sampling 
on a blood agar plate with 5% sheep blood to isolate S. pneumoniae. Infants, who used 
antibiotics 48 hours preceding the visit, were excluded. All pneumococci were serotyped 
by capsular swelling method (Quellung reaction) with commercially available antisera 
(Statens Seruminstitut, Copenhagen, Denmark), according to the instructions of the 
manufacturer. These procedures are in line with the standard method as described by 
O’Brien et al.6 and applied by our lab in a previous study (25). All children were born 
before the start of the national pneumococcal vaccination program in the Netherlands. 
The registry of the baby well clinic showed that none of the infants of the cohort was 
vaccinated. In the currently used conjugate vaccine in children under the age of 2 years 
7 serotypes are included (4, 6B, 9V, 14, 18C, 19F and 23F). Based on these 7 serotypes, 
we divided the pneumococci into vaccine-types (VT) and non-vaccine-types (NVT). The 
number of swabs were taken as denominator for the prevalence rate of pneumococcal 
carriage.
Data on gender, parity, birth weight and gestational age were obtained by midwives 
and hospital registries. Information about siblings, breastfeeding, educational level of 
mother, smoking and day care attendance was obtained by postal questionnaires at 
the infants’ age of 6 and 12 months. Mothers were asked whether they ever breastfed 
their infant (no, yes). The duration of breastfeeding was categorized into the groups of 
never breastfeeding, less than 3 months, 3 to 6 months and 6 months or longer. The 
duration of exclusive breastfeeding was estimated by combining the question of dura-
tion of breastfeeding and the questions at what age formula feeding, other types of milk 
and solid food were started in the fi rst 6 months of life. This resulted in three categories: 
1. never breastfed; 2. partially breastfed (breastfeeding, other milk and/or solid food); 
and 3. exclusively breastfed for at least 3 months (‘exclusive’ indicates only breastfeed-
ing, no other milk, solid food, or fl uids other than water). The socio-economic status of 
the mother was defi ned as highest followed education according to the classifi cation of 
Statistics Netherlands and categorized in low, medium and high (26).
Diff erences of infant characteristics between infants with and without nasopharyn-
geal samples were assessed by the independent sample t-test for continuous normal 
distributed variables, non-parametric Mann-Whitney test for continuous non-normal 
distributed variables and the chi-square test for categorical variables. Diff erences of 
pneumococcal carriage between groups with missing risk factors and complete data 
were assessed in the same way. For the longitudinal analyses, the proportion of children 
with pneumococcal carriage was calculated at the age of 1.5, 6 and 14 months. Because 
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repeated measurements within subjects are correlated, a Generalized estimating equa-
tions (GEE) model adjusting for this correlation was applied. Additionally, these regres-
sion models were adjusted for the potential confounders birth weight, parity gestational 
age, gender, siblings, educational level of mother, day care attendance, smoking and 
duration of breastfeeding. Associations of risk factors with pneumococcal carriage are 
presented with odds ratios (OR) with their 95% confi dence interval (CI). All tests were car-
ried out using a two-sided alpha level of 5%. The repeated measurement analyses were 
performed using SAS statistical software, version 9.1 (SAS Institute, Cary, NC, USA). The 
other statistical analyses were performed using the Statistical Package of Social Sciences 
version 11.0 for Windows (SPSS Inc, Chicago, IL, USA). 
Results
Of the 1,232 pregnant women enrolled in the Generation R Focus Study 3 mothers had 
a stillborn infant. The remaining mothers gave birth to 1,244 live born infants. Of 138 of 
these children the consent was withdrawn after birth. Twins (n=27) were excluded from 
the present analyses since they are correlated. Our cohort for analysis consisted of 1,079 
 Table 1. General and infant characteristics (n=1079).
Birth weight (grams) 3509 (538)
Gestational age (weeks) 40.3 (27.6-43.4)
Parity ≥ 1 (%) 38.0 (420)
Gender girl (%) 48.3 (521)
Maternal smoking (%) 12.7 (85)
Educational level mother (%)
Primary school 2.0 (21)
Secondary school 33.9 (361)
Higher education 64.1 (683)
Siblings ≥ 1 (%) 36.7 (256)
Day care (%)
At 6 months 63.7 (611)
At 12 months 69.0 (666)
Breastfeeding (%)
Never 12.7 (98)
< 3 months 25.4 (196)
3-6 months 22.3 (172)
> 6 months 39.6 (306)
Values of birth weight is mean (standard deviation), gestational age is median (range). Other values are percentages (absolute 
numbers). Data were missing on parity (n=2), maternal smoking (n=411), educational level of mother (n=14), siblings (n=381), 
day care attendance at 6 and 12 months of age (n=413 and n=193, respectively) and breastfeeding (n=307).
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infants. The response rates of the visits were 81.8% (n=883) at 1,5 months, 81.6% (n=881) 
at 6 months and 80.0% (n=863) at 14 months of age. Seventy percent of the infants came 
Table 2. Risk factors for pneumococcal carriage at diff erent ages of the infant.
S. pneumoniae 1.5 months S. pneumoniae 6 months S. pneumoniae 14 months
OR aOR OR aOR OR aOR
Birth weight
2.69 
(1.51-4.79)***
2.67 
(1.22-5.86)*
1.41 
(1.07-1.85)*
1.30 
(0.84-2.01)
1.34 
(1.02-1.75)*
1.09 
(0.70-1.71)
Gestational age
1.08 
(0.99-1.17)
1.07 
(0.86-1.34)
1.10 
(1.01-1.20)*
1.05 
(0.91-1.21)
1.13 
(0.96-1.33)
0.96 
(0.84-1.10)
Parity
7.98 
(3.91, 16.26)***
6.85 (
1.96, 23.92)**
1.96 
(1.45, 2.64)***
1.87 
(0.70-5.00)
1.74 
(1.29, 
2.33)***
1.19 
(0.43-3.26)
Gender
1.10 
(0.62-1.93)
1.27
(0.62-2.61)
1.12 
(0.84-1.50)
1.18 
(0.78-1.78)
1.11 
(0.84-1.48)
1.04 
(0.68-1.58)
Educational level 
mother
1.51 
(0.84-2.70)
1.35 
(0.62-2.97)
1.77 
(1.31-2.39)***
1.31 
(0.82-2.08)
1.58 
(1.18-2.12)**
0.95 
(0.59-1.53)
Siblings
9.58 
(3.87-23.71)***
4.33 
(1.22-15.35)***
2.45 
(1.68-3.58)***
1.37 
(0.50-3.73)**
1.69 
(1.16-2.44)**
0.81 
(0.29-2.25)
Day care attendance n.a. n.a.
3.22 
(2.05-5.06)***
3.05 
(1.88-4.95)***
3.14 
(2.17-4.53)***
2.78 
(1.70-4.55)***
Duration of 
breastfeeding
Continuous variable n.a. n.a.
1.33** 
(1.12-1.57)
1.14 
(0.93-1.40)
1.24** 
(1.06-1.46)
1.11 
(0.91-1.37)
Never (reference)
<3 months n.a. n.a.
1.15 
(0.59-2.25)
1.42 
(0.63-3.20)
0.86 
(0.47-1.61)
0.50 
(0.21-1.19)
3-6 months n.a. n.a.
1.71 
(0.88-3.32)
1.82 
(0.82-4.04)
1.50 
(0.81-2.78)
1.10 
(0.47-2.55)
>6 months n.a. n.a.
2.16 
(1.18-3.98)
1.46 
(0.67-3.20)
1.59 
(0.91-2.81)
1.23 
(0.55-2.74)
Exclusive breastfeeding
Formula fed only 
(reference)
Partially breastfed n.a. n.a.
1.63 
(0.89-2.99)
1.76 
(0.84-3.68)
1.31 
(0.75-2.29)
0.91 
(0.42-1.98)
Exclusive breastfed 
> 3 months
n.a. n.a.
1.48 
(0.77-2.81)
1.19 
(0.54-2.65)
1.31 
(0.72-2.37)
0.95 
(0.42-2.14)
Pneumococcus 
at 1.5 months
n.a. n.a.
2.01* 
(1.08-3.73)
1.26 
(0.50-3.14)
1.02 
(0.53-1.95)
0.55 
(0.23-1.30)
Pneumococcus 
at 6 months
n.a. n.a. N.A. N.A.
2.42*** 
(1.73-3.39)
2.43*** 
(1.50-3.94)
Values are crude odds ratios (OR) and adjusted odds ratios (aOR), assessed using a GEE model. Birth weight, gestational age 
and educational level of mother were included in the models as continuous variables (Table 1). Breastfeeding was included 
as continuous variable and as categorical variable. Other variables are binary. 
* p<0.05, ** p<0.01, ***p<0.001.
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to all three visits. The fi rst postnatal measurements in the Generation R Focus Study start-
ed June 2003, data collection on pneumococcal carriage started November 2003, so data 
on pneumococcal carriage in the fi rst 224 participants at 1.5 months of age are missing. 
Therefore, the number of swabs taken was 627 at 1.5 months, 832 at 6 months and 757 
at 14 months of age. The number of swabs were taken as denominator for the prevalence 
rate of pneumococcal carriage. Characteristics of the infants are presented in Table 1. 
Prevalence of pneumococcal carriage increased signifi cantly (p<0.001) from 8.3% 
(52/627) to 31.3% (260/832) to 44.5% (337/757) at the ages of 1.5, 6 and 14 months, 
respectively. The prevalence of serotypes covered by the 7-valent conjugate vaccine (VT) 
increased from 3.0% (19/627) to 16.2% (135/832) and 27.2% (206/757), at the diff erent 
ages. VT-related serotype 6A was found in 1.0% (6/627), 3.4% (28/832) and 5.8% (44/757) 
infants at the diff erent ages. Diff erences in prevalence of VT and NVT carriage at diff erent 
ages were statistically signifi cant (p<0.05). Of the 21 children who carried pneumococci 
at both 1.5 and 6 months of age, fi ve (23.8%) pneumococci were of the same serotype. Of 
the 116 children who carried pneumococci at both 6 and 14 months of age, 17 (14.6%) 
pneumococci were of the same serotype. The distribution of serotypes in the infants 
carrying pneumococci at two ages was comparable to the serotype distribution in the 
infants with one positive pneumococci sample. Pneumococcal carriage at three sample 
time points was found in 6 infants. None of these were the same serotype. 
Risk factors for pneumococcal carriage at diff erent ages are shown in Table 2. Analy-
ses of missing nasapharyngeal samples showed that infants without nasapharyngeal 
samples at the age of 1.5 months more often were breastfed than infants with nasapha-
ryngeal samples (94.0% and 86.8%; p-value<0.001). Infants without nasapharyngeal 
samples at the age of 14 months had a lower birth weight than infants with nasopharyn-
geal samples (3451 grams and 3533 grams; p-value=0.02). All other risk factors showed 
no signifi cant diff erences between children with and without nasopharyngeal samples 
at diff erent ages. Analyses of missing risk factors showed that infants with missing data 
on siblings more often carried pneumococci (p< 0.05) Analyses of all other missing risk 
factors showed no diff erences in pneumococcal carriage between children with non-
missing and missing risk factors.
Discussion
In our study pneumococcal carriage increased during the fi rst year of life from 8.3% to 
31.3% to 44.5% at the ages of 1,5, 6 and 14 months of age. This is in line with other studies 
of comparable populations (8, 10, 25, 27-29). Interestingly, the prevalence of serotypes 
that are present in the 7-valent conjugate vaccine was low 3.0% at 1.5 months of age, 
and increases to 27.2% at 14 months of age. At 1.5 months of age the prevalence as well 
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as the vaccine-type versus non-vaccine-type distribution mirrors that of the adults (25, 
30), while at 6 and 14 months of age carriage rates and vaccine-type non-vaccine-type 
distribution showed a similar pattern as found in children (25). The reason for the diff er-
ence in carriage rates among adults and children is not yet known. Regev-Yochay et al. 
(31) speculate that the presence of antibodies to pneumococci in adults might be the 
explanation. Circulating maternal antibodies in young infants might explain the adult 
pneumococcal carriage pattern in infants at 1.5 months of age.
Pneumococcal carriage is determined by environmental and host factors. The 
most important environmental factors in our study were having siblings and day care 
attendance. This is in line with previous studies (5). No association was found between 
pneumococcal carriage and maternal smoking. However, number of mothers who smoke 
is rather low. The cohort represents a rather healthy population (24). Detailed data of 
exposure to passive smoking are missing. We found no association between pneumo-
coccal carriage and duration of breastfeeding or exclusive breastfeeding. The duration 
of breastfeeding showed a tendency to be a risk factor for pneumococcal carriage in 
the univariate analysis, but the confounding factors siblings, day care attendance and 
educational level of mother explained this eff ect. In vitro studies have shown that human 
milk and colostrums inhibits the attachment of pneumococci to epithelial cells (18, 19, 
31). On the other hand, Rosen et al. (22) showed that pneumococcal capsular antibod-
ies in human milk do not protect against carriage. Lower rates of carriage in exclusively 
breastfed children were described once, while another study concluded no association 
between breastfeeding and pneumococcal carriage (20, 21). One study has demonstrat-
ed that colostrum-fed infants were more likely to carry pneumococci at 2 months of age 
than infants from whom colostrum was withheld (9). We expected breastfeeding to be 
protective against pneumococcal carriage because it is shown to protect against otitis 
media, other respiratory tract infections (14-16), and invasive pneumococcal disease (17, 
32). An explanation that breastfeeding does not protect against pneumococcal carriage 
but does protect against mucosal infections is given by Finn et al. (33). They showed that 
secretory IgA-associated killing by phagocytes is complement-dependent, but levels of 
complement at mucosal surfaces are low. It is speculated that in the presence of active 
mucosal infection, suffi  cient amounts of complement may exude from plasma into the 
mucosal site to support killing of pneumococci.
In our study, high birth weight was associated with pneumococcal carriage at 1.5 
months of age. To our knowledge this has never been reported before. One might specu-
late that infants with higher birth weight are exposed to crowding environment more 
easily, because infants with low birth weight are treated diff erently by their parents. 
We found an independent association between pneumococcal carriage at 6 months 
of age and carriage at 14 months of age. This was not explained by any of the risk factors 
or by lengthy carriage of the same serotype. Only 17 (14.6%) out of the 116 pneumococci 
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carried at both 6 and 14 months of age were of the same serotype. The distribution of 
serotypes in the group carrying pneumococci at two sample times was comparable to 
the serotype distribution in the infants carrying pneumococci once. This fi nding implies 
that repeated pneumococcal carriage is not restricted to specifi c serotypes. Our fi ndings 
suggest that, besides the studied environmental factors, other unknown environmental 
(exposure) factors not evaluated in our cohort or (genetic) host characteristics might 
infl uence the risk of being colonized at 14 months of age. 
To appreciate the results some methodological issues should be considered. The 
response in the Generation R Focus Study is above 80%. None of the participating infants 
had used antibiotics in the previous 48 hours. This suggests that children with active infec-
tious diseases were not attending at the scheduled visit and their visits to the research 
centre were delayed by the parents. Excluding participants with missing data would lead 
to selection bias if the associations of the risk factors with pneumococcal carriage diff er 
between infants with and without missing data. No diff erence in the distribution of the 
risk factors siblings, day care attendance and breastfeeding was found between those 
with and without data on pneumococcal carriage at any of the ages. Complete data 
were available for birth weight, gestational age and gender. Infants with missing data 
on siblings more often carried pneumococci than infants with data on siblings. Due to 
selective missing data on siblings the observed association of siblings with pneumococ-
cal carriage might be underestimated. No other diff erences in carriage rates were found 
between those with and without missing data on all other risk factors.
In summary, having siblings and day care attendance are independent risk factors 
for pneumococcal carriage, as well as previous pneumococcal carriage. No association 
between duration and exclusive breastfeeding and pneumococcal carriage was found. 
In infants 1.5 months of age the prevalence of VT’s is signifi cantly lower than in infants 
of age 6 and 14 months. Besides the environmental factors, additional research is justi-
fi ed to clarify the role of circulating maternal antibodies in infants, mucosal antibody 
response and genetic predispositions of the infants in pneumococcal carriage. 
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Abstract
Objective: To examine the maturation of T, B and NK lymphocytes in children from birth 
until the age of 24 months. 
Methods: This study was embedded in the Generation R Study, a population-based 
prospective cohort study from fetal life onwards. Lymphocytes (T, B and NK) and their 
diff erent maturation phases were immunophenotyped in (cord) blood samples at birth 
(n=570), 6 months (n=384), 14 months (n=251) and 24 months (n=200) by 6-color fl ow 
cytometry.
Results: A large pool of naïve lymphocyte subsets was present at all ages. Within the T 
lymphocytes, both the subsets of memory D and eff ector CD8+ T lymphocytes increased 
(0.1% to 1.5%) from birth until 24 months. Memory CD19+ B lymphocytes increased from 
0.5% to 3.0%. Within this subset, IgM decreased (65% to 36%), IgA remained stable (20%) 
and IgG increased (11% to 19%). The amount of eff ector CD19+ B lymphocytes did not 
materially change (4%). The percentage of ‘memory’ CD19+ B lymphocytes decreased 
from birth until 6 months (6% to 4%) and increased thereafter (6%). Of the CD56+ NK 
lymphocytes, both the immature CD56bright subsets increased from birth until 6 months 
(2% to 6% and 7% to 13%, respectively). Immature CD56dim decreased 1.5-fold in the fi rst 
6 months of age and remained stable thereafter (50%). A 1.7-fold increase from birth 
until 6 months was observed for eff ector CD56+ NK lymphocytes (18% to 31%).
Conclusions: Our study showed that in the fi rst postnatal years the largest change in 
maturation phases of lymphocytes subsets occurs in the fi rst 6 months of life.
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Introduction
Lymphocytes have an important role in the adaptive human immune response. The lym-
phocyte compartment in the peripheral blood consists of three major subsets; T, B and 
NK lymphocytes. It is known that the amount of T, B and NK lymphocytes changes during 
childhood (1, 2). Within each of these lymphocyte populations several subsets might be 
identifi ed and related to their diff erent function or maturation state.
T lymphocytes: in the peripheral blood, T lymphocytes can be divided into two major 
subsets based on the expression of CD4 or CD8. While CD4+ T lymphocytes are deter-
mined as ‘helper’ T lymphocytes, CD8+ T lymphocytes are cytotoxic lymphocytes which 
might react upon viral infections in the host. They recognize viral peptides in the con-
text with MHC class I and lyse cells bearing these complexes. CD8+ T lymphocytes can 
be divided into diff erent subsets according to their maturation stage (3, 4). Naïve CD8+ 
T lymphocytes are lymphocytes that have not been exposed to antigens yet. During a 
viral infection, naïve CD8+ T lymphocytes become activated and either diff erentiate into 
eff ector CD8+ T lymphocytes or convert into memory-type CD8+ T lymphocytes. Memory 
CD8+ T lymphocytes await re-challenge with antigens and than become eff ector lympho-
cytes. Memory CD8+ T lymphocytes can be further subdivided based on the frequency of 
antigen-stimulation and proliferation capacity (5). The eff ector CD8+ T lymphocytes are 
lymphocytes that are capable of lysis of target (virus infected) lymphocytes. 
Based on the expression of CD45RO, CD45RA, CD27, CD28 and CD197, the diff erent 
CD8+ T lymphocyte subsets can be discriminated in naïve, memory A to D and eff ector 
cells (3, 4). It could be expected that with increasing age, CD8+ T lymphocytes have more 
often been exposed to antigens so that more ‘mature’ memory and eff ector T lympho-
cytes will arise. 
B lymphocytes: B lymphocytes appear in peripheral blood and in secondary lym-
phoid tissues after they have diff erentiated from precursor B lymphocytes in the bone 
marrow. Multiple B lymphocyte subsets have been identifi ed in the peripheral blood, 
either naïve or already exposed to antigens (6-8). The transitional B lymphocytes are the 
most immature lymphocytes that appear in the peripheral blood and can be identifi ed 
due to expressing CD38+/ CD24+/ IgD+. They form a relatively small subset compared with 
CD38+/IgM+/IgD+/CD27- naïve mature B lymphocytes (9, 10). A substantial fraction of the 
naïve B lymphocytes express the CD5 antigen and is capable of producing polyreactive 
antibodies (11). The natural eff ector B lymphocytes in blood are the counterparts of 
splenic marginal zone B lymphocytes expressing IgM, IgD and CD27. The last B lympho-
cyte subset that can be identifi ed in peripheral blood are the memory B lymphocytes 
(IgD-/CD27+), which can be further subdivided into IgM, IgG and IgA expressing memory 
B lymphocytes.
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NK lymphocytes: NK lymphocytes represent approximately 10-15% of the circulating 
lymphocytes in the peripheral blood. These lymphocytes are critical for host immunity 
because of their ability to quickly mediate cytotoxicity against pathogen infected or 
malignantly transformed lymphocytes. They also produce a wide variety of cytokines and 
chemokines that infl uence other lymphocytes of the immune system. The phenotype of 
NK lymphocytes is based on the absence of CD3 and expression of CD56. Based on their 
CD56 expression, NK lymphocytes can be divided into two subsets: the major part mildly 
expressing this antigen (CD56dim) and a small part (approximately 2-5% of the total CD3-/
CD56+ population) with a very bright expression of this antigen (CD56bright) (12, 13). The 
CD56dim and CD56bright lymphocytes diff erently express several other antigens. In adults, at 
least 48 subsets within the NK lymphocyte population can be identifi ed in the peripheral 
blood (14). For example CD16, CD94, CD2 and CD25 are all heterogeneously expressed on 
NK lymphocytes, but with diff erent intensity within the CD56dim and CD56bright subsets. It 
has been postulated that these subsets of NK lymphocytes represent diff erent functions, 
which also might explain the diff erences in marker expression of adhesion molecules 
and killer inhibitory receptors (KIR) (15). It has been suggested that CD56dim lymphocytes 
are granular cytotoxic lymphocytes and that CD56bright lymphocytes are modulators by 
producing cytokines (16). The general idea is that the CD56bright are immature lympho-
cytes which can give rise to CD56dim lymphocytes (17, 18). This maturation step of NK 
lymphocytes is based on the diff erential expression of CD94 and CD16.
During childhood, absolute and relative numbers of T, B and NK lymphocytes change 
(1, 2). However, detailed information of the normal distribution and maturation of the 
subsets of these lymphocytes are lacking. Therefore, our aim was to examine the diff erent 
maturation phases of T, B and NK lymphocytes in peripheral blood samples of children 
from birth until 24 months in a population-based prospective cohort study.
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. The Generation R Study was designed 
to identify early environmental and genetic determinants of growth, development and 
health and has been described previously in detail (19, 20). Detailed assessments of fetal 
and postnatal growth and development were conducted in a subgroup of Dutch preg-
nant women and their children, referred to as the Generation R Focus Study (19, 20). This 
subgroup is ethnic homogeneous to exclude possible confounding or eff ect modifi ca-
tion by ethnicity. Of all approached Dutch pregnant women and their partners, 1,232 
(79%) participated in the Generation R Focus Study. Their children were born between 
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February 2003 and August 2005. The Medical Ethics Committee of the Erasmus Medical 
Center, Rotterdam, has approved the study. Written informed consent was obtained from 
all participants. Sampling of (cord) blood was performed at birth and at the ages of 6, 14 
and 24 months.
Immunophenotyping of lymphocyte subsets 
At birth, venous cord blood was sampled in heparinized tubes by midwifes and obstetri-
cians immediately after delivery and transported at room temperature to the Laboratory 
of Immunology of the Erasmus Medical Center within 24 hours. Umbilical cord blood 
samples not received within 24 hours (weekend days) were excluded since fl ow cyto-
metric analyses of those samples showed no reliable results in the pilot phase of the 
study. At the ages of 6, 14 and 24 months, venous blood was sampled in tubes with EDTA 
as anticoagulant. Flow cytometric immunophenotyping was performed to determine 
absolute numbers of lymphocytes (T, B, NK, CD4+, CD8+ and TCRγδ). Furthermore, relative 
numbers of the subsets within the T, B and NK lymphocyte population were detected. 
For this, the several monoclonal antibodies were conjugated with the labels fl uorescein 
isothiocyanate (FITC1), peridin chlorophyll protein (PerCP1), peridin chlorophyll protein-
cychrome 5.5 (PerCP-Cy5.51), allophycocyanin (APC1), phycoerythrin (PE1,3), phycoeryth-
rin-cyanin dye (PE-cy71), allophycocyanin-cyanin dye (APC-cy71) and rhodamine (RD12) 
(1Becton Dickinson,2Beckman Coulter and 3Dako) (Table 1). Absolute numbers of T, B and 
NK lymphocytes were determined with the lysed whole blood technique (50 μl of whole 
blood per sample) using the routine standardized single platform method with BD Tru-
COUNT Tubes of Becton Dickinson (BD). With this, lymphocytes were gated on the basis 
of CD45 and FSC to prevent contamination of unlysed erythrocytes (21, 22). The samples 
Table 1. Flow cytometric monoclonal antibodies.
Monoclonal antibody labels
FITC PE PerCPCy5.5 PE-Cy7 APC APC-Cy7
1 CD3 CD16.56 CD45 CD4 CD19 CD8
2 CD27 CD45RA CD3 CD4 CD45RO CD8
3 CD2 CD56 CD3 CD7 CD5 CD8
4 CD28 CD197 CD3 CD8 CD45RO CD27
5 TCRAB TCRGD CD3 CD4 CD8 -
6 CD94 CD16 CD3 CD56 CD8 CD2
7 SmIgK SmIgL CD19 CD21 CD22 CD81
8 SmIgD CD23 CD19 CD21 SmIgM CD5
9 SmIgA SmIgG CD19 CD40 SmIgM CD27
10 CD57 CD38 CD3 CD56 HLA-DR CD8
FITC=fl uorescein isothiocyanate, PE=phycoerythrin, PerCPCy5.5=peridin chlorophyll protein, PE-cy7=phycoerythrin-cyanin 
dye, APC=allophycocyanin and APC-cy7=allophycocyanin-cyanin dye.
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were measured on a FACS Calibur fl ow cytometer (BD) and analyzed with BD Lympho-
cyteQuestTM software as indicated by the manufacturer. This fl ow cytometer is routinely 
used in the diagnostic laboratory and every day reference calibration beads are used. 
Subsets within the T, B and NK lymphocytes were determined using 6-colour staining 
and detected on a BDTM LSR II fl ow cytometer (Becton Dickinson, San Jose, California, US). 
Therefore, erythrocytes of 1 ml whole blood were lysed using 50 ml ammoniumchloride. 
After centrifugation, leucocytes were washed twice and suspended in 900 μl PBS/1% 
BSA/0.1% NaAz. Of this suspension (5-10*106/ml), 50 μl was incubated for 10 minutes 
at room temperature with combinations of the optimally titrated labeled monoclonal 
antibodies. After incubation the cells were washed and subsequently identifi ed by fl ow 
cytometry. Using a BDTM LSR II fl ow cytometer that had been calibrated with rainbow 
beads, 10,000 lymphocytes were measured. 
Subsets of within the T, B and NK populations were analyzed as percentages of the 
total population using BD FacsDIVATM. For the helper T, cytotoxic T and TCRγδ lymphocytes, 
absolute counts could not be obtained directly from the TruCOUNT method. Therefore, 
the absolute counts for these subsets were calculated as follows: the relative counts of 
helper T, cytotoxic T and TCRγδ lymphocytes were expressed as the percentage within the 
total T lymphocyte population and, if possible, calculated by the average of 2-4 indepen-
dent incubations for each subset. The absolute counts of these T lymphocyte subsets 
were subsequently calculated from the absolute T lymphocyte counts as obtained by 
the lysed whole blood technique. The absolute counts of the total T lymphocytes deter-
mined with the single platform method were compared with the recalculated counts of 
the total T lymphocytes (% of lymphocytes within the leukocyte count, determined by 
a lymphocyte counter). There was no signifi cant diff erence between the two methods 
(23). 
Statistical analysis
Absolute numbers and percentages of lymphocyte subsets are presented as medians 
with their 5 to 95% range, since these variables were not normally distributed. The sta-
tistical analyses were performed using the Statistical Package of Social Sciences version 
11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Cohort for analysis 
In total, 1,232 women were enrolled in the Generation R Focus Study. Of these women, 
901 (73%), 882 (72%) and 856 (70%) children participated on the postnatal examina-
tions at the age of 6, 14 and 24 months, respectively. In June 2007, blood samples for 
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immunophenotyping were available from 571 (birth), 384 (6 months), 251 (14 months) 
and 200 (24 months) children. Main reasons for missing cord blood sample data were due 
to logistic constraints at delivery (27%) and non-heparinized cord blood samples (26%). 
Missing blood sample data at the postnatal visits were mainly due to no consent of the 
parents (approximately 55% per visit) and technical failure (approximately 10% per visit). 
Of the children with available blood sample data 2% were twins and 10% were siblings 
since mothers were allowed to participate with second pregnancies. These children were 
included in the present study since there were no diff erences in results between twins 
and siblings mutually or between twins or siblings and the other participating children. 
At birth, 301 (53%) children were boys and 207 (47%) were girls. Median ages (90% range) 
of the children at the timing of blood sampling were gestational age 40.4 (37.7-42.1) 
weeks, 6.2 (5.5-7.8) months, 14.4 (13.5-16.3) months and 25.2 (23.8-27.5) months.
T, B and NK lymphocytes
Absolute numbers of T lymphocytes increased 1.6-fold from birth (median 2.81 (90% 
range: 1.51, 4.79) x 109/L) until 6 months (4.61 (2.51, 7.73) x 109/L) (Figure 1). Thereaf-
ter, absolute numbers gradually decreased to a median of 2.82 (1.59, 5.04) x 109/L at 24 
months. For B lymphocytes, a 2.5-fold increase from birth (0.70 (0.29, 1.73) x 109/L) until 6 
months (1.72 (0.79, 3.34) x 109/L), followed by a decrease to 1.17 (0.52, 1.89) x 109/L at 24 
months was observed. The medians of absolute numbers of NK lymphocytes were 0.88 
(0.23, 2.02) x 109/L at birth gradually decreasing to 0.23 (0.12, 0.61) x 109/L at 24 months. 
The absolute numbers of TCRγδ+ showed a 2-fold increase from birth (0.07 (0.03, 0.18) x 
109/L) until 6 months (0.14 (0.06, 0.29) x 109/L) and remained stable thereafter.
Maturation of lymphocyte subsets
T lymphocytes
Absolute numbers of CD3+/CD4+ helper T lymphocytes and CD3+/CD8+ cytotoxic T lym-
phocytes both followed the trend of absolute numbers of total T lymphocytes with a 
1.6-fold increase from birth until 6 months and a gradual decrease thereafter (fi gure 1). 
Of the CD3+/CD8+ cytotoxic T lymphocytes, the percentage of naïve CD8+ lymphocytes 
increased from 66% to 75% from birth until 24 months (Figure 2). From birth until 6 
months, memory A and C CD8+ lymphocytes decreased 2-fold and memory B CD8+ lym-
phocytes increased 2-fold. Thereafter, all showed a gradual decrease until 24 months. 
Memory D and eff ector CD8+ lymphocytes increased from 0.1% to 1.5% and 0.1 to 1.2%, 
respectively, from birth until 24 months.
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B lymphocytes
The percentage of naïve CD19+B lymphocytes remained stable at all ages (Figure 3). An 
increase from 0.5% to 3% of absolute numbers of memory CD19+B lymphocytes was 
observed from birth until 24 months. Within this subset, Ig’s redistributed largely. IgM 
decreased from 65% to 36%, IgA remained stable around 20% and IgG increased from 
11% to 19%. The percentage of eff ector CD19+B lymphocytes did not materially change 
(approximately 4%). The percentage of ‘memory’ CD19+B lymphocytes decreased from 
birth until 6 months (6% to 4%) but increased again to 6% thereafter. The SmIgκ/SmIgλ-
ratio increased from birth until 6 months (1 to 1.5) and remained stable thereafter.
Figure 1. Absolute numbers (x 109/L) of the main lymphocyte subsets in children from birth until 24 months. Age 
groups and the number of individuals per age group are indicated. NCB, neonatal cord blood.
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NK lymphocytes
NK lymphocyte subsets determination was based on the expression of CD56, CD16 and 
CD94, which might refl ect diff erent maturation stages. Of the CD56+ NK lymphocytes, 
the percentage of both immature CD56bright/CD94-/CD16- (immature I) and immature 
CD56bright/CD94+/CD16- (immature II) lymphocytes increased from birth until 6 months 
(2% to 6% and 7% to 13%, respectively) and did not materially change thereafter (Figure 
4). Immature CD56dim/CD94-/CD16-) decreased 1.5-fold in the fi rst 6 months but remained 
stable thereafter (50%). A 1.7-fold increase from birth until 6 months was observed for 
eff ector CD56+ NK lymphocytes (18% to 31%).
Discussion
This large prospective cohort study from birth until the age of 24 months showed major 
changes in absolute numbers of lymphocyte subsets mostly during the fi rst 6 months 
after birth. These results are in line with previously published, mostly smaller sample 
sized, studies (1, 2, 24). A large pool of naïve lymphocytes of all subsets was present 
at all the measured age points (birth, 6, 14 and 24 months). The maturation phases of 
the diff erent lymphocyte subsets largely changed between birth and 6 months. It seems 
that the adapted immune system at birth quickly matures and probably responses after 
being exposed to antigens for the fi rst time. At the time of a viral infection, CD8+ T lym-
phocytes become activated and diff erentiate into eff ector lymphocytes or convert into 
memory-type lymphocytes. Viral infections occur mostly in the fi rst years of life and are 
the leading cause of morbidity in infancy (25, 26). In line with this, our study showed 
that with increasing age more ‘mature’ memory and eff ector CD8+ T lymphocytes arise. 
Whether there are direct associations between the number and severity of infections and 
the maturation of the CD8+ T lymphocytes in children remains to be studied. 
From birth until 24 months, the percentage memory CD19+ B lymphocytes increased 
with a decreased expression of IgM and increased expression of IgG. This class switch 
is in line with the maturation of B lymphocytes. Which and to whether extent these Ig 
receptors recognize and respond to antigens needs to be studied in further detail. We 
observed a switch of CD27+ memory B lymphocytes into CD27- B lymphocytes in our 
cohort. CD27- B lymphocytes recently showed to be post germinal center cells belong-
ing to the memory compartment (27). In our cohort, these new ‘memory’ B lymphocytes 
comprised 4 to 6% of the CD19+ B lymphocytes and approximately 80% of the IgG+ B 
lymphocytes. In adults, the percentage of this specifi c ‘memory’ B lymphocytes is only 
approximately 1% of the CD19+ B lymphocytes and 25% of the IgG+ B lymphocytes 
(27-29). The reason for the percentual diff erence of this B lymphocyte subset between 
children and adults needs to be investigated.
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Median absolute numbers of CD56+ NK lymphocytes were high at birth (0.9 x109/L) 
after which they decreased and remained stable over time (0.3 x109/L). The large pool 
of absolute numbers of CD56+ NK lymphocytes at birth might be explained by mode of 
delivery related stress and hypoxia during delivery (30). Of the CD56+ NK lymphocytes, 
an increase of both immature CD56bright subsets (I and II) and eff ector CD56+ NK lympho-
cytes was observed. The distribution of the diff erent NK lymphocyte subsets at the age 
of 6 months was already similar as in adults (14). Whether these changes are part of the 
maturation process or related to the NK lymphocyte function remains to be studied. 
Some methodological issues need to be considered. Analyses of missing umbili-
cal cord blood samples showed that neonates without cord blood samples more often 
had a lower median gestational age and lower mean birth weight than neonates with 
cord blood samples (median gestational age: 40.1 and 40.4 weeks (Mann-Whitney test, 
p<0.01); mean birth weight: 3454 and 3562 grams (independent sample t-test, p<0.01); 
respectively). Missing postnatal blood samples were mainly due to refusal to participate 
by the parents (55%), although we minimized the pain by using local anaesthetics like 
lidocain/prilocain (Emla ©). Unfortunately, we did not have information on possible 
underlying diseases of the children. It could be expected that parents whose children are 
‘sick’ and regularly need blood examinations more often refuse to participate. Therefore, 
it might be that our cohort is selected towards a more healthy study population. How-
ever, for presenting our data as ‘normal’ maturation of lymphocyte subsets this potential 
selection to a ‘healthy’ group may be advantageous.
In conclusion, our extensive study on more than 200 blood samples per age group 
provides reliable insight into maturation phases of the diff erent subsets of lymphocytes 
from birth until the age of 24 months of age. The largest changes in the maturation phas-
es of these lymphocytes seem to occur in the fi rst 6 months after birth probably due to 
contact with antigens for the fi rst time. These immunophenotyping data might be used 
as reference values. However, when interpreting the values of the diff erent lymphocyte 
subsets other potential infl uencing factors like growth, perinatal stress or hypoxia and 
infectious diseases that induce changes in the maturation phases of these lymphocytes 
need to be kept in mind. 
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Abstract
Background: Preterm born and low birth weight infants are at risk for severe infections in 
infancy. It has been suggested that these infants have an immature immune system.
Objective: To assess the associations of gestational age, birth weight and fetal growth 
with absolute lymphocyte subset counts at birth. 
Methods: This study was conducted in 571 infants participating in the Generation R 
Study, a population-based prospective cohort study from fetal life onwards. Gestational 
age and birth weight were obtained from midwives and hospital registries. Fetal growth 
was defi ned as increase in weight between late pregnancy and birth. Lymphocytes and 
T lymphocyte subset counts in cord blood were determined by 6-color fl owcytometry. 
Mulivariate linear regression models with adjustment for gender, maternal education, 
smoking, alcohol use, fever and mode of delivery were applied.
Results: Per week increase of gestational age, T, B and NK lymphocyte counts increased 
with 3%, 5% and 6%, respectively (p-values<0.05). Helper, cytotoxic and naïve T lympho-
cyte counts increased with 3%, 4% and 5%, respectively (p-values<0.05), but memory T 
lymphocyte counts did not. Increased birth weight and fetal growth were signifi cantly 
associated with higher B lymphocyte counts, independent of gestational age, but not 
with the other lymphocyte subset counts. 
Conclusions: Lymphocyte subset counts increase with prolonged gestation, suggesting 
an ongoing development of the immune system. Birth weight and fetal growth seem to 
infl uence only B lymphocyte counts. 
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Introduction
Preterm born or low birth weight infants are at risk for severe infections in infancy (1, 2). 
It has been suggested that these infants have an immature immune system. Decreased 
percentages or absolute counts of lymphocytes are described in infected preterm infants 
(3).
Previous studies, mostly small sample sized, presented lower percentage and abso-
lute numbers of T lymphocytes and T lymphocyte subsets at an earlier gestational age, yet 
results on NK and B lymphocyte counts are inconclusive (4-11). A small number of studies 
on birth weight and the development of the immune system have been performed and 
showed lower absolute lymphocyte subset counts in low birth weight infants (9, 12, 13). 
However, most of these studies did not take gestational age into account. Birth weight 
is only a proxy for fetal growth since several fetal growth and development patterns 
may lead to the same birth weight. Fetal growth restriction may lead to normal birth 
weight if the fetus is actually supposed to grow on the upper percentiles based on the 
genetic growth potential. Fetal growth restriction with impaired fetal thymus and liver 
growth has been suggested to infl uence the development of the immune system (14-16). 
Therefore, longitudinally measured fetal growth may be stronger related to lymphocyte 
counts than birth weight per se.
We examined in the Generation R Focus Study, a population-based prospective 
cohort study from fetal life onwards, the associations of gestational age, birth weight 
and longitudinally measured fetal growth with absolute numbers of lymphocytes (T, B 
and NK) and T lymphocyte subsets (helper, cytotoxic, naïve and memory) at birth. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood in Rotterdam, The Netherlands. The 
Generation R Study was designed to identify early environmental and genetic deter-
minants of growth, development and health and has been described previously in 
detail (17, 18). Additional, more detailed assessments of fetal and postnatal growth and 
development were conducted in a subgroup of 1,232 Dutch pregnant women and their 
children, referred to as the Generation R Focus Study (17, 18). This subgroup is ethnic 
homogeneous to exclude possible confounding or eff ect modifi cation by ethnicity. Of 
all approached pregnant women and their partners, 79% participated in the Generation 
R Focus Study. Their children were born between February 2003 and August 2005. The 
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Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, has approved the 
study. Written informed consent was obtained from all participants. 
Gestational age, birth weight and fetal growth
Information about date of birth and birth weight was obtained from standardized mid-
wife and hospital registries. Gestational age at birth was based on pregnancy dating 
by ultrasound in early pregnancy (19). Estimated fetal weight was determined in late 
pregnancy (>25 weeks) using the formula of Hadlock with the parameters abdominal 
circumference, head circumference and femur length measured by ultrasound (20). Fetal 
weight measurements were converted into gestational age adjusted standard devia-
tion scores (SDS) (21). Fetal growth was defi ned as fetal weight gain (SDS) between late 
pregnancy and birth. For the latter analysis, gestational age adjusted standard deviation 
scores (SDS) were also constructed for birth weight measurements. 
Immunophenotyping of lymphocyte subsets 
Heparinized sampling of venous cord blood was carried out by midwifes and obstetri-
cians immediately after delivery and transported to the Immunology laboratory of the 
Erasmus Medical Center within 24 hours. Umbilical cord blood samples not received 
within 24 hours (weekend days) were excluded since fl ow cytometric analyses of those 
samples showed no reliable results in the pilot phase of the study. Flow cytometric 
immunophenotyping was performed to determine absolute numbers of lymphocytes (T, 
B and NK) and T lymphocyte subsets (helper, cytotoxic, naïve and memory T). For this, the 
monoclonal antibodies CD3, CD19, CD16.CD56, CD4, CD8, CD45RA and CD45RO were 
conjugated with the labels fl uorescein isothiocyanate (FITC1), peridin chlorophyll pro-
tein (PerCP1), peridin chlorophyll protein-cychrome 5.5 (PerCP-Cy5.51), allophycocyanin 
(APC1), phycoerythrin (PE1,3), phycoerythrin-cyanin dye (PE-cy71), allophycocyanin-cyanin 
dye (APC-cy71) and rhodamine (RD12) (1Becton Dickinson,2Beckman Coulter and 3Dako). 
Absolute numbers of T, B and NK lymphocytes were determined with the lysed whole 
blood technique (22). Subsets of the T lymphocytes were determined by 6-color fl ow 
cytometry. Therefore, erythrocytes of 1 ml whole blood were lysed using 50 ml ammoni-
umchloride. After centrifugation, leucocytes were washed twice and suspended in 900 
μl PBS/1% BSA/0.1% NaAz. Of this cell suspension (5-10*106/ml), 50 μl was incubated 
for 10 minutes at room temperature with combinations of the optimally titrated labeled 
monoclonal antibodies. After incubation the cells were washed and subsequently identi-
fi ed by fl ow cytometry. Using a BDTM LSR II fl ow cytometer (Becton Dickinson, San Jose, 
California, US) that had been calibrated with rainbow beads, 10,000 lymphocytes were 
measured. The relative count of helper T lymphocytes, cytotoxic T lymphocytes, naïve 
T lymphocytes and memory T lymphocytes was expressed as the percentage within 
the total T lymphocyte population and calculated by the average of 2-4 independent 
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incubations for each subset. The absolute counts of the T lymphocyte subsets were sub-
sequently calculated from the absolute T lymphocyte counts as obtained by the lysed 
whole blood technique.
Covariates
Information about maternal education, smoking and alcohol use was obtained by 
postal questionnaires in early, mid- and late pregnancy. Educational level was defi ned 
as highest followed education (lower or higher education) according to the classifi ca-
tion of Statistics Netherlands (23). Maternal smoking and alcohol use during pregnancy 
were categorized into ‘not during pregnancy’ and ‘ during pregnancy’. Information about 
maternal fever (>380 C), indicating a possible underlying infection, was recorded in late 
pregnancy. Mode of delivery was registered by midwives and obstetricians.
Statistical analysis
Diff erences of maternal and infant characteristics between infants with and without 
umbilical cord blood samples were assessed by the independent sample t-test for con-
tinuous normal distributed variables, non-parametric Mann-Whitney test for continuous 
non-normal distributed variables and the chi-square test for categorical variables. 
Data on all lymphocyte subsets were log-transformed to obtain normal distributed 
variables. Associations of continuously measured gestational age, birth weight and 
fetal growth in late pregnancy with absolute numbers of lymphocyte and T lymphocyte 
subsets were analyzed using linear regression models. Additionally, these models were 
adjusted for the potential confounders including gender, maternal education, smoking, 
alcohol use, fever and mode of delivery. Measures of associations are presented as log-
transformed regression coeffi  cients, interpreted as percentages after multiplying by 100 
(24), or as back-transformed regression coeffi  cients, with their 95% confi dence interval 
(CI).
The statistical analyses were performed using the Statistical Package of Social Sci-
ences version 11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Cohort 
In total, 1,232 women were enrolled in the Generation R Focus Study. Mothers with week-
end deliveries (n=202), twin pregnancies (n=24) and pregnancies leading to perinatal 
death (n=2) were excluded from the present analysis. Of the remaining 1,004 singleton 
live births, cord blood was collected in 889 (88.5%) infants. Immunophenotyping of lym-
phocytes in cord blood was not possible in 318 infants, mainly due to non-heparinized 
Liesbeth BW 16-4.indd   135 24-Apr-08   12:05:31 PM
136
Ch
ap
te
r 4
.2
cord blood samples. Of the remaining 571 infants, 10.0% (n=57) were siblings since 
mothers were allowed to participate with second or more pregnancies in the defi ned 
Table 1. Maternal and infant characteristics of the study population (n=571).
Infants
Boys
(n=301)
Girls 
(n=270)
Mother
Maternal age (years) 31.5 (4.1) 31.9 (4.0)
Education (%)
Lower 39.6 39.0
Higher 60.4 61.0
Smoking during pregnancy (%)
No 87.4 88.5
Yes 12.6 11.5
Alcohol use during pregnancy (%)
No 29.2 39.6
Yes 70.8 60.4
Fever (%) 7.2 4.1
Mode of delivery (%)
Vaginal 72.1 73.3
Forceps or vacuum assisted 17.3 12.8
Caesarean section 10.6 14.0
Infant
Gestational age (weeks)# 40.4 (34.6-43.3) 40.4 (34.1-43.0)
Birth weight (grams) 3613 (494)* 3507 (472)*
Late pregnancy estimated fetal weight (grams) 1638 (271) 1613 (263)
Lymphocyte subsets (x109/L)#
Total lymphocytes 4.40 (1.15-10.91) 4.54 (0.96-12.40)
CD3+ T lymphocytes 2.80 (0.86-7.15) 2.80 (0.69-5.79)
CD19+ B lymphocytes 0.68 (0.01-2.40) 0.72 (0.0.7-2.85)
CD16-/CD56+ NK lymphocytes 0.85 (0.03-2.53) 0.89 (0.10- 2.50)
CD3+/CD4+ helper T lymphocytes 1.92 (1.03-3.38) 2.05 (1.01-3.47)
CD3+/CD8+ cytotoxic T lymphocytes 0.76 (0.33-1.45)* 0.65 (0.29-1.22)*
CD3+/CD45RA+ naïve T lymphocytes 2.21 (0.93-1.98) 2.19 (0.99-4.07)
CD3+/CD45RO+ memory T lymphocytes 0.18 (0-1.12) 0.21 (0-0.95)
Values are means (standard deviation) or percentages. #Median (range). Data were missing on education (n=35), maternal 
fever (n=44), mode of delivery (n=30), estimated fetal weight (n=10), total lymphocytes (n=2), T lymphocytes (n=1), B 
lymphocytes (n=2), CD4+ helper T lymphocytes (n=3), CD8+ cytotoxic T lymphocytes (n=3), CD45RA+ naïve T lymphocytes 
(n=3) and CD45RO+ memory T lymphocytes (n=5). 
Diff erences were tested using the independent sample t-test, non-parametric Mann-Whitney test or Chi-square test. *P-value 
< 0.01.
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study period of the Generation R Focus study. These infants were included in the present 
study since there were no diff erences in results after excluding them from the analyses. 
Analyses of missing cord blood samples (n=433) showed that infants without cord 
blood samples had a shorter median gestational age (40.1 and 40.4 weeks, p-value<0.01), 
a lower mean birth weight (3454 and 3562 grams, p-value<0.01) and more often were 
born by caesarean delivery (20.3% and 12.2%, p-value < 0.05) than infants with cord 
blood samples. 
Subject characteristics
Characteristics of the mothers and their infants are presented in Table 1. Of the study 
group, 52.7% (n=301) were boys. The age of mothers at enrolment ranged from 18.5 to 
42.9 years (mean 31.7 years). In general, 60.6% of the mothers had a higher education, 
12.1% smoked and 65.8% consumed alcohol throughout pregnancy. Of the mothers, 
72.6% had a vaginal, 15.2% a vacuum or forceps assisted and 12.2% a cesarean section 
delivery. Median gestational age of the infants was 40.4 weeks (range 34.1 to 43.4 weeks) 
and was similar in boys and girls. Mean birth weight of the infants was 3563 grams (stan-
dard deviation 487 grams) and was lower in girls than boys. The medians of the lympho-
cyte subset counts for boys and girls are demonstrated in Table 1. 
Gestational age, birth weight, fetal growth and lymphocyte subsets
Table 2 presents the unadjusted associations of gestational age, birth weight and fetal 
growth with absolute numbers of lymphocyte subsets at birth. Per week longer gestation, 
infants had a 3% increase of T lymphocyte counts (p=0.002), 5% increase of B lymphocyte 
counts (p=0.003) and 6% increase of NK lymphocyte counts (p=0.005). Of the T lympho-
cyte subsets, per week longer gestation an increase of 3%, 4% and 5% was observed 
Table 2. Associations of gestational age, birth weight and fetal growth with absolute numbers of lymphocyte 
subsets at birth.
Lymphocyte subsets
T B NK
Gestational age (weeks) 3 (1, 6)** 5 (2, 9)** 6 (1, 10)*
Birth weight (kilograms) 5 (-2, 12) 13 (2, 25)* -5 (-19, 9)
Fetal growth (sds) 1 (-20, 4) 6 (1, 11)* -3 (-9, 3)
T lymphocyte subsets
Helper Cytotoxic Naïve Memory
Gestational age (weeks) 3 (1, 5)** 4 (1, 7)** 5 (2, 8)** -2 (-9, 4)
Birth weight (kilograms) 4 (-4, 11) 8 (-2, 17) 2 (-7, 11) 14 (-8, 35)
Fetal growth (sds) 1 (-2, 4) 2 (-3, 6) 1 (-3, 5) 3 (-6, 13)
Values are log-transformed regression coeffi  cients (95% confi dence interval) and refl ect the increase of lymphocyte subsets 
(%) per week increase in gestational age, per kilogram increase in birth weight and per SDS increase in fetal growth between 
late pregnancy and birth. *P-value < 0.05, **p-value 0.01. 
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for helper, cytotoxic and naïve T lymphocyte counts, respectively (all p-values<0.01). 
Gestational age was not associated with memory T lymphocyte counts (p=0.49). Per 
kilogram increase in birth weight, adjusted for gestational age, infants had 13% higher 
B lymphocyte counts (p=0.01). An increase of 6% of B lymphocyte counts was found per 
SDS increase in fetal growth between late pregnancy and birth (p=0.02). Total T and NK 
lymphocyte counts and T lymphocyte subset counts were not signifi cantly associated 
with birth weight or fetal growth. 
After adjusting for gender, maternal education, smoking, alcohol use, fever and 
mode of delivery the eff ect estimates of gestational age, birth weight and fetal growth 
on absolute T, B, NK and T lymphocyte subset counts did not materially change. The 
adjusted associations are graphically presented in Figures 1, 2 and 3.
Discussion
This prospective cohort study showed that with increasing gestational age at birth abso-
lute numbers of T, helper, cytotoxic and naïve T lymphocytes, B and NK lymphocytes 
increase. Increased birth weight and fetal growth in late pregnancy were associated with 
higher absolute numbers of B lymphocytes, but not with T, NK and T lymphocyte subset 
counts. 
To our knowledge, no large population-based prospective cohort studies have 
assessed the eff ects of gestational age, birth weight and fetal growth in late pregnancy 
on diff erent lymphocyte subsets at birth. Previous studies of smaller sample sizes (50-120 
subjects), showed that preterm birth infants had lower mean T lymphocyte counts and 
lower mean helper, cytotoxic and naïve T lymphocyte counts compared to infants born 
at term (5-7, 25, 26). Furthermore, it was shown that T lymphocyte subsets in fetal blood, 
obtained with cordocentesis during pregnancy, were lower in preterm than in term born 
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Figure 1. Absolute numbers of lymphocyte subsets in infants of diff erent gestational ages. 
The estimated back-transformed regression lines refl ect the number of lymphocyte subsets per week increase of 
gestational age. All models were adjusted for gender, maternal education, smoking, alcohol use, fever and mode of 
delivery. *P-value < 0.05, **p-value 0.01. 
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infants (25, 27, 28). Our results, showing an infl uence of gestational age at birth on T lym-
phocyte subset counts, are in line with these previous studies and suggest an ongoing 
development of the immune system during pregnancy. For the association of gestational 
age with B and NK lymphocyte counts, previous studies showed inconsistent results (5-7, 
9, 10, 25, 26). One large study of cord blood samples (more than 8000 cord blood units), 
collected at birth and banked for future umbilical cord blood transplantation, showed 
small positive partial correlations of gestational age at birth with NK, helper T and cyto-
toxic T lymphocyte counts. The exact amount of change in lymphocyte subset counts 
was not presented (9). Percentages or absolute counts of lymphocytes seem decreased 
in infected preterm infants or immunocompromised children with severe respiratory 
syncytial virus infections (3, 29). However, neonatal lymphocytes may have a near normal 
capacity to proliferate when needed (28). The precise functional role and consequences 
for morbidity of low lymphocyte counts in preterm infants remains to be studied.
Previous studies found that infants with a lower birth weight had lower or similar 
lymphocyte subset counts compared to term infants (9, 12, 13, 30). These studies did not 
examine birth weight independent of gestational age. One study assessed the eff ect of 
birth weight on numbers of diff erent lymphocytes taking gestational age into account, 
and found that small for gestational age infants (SGA) had lower T and B lymphocyte 
counts and lower helper and cytotoxic T lymphocyte counts than appropriate for gesta-
tional age infants or preterm SGA infants (31). Studies assessing the association of fetal 
growth restriction and lymphocytes found a reduction of T lymphocyte counts, helper 
and cytotoxic T lymphocyte counts, neutrophils and monocytes in fetal growth restricted 
infants (16, 32). An explanation for the diff erent results with our study could be that stud-
ies of low birth weight and fetal growth were performed in small sample sizes (19-104 
subjects) with an other defi nition of fetal growth restriction (fetal abdominal circumfer-
ence < 5th percentile for gestation and abnormal Doppler ultrasound measurements of 
the uterine or umbilical arteries) and without adjustment for potential confounders.
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Figure 2. Absolute numbers of lymphocyte subsets in infants with diff erent birth weights. 
The estimated back-transformed regression lines refl ect the number of lymphocyte subsets per kilogram increase 
in birth weight. All models were adjusted for gender, maternal education, smoking, alcohol use, fever and mode of 
delivery. *P-value < 0.05, **p-value 0.01. 
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We found an association of reduced birth weight and fetal growth with lower B lym-
phocyte counts. A biological mechanism might be that low birth weight and fetal growth 
restricted infants have a reduced abdominal circumference, the so called ‘brain sparing 
eff ect’ (33). The reduced abdominal circumference can partly be explained by a reduced 
fetal liver size that may be caused by fetal malnutrition. Since B lymphocytes in fetal life 
are primarily produced by the fetal liver, a reduced fetal liver size might consequently lead 
to a decrease in B lymphocyte production. In line with this, we observed a 2% decrease 
of immature B lymphocytes (CD5+) per SDS decrease of fetal growth (p-value < 0.01). 
Similarly, an 8% decrease of immature B lymphocytes per kilogram decrease of birth 
weight was found (p-value < 0.01). However, the exact underlying pathophysiological 
mechanism of birth weight and fetal growth with diff erent maturational stadia of B lym-
phocytes needs to be studied in more detail. Our study found no eff ect of birth weight 
or fetal growth on T lymphocyte counts. During pregnancy, T lymphocytes are mainly 
produced by the fetal thymus. Lower birth weight is associated with a reduced thymus 
size at birth, however, size of the fetal thymus relevant to its T lymphocyte production 
and function needs to be further explored (34, 35). 
Some methodological issues should be considered. In our study, excluding par-
ticipants with missing data would lead to selection biased results if the associations of 
gestational age, birth weight and fetal growth with lymphocyte subsets diff er between 
participants with and without data. Of all single live births, information about gestational 
age and birth weight were not missing. Information about fetal growth was only missing 
in 1.5% of the infants. Participating infants without cord blood samples more often had 
a lower gestational age and lower birth weight, but not a lower estimated fetal weight in 
late pregnancy, than participating infants with cord blood samples. Therefore it is likely 
that due to these selective missing of cord blood samples the observed eff ects of gesta-
tional age and birth weight with lymphocyte subsets may be underestimated.
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Figure 3. Absolute numbers of lymphocyte subsets in infants with diff erent fetal growths. 
The estimated back-transformed regression lines refl ect the number of lymphocyte subsets per standard deviation 
increase in fetal growth. All models were adjusted for gender, maternal education, smoking, alcohol use, fever and 
mode of delivery. *P-value < 0.05, **p-value 0.01. 
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In summary, this population-based prospective cohort study implies that with 
increasing gestational age development of the various lymphocyte subsets progresses. 
Birth weight and fetal growth seem to only infl uence B lymphocyte counts. These results 
contribute to a better understanding of the early development of the immune system 
and to conditions that might aff ect this process. Long-term eff ects of gestational age, 
birth weight and fetal growth on lymphocyte subsets and their consequences remain to 
be studied. 
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Abstract
In the general population, it is unknown whether stress-related perinatal factors infl u-
ence lymphocyte subset counts in neonates. The aim of this study was to assess the asso-
ciations of perinatal factors related to stress and hypoxia (mode of delivery, Apgar scores 
and umbilical cord blood pH) with absolute lymphocyte subset counts (T, B, NK, helper T, 
cytotoxic T, naïve, memory T) in cord blood of 571 neonates. This study was embedded 
in a population-based prospective cohort study from fetal life onwards. All models were 
adjusted for gestational age, birth weight, gender, maternal fever and each of the other 
perinatal stress-relating factors. Our results showed that increasing stress-related mode 
of delivery was positively associated with NK and memory T lymphocyte subset counts 
(all p-values < 0.01). Eff ects of Apgar scores on lymphocyte subsets were explained by 
umbilical cord blood pH. Lower umbilical cord blood pH was associated with higher B, NK 
and memory T lymphocyte counts (all p-values < 0.05). Eff ects of mode of delivery and 
umbilical cord blood pH on other lymphocyte subsets were not observed. We conclude 
that in the general population, lymphocyte subset counts in neonates increase with 
increasing stress- and hypoxia related perinatal factors. 
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Introduction
The immunologic status of the neonate is frequently established by assessing absolute 
numbers of various lymphocyte subsets in cord blood (1-4). However, such data at birth 
must be interpreted with care since the lymphocyte subset counts might be infl uenced 
by growth, stress and hypoxia related events that occur in late prenatal and early post-
natal life. It has been suggested that the distribution of lymphocyte subsets is related 
to gestational age at birth and birth weight (5-8). It is not well known whether other 
perinatal factors associated with fetal well-being, stress and hypoxia, including mode 
of delivery, Apgar scores or umbilical cord blood pH, infl uence the various lymphocyte 
subset counts at birth. 
So far, studies on mode of delivery and lymphocyte subsets remain inconclusive. This 
might be due to small study populations, the variability of lymphocyte subsets studied 
or not taking other possible infl uencing factors into account (5, 6, 9-16). Results of the 
majority of these studies suggested a tendency towards increased lymphocyte subset 
counts in neonates born by vaginal delivery compared to neonates born by caesarean 
section (9-11, 13-16). The endocrine-metabolic variations during a stressful delivery, par-
ticularly hypoxia and the increase of catecholamines and cortisol, were considered as the 
main cause of these eff ects (17-19). Additionally to this stress concept, adverse Apgar 
scores and umbilical cord blood pH, both results of perinatal hypoxia, are thought to 
infl uence lymphocyte subset counts at birth (9, 20-22).
We examined in 571 neonates participating in a population-based prospective 
cohort study, the associations of perinatal factors related to stress and hypoxia, includ-
ing mode of delivery, Apgar scores and umbilical cord blood pH with absolute numbers 
of lymphocytes (T, B and NK) and T lymphocyte subsets (helper, cytotoxic, naïve and 
memory T) in cord blood of neonates. 
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life until young adulthood. The Generation R Study was designed 
to identify early environmental and genetic determinants of growth, development and 
health and has been described previously in detail (23, 24). More detailed assessments 
of fetal and postnatal growth and development were conducted in a subgroup of 1,232 
Dutch pregnant women and their children, referred to as the Generation R Focus Study 
(23, 24). Of all approached pregnant women and their partners, 79% participated in the 
Generation R Focus Study. Their children were born between February 2003 and August 
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2005. The Medical Ethics Committee of the Erasmus Medical Center, Rotterdam, has 
approved the study. Written informed consent was obtained from all participants. 
Mode of delivery, Apgar scores and umbilical cord blood pH 
Information about mode of delivery, 1- and 5- minute Apgar scores (assigning a score of 
0 to 2 to heart rate, respiratory eff ort, muscle tone, refl ex irritability and color) and umbili-
cal cord blood pH were obtained from standardized delivery registrations of midwives 
and obstetricians (23-26). Heparinized cord blood samples were taken from an immedi-
ate clamped, isolated piece of the umbilical cord. Cord blood gases were analyzed on 
routine automatic gas check machines for pH, P02 and PC02, whereas base excess was 
computed. The delay between cord blood sampling and determination was less than 60 
minutes. The blood gas analyzers were calibrated and standardized with reference gases 
and pH solutions.
Immunophenotyping of lymphocyte subsets 
Venous cord blood was sampled in heparinized tubes by midwifes and obstetricians 
immediately after delivery and transported at room temperature to the Immunology lab-
oratory of the Erasmus Medical Center within 24 hours. Umbilical cord blood samples not 
received within 24 hours (weekend days) were excluded since fl ow cytometric analyses of 
those samples showed no reliable results in the pilot phase of the study. Flow-cytometric 
immunophenotyping was performed to determine absolute numbers of lymphocytes (T, 
B and NK) and T lymphocyte subsets (helper, cytotoxic, naïve and memory T). For this, the 
monoclonal antibodies CD3, CD19, CD16.CD56, CD4, CD8, CD45RA and CD45RO were 
conjugated with the labels fl uorescein isothiocyanate (FITC1), peridin chlorophyll pro-
tein (PerCP1), peridin chlorophyll protein-cychrome 5.5 (PerCP-Cy5.51), allophycocyanin 
(APC1), phycoerythrin (PE1,3), phycoerythrin-cyanin dye (PE-cy71), allophycocyanin-cyanin 
dye (APC-cy71) and rhodamine (RD12) (1Becton Dickinson,2Beckman Coulter and 3Dako) 
Table 1. Flow cytometric reagents.
Lymphocyte subsets Cluster of diff erentiation (CD) Monoclonal antibodies labels
T lymphocyte CD3 FITC (Sk71) / PerCP (Sk71)
Helper T lymphocyte CD4 PE-Cy7 (Sk31)
Cytotoxic T lymphocyte CD8 APC (Sk11) / APC-Cy7 (Sk11)
Naïve T lymphocyte CD45RA RD1 (2H4 2)
Memory T lymphocyte CD45RO APC (UCHL-11)
B lymphocyte CD19 PerCPCy5.5 (SJ25C11) / APC (SJ25C11)
NK lymphocyte CD16.CD56 PE (B73.11) . PE (C5.93)
FITC=fl uorescein isothiocyanate, PerCP=peridin chlorophyll protein, PE-cy7=phycoerythrin-cyanin dye, APC=allophycocyanin, 
APC-cy7=allophycocyanin-cyanin dye, RD1= rhodamine and PE=phycoerythrin. Company: Becton Dickinson1, Beckman 
Coulter2 and Dako3
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(Table 1). Absolute numbers of T, B and NK lymphocytes were determined with the lysed 
whole blood technique (50 μl of whole blood per sample) using the routine standard-
ized single platform method with BD TruCOUNT Tubes of Becton Dickinson (BD). With 
this, lymphocytes were gated on the basis of CD45 and FSC to prevent contamination 
of unlysed erythrocytes (27, 28, 29). The samples were measured on a Beckman Coulter 
fl ow cytometer (BD) and analyzed with BD CellQuestTM software as indicated by the 
manufacturer. Subsets of the T lymphocytes were determined using 6-colour staining 
and detected on a BDTM LSR II fl ow cytometer (Becton Dickinson, San Jose, California, US). 
This fl ow cytometer is routinely used in the diagnostic laboratory and every day refer-
ence calibration beads are used. The subsets of T lymphocytes were analyzed with BD 
FacsDIVATM. Therefore, erythrocytes of 1 ml whole blood were lysed using 50 ml ammo-
niumchloride. After centrifugation, leucocytes were washed twice and suspended in 900 
μl PBS/1% BSA/0.1% NaAz. Of this cell suspension (5-10*106/ml), 50 μl was incubated 
for 10 minutes at room temperature with combinations of the optimally titrated labeled 
monoclonal antibodies. After incubation the cells were washed and subsequently identi-
fi ed by fl ow cytometry. Using a BDTM LSR II fl ow cytometer that had been calibrated with 
rainbow beads, 10,000 lymphocytes were measured. The relative count of helper T lym-
phocytes, cytotoxic T lymphocytes, naïve T lymphocytes and memory T lymphocytes was 
expressed as the percentage within the total T lymphocyte population and calculated 
by the average of 2-4 independent incubations for each subset. The absolute counts of 
the T lymphocyte subsets were subsequently calculated from the absolute T lymphocyte 
counts as obtained by the lysed whole blood technique. The absolute counts of the total 
T lymphocytes determined with the single platform method were compared with the 
recalculated counts of the total T lymphocytes (% of lymphocytes within the leukocyte 
count, determined by a cell counter). There was no signifi cant diff erence between the 
two methods (30).
Covariates
Information about date of birth, birth weight and gender was obtained from midwives 
and hospital registries. Gestational age was established by the fi rst fetal ultrasound 
examination after enrolment (31). Information about maternal fever (> 380 C), indicat-
ing a possible systemic underlying infection, was asked for in the questionnaire send to 
mothers > 30 weeks of gestation (‘did you had a fever (>380 C) in the last two months?’) 
(24).
Statistical analysis
Diff erences of maternal and neonatal characteristics between neonates with and without 
umbilical cord blood samples were assessed by the independent sample t-test for con-
tinuous normal distributed variables, non-parametric Mann-Whitney test for continuous 
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non-normal distributed variables and the chi-square test for categorical variables. Data 
on all lymphocyte subsets were log-transformed to obtain normally distributed variables. 
Associations of mode of delivery, continuously measured Apgar scores and umbilical cord 
blood pH with absolute numbers of lymphocyte subsets were analyzed using multiple 
linear regression models. Additionally, regression models were adjusted for the potential 
confounders gestational age, birth weight, gender and maternal fever. Finally, regres-
sion models were additionally adjusted for each of the stress-related perinatal factors to 
determine the independent eff ect of mode of delivery, Apgar scores and umbilical cord 
blood pH. Measures of associations are presented as log-transformed mean diff erences 
and regression coeffi  cients, which can be interpreted as percentages after multiplying 
by 100 (32), or as geometric mean diff erences with their 95% confi dence interval (CI). 
The statistical analyses were performed using the Statistical Package of Social Sciences 
version 11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
In total, 1,232 women were enrolled in the Generation R Focus Study. Mothers with week-
end deliveries (n=202), twin pregnancies (n=24) and pregnancies leading to perinatal 
death (n=2) were excluded from the present analysis. Of the remaining 1,004 singleton 
live births, cord blood was collected in 889 (88.5%) infants. Immunophenotyping of lym-
phocytes in cord blood was not possible in 318 infants, mainly due to non-heparinized 
cord blood samples. Of the remaining 571 infants, 10.0% (n=57) were siblings since 
mothers were allowed to participate with second or more pregnancies in the Generation 
R Focus study. These infants were included in the present study since there were no dif-
ferences in results after excluding them from the analyses. 
Analyses of missing immunophenotyped cord blood samples (n=433) showed that 
neonates without immunophenotyped cord blood samples more often were born by 
caesarean delivery (20.3% and 12.2%, p-value < 0.05), had a lower median gestational 
age (40.1 and 40.4 weeks, p-value < 0.01) and lower mean birth weight (3454 and 3562 
grams, p-value < 0.01) than neonates with immunophenotyped cord blood samples.
Characteristics of the mothers and their neonates are presented in Table 2. Of the 
mothers, 72.6% had a vaginal, 15.2% a vacuum or forceps assisted and 12.2% a cesarean 
section delivery. Median Apgar scores of 1 and 5 minutes after birth of the neonates were 
9 (range 2 to 10) and 10 (range 5 to 10), respectively. Mean umbilical cord blood pH was 
7.26. The medians of the lymphocyte subset counts are demonstrated in Table 2.
Neonates born by a forceps or vacuum assisted delivery had 45% higher NK lympho-
cyte counts (p < 0.001) than neonates born by a vaginal delivery (Table 3). No diff erences 
were found for T and B lymphocyte counts. Within the T lymphocyte population, cyto-
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toxic and memory T lymphocyte counts were increased. Neonates born by a caesarean 
section had 9% lower T (p = 0.04) and 40% lower NK lymphocyte counts (p < 0.001) than 
neonates born by a vaginal delivery. B lymphocyte counts did not diff er. Within the T lym-
phocyte population, helper and naïve T lymphocyte counts were decreased in caesarean 
section delivered neonates.
Table 2. Maternal and neonatal characteristics of the study population (n=571).
Single live births
Mothers
Age (years) 31.7 (4.0)
Fever (%) 5.9 (31)
Mode of delivery (%)
Vaginal 72.6 (393)
Forceps or vacuum assisted 15.2 (82)
Caesarean section 12.2 (66)
Neonates
Boy (%) 52.7 (301)
Girl (%) 47.3 (270)
Gestational age (weeks)* 40.4 (34.1-43.4)
Birth weight (grams) 3563 (487)
Apgar scores*
1-minute 9 (2-10)
5-minute 10 (5-10)
pHcord blood 7.26 (0.09)
Lymphocytes (x109/L)*
Total lymphocytes 4.49 (0.96-12.40)
CD3+ T lymphocytes 2.80 (0.69-7.15)
CD19+ B lymphocytes 0.70 (0-3.91)
CD16-/CD56+ NK lymphocytes 0.87 (0.03-3.36)
CD3+/CD4+ helper T lymphocytes 1.97 (0.41-6.10)
CD3+/CD8+ cytotoxic T lymphocytes 0.70 (0.10-2.16)
CD3+/CD45RA+ naïve T lymphocytes 2.21 (0.03-6.01)
CD3+/CD45RO+ memory T lymphocytes 0.20 (0-2.36)
Values are means (standard deviation) or percentages (absolute numbers). *Median (range). 
Data were missing on maternal fever (n=44), mode of delivery (n=30), 1-minute Apgar score (n=15), 5-minute Apgar score 
(n=11), pHcord blood (n=290), total lymphocytes (n=2), T lymphocytes (n=1), B lymphocytes (n=2), CD4
+ helper T lymphocytes 
(n=3), CD8+ cytotoxic T lymphocytes (n=3), CD45RA+ naïve T lymphocytes (n=3) and CD45RO+ memory T lymphocytes (n=5). 
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Per point increase in 1-minute Apgar score, neonates had 8% lower B lymphocyte 
(p = 0.001) and 12% lower NK lymphocyte counts (p < 0.001). No signifi cant changes in 
T lymphocytes and T lymphocyte subset counts were found for 1-minute Apgar score. 
Apgar scores at 5 minutes after birth revealed 5%, 11% and 15% lower T, B and NK lym-
phocyte counts, respectively, per point increase (all p-values < 0.01). Cytotoxic T lympho-
cyte counts were decreased with 7% (p = 0.006). No eff ect of the 5-minute Apgar score 
was seen on the other T lymphocyte subset counts.
Per 0.1-point increase in umbilical cord blood pH, 5%, 22% and 30% lower T, B and NK 
lymphocytes were found, respectively (all p-values < 0.05). Umbilical cord blood pH was 
not associated with the absolute numbers of T lymphocyte subsets. 
The adjusted eff ect estimates of the various modes of delivery on T and B lympho-
cyte counts improved (p-values < 0.05), but on cytotoxic and naïve T lymphocyte counts 
declined (p-values > 0.05) (Figure 1). The associations of modes of delivery with the other 
absolute numbers of lymphocyte subsets did not materially change, nor did the associa-
tions of 1- and 5-minute Apgar scores and umbilical cord blood pH with absolute num-
bers of T, B and NK lymphocytes and T lymphocyte subsets (Figure 2 and 3). 
Table 3. Associations of stress-related perinatal factors with absolute numbers of lymphocyte subsets in neonates.
Lymphocyte subsets
T B NK
Mode of delivery 
Vaginal Reference Reference Reference
Forceps or vacuum assisted 8 (0, 16) 13 (-1, 27) 45 (30, 61)**
Caesarean section -9 (-18, -0)* -13 (-28, 3) -40 (-57, -23)**
Apgar scores
1-minute -2 (-5, 0) -8 (-12, -3)** -12 (-17, -6)**
5-minute -5 (-9, -1)** -11 (-18, -5)** -15 (-23, -7)**
pHcord blood -5 (-10, -0.7)* -22 (-29, -15)** -30 (-38, -21)**
T lymphocyte subsets
Helper Cytotoxic Naïve Memory
Mode of delivery 
Vaginal Reference Reference Reference Reference
Forceps or vacuum assisted 7 (-2, 16) 11 (0, 22)* 1 (-10, 12) 28 (2, 54)*
Caesarean section -12 (-22, -3)* -2 (-14, 10) -12 (-24, -0)* -4 (-33, 25)
Apgar scores
1-minute -2 (-5, 1) -3 (-7, 1) -2 (-6, 2) 2 (-6, 11)
5-minute -4 (-8, 1) -7 (-13, -2)** -4 (-9, 2) -4 (-17, 8)
pHcord blood -4 (-9, 10) -6 (-12, 0.5) -3 (-10, 4) -14 (-29, 0.5)
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in lymphocyte subsets (%) of forceps 
or vacuum assisted and caesarean section delivered infants with vaginal delivered infants and the increase of lymphocyte 
subsets (%) per point increase in Apgar scores and umbilical cord blood pH. 
*P-value < 0.05, **p-value 0.01. 
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Figure 1. Absolute numbers of lymphocyte and T lymphocyte subsets in neonates born by various modes of 
deliveries.
All models were adjusted for gestational age, birth weight, gender and maternal fever. 
 = forceps or vacuum assisted delivery,  = vaginal delivery and  = caesarean section delivery. 
Values are geometric means (95% confi dence intervals); reference category is vaginal delivered neonates. 
*P-value < 0.05, **p-value 0.01.
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Figure 2. A and B. Absolute numbers of lymphocyte subsets in neonates with 1-minute Apgar scores at birth. All 
models were adjusted for gestational age, birth weight gender and maternal fever. 
The estimated back-transformed regression lines refl ect the number of lymphocyte subsets per point increase in 
1-minute Apgar score. C and D. Absolute numbers of lymphocyte subsets in neonates with 5-minute Apgar scores 
at birth. All models were adjusted for gestational age, birth weight gender and maternal fever. The estimated back-
transformed regression lines refl ect the number of lymphocyte subsets per point increase in 5-minute Apgar score.
Both panels (line, no symbol) T lymphocytes; y B lymphocytes; { NK lymphocytes;  Helper T lymphocytes;  
cytotoxic T lymphocytes; S naïve T lymphocytes; U memory T lymphocytes.
*P-value < 0.05, **p-value 0.01. 
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An independent eff ect for mode of delivery on NK lymphocyte and memory T lym-
phocyte counts (p-values < 0.01) was found, but not for the other lymphocyte subset 
counts (Table 4). The eff ect of Apgar scores on all lymphocyte subset counts declined 
(p-values > 0.05). Umbilical cord blood pH showed an independent association with B, 
NK and memory T lymphocyte counts (p-value < 0.05), but not with the other T lympho-
cyte subset counts. 
Discussion
This study showed that independent of the other perinatal stress-relating factors, 
increasing mode of delivery associated stress showed increasing NK and memory T lym-
phocyte counts and lower umbilical cord blood pH showed higher NK, B and memory T 
lymphocytes. We did not observe independent eff ects of 1- and 5-minute Apgar scores 
on lymphocyte subsets.
Previous studies on mode of delivery did not assess the eff ects on all lymphocyte 
and T lymphocyte subset counts (5, 9-13, 15, 16, 33). These studies showed inconclu-
sive results, probably due to the small study populations (12 to 126 subjects). One large 
study of umbilical cord blood samples (more than 8000 cord blood units), banked for 
future umbilical cord blood transplantation, showed decreased percentages of helper 
T, cytotoxic T and B lymphocytes and increased percentages of NK lymphocytes in 
cord blood of caesarean section delivered neonates compared to vaginally delivered 
neonates (6). Diff erences between vaginal and forceps or vacuum deliveries, the exact 
amount of change in absolute numbers of lymphocyte subsets and the specifi c maternal 
and neonatal characteristics were not presented. Our study showed eff ects of mode of 
delivery mainly on NK lymphocytes. The precise functional role of these lymphocytes 
during labor remains to be studied. Forceps and vacuum assisted delivered neonates 
showed the highest lymphocyte subset counts and caesarean delivered neonates the 
lowest lymphocyte subset counts. This phenomenon suggests a continuous trend of 
increasing recruitment of lymphocyte subsets into neonatal blood with increasing mode 
of delivery-associated stress. Underlying biological mechanisms might be that neonates 
born by vaginal deliveries have higher levels of catecholamines and cortisol compared 
to neonates born by caesarean deliveries (16-19, 33-35). Vaginal delivered neonates with 
higher umbilical cord blood cortisol levels have higher lymphocyte counts (16, 19). It 
is has been suggested that caesarean section delivered infants have less recruitment 
of lymphocyte subsets due to maternal anaesthetics, which crosses the placenta and 
inhibit release of catecholamines and cortisol (33, 36, 37). A limitation in our study is that 
we could not made a distinction between a primary caesarean section delivery, usually 
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Figure 3. Absolute numbers of lymphocyte subsets in neonates with various umbilical cord blood pH at birth.
All models were adjusted for gestational age, birth weight gender and maternal fever. 
The estimated back-transformed regression lines refl ect the number of lymphocyte subsets per 0.1 point increase in 
umbilical cord blood pH. 
(line, no symbol) T lymphocytes; y B lymphocytes; { NK lymphocytes;  Helper T lymphocytes;  cytotoxic T 
lymphocytes; Snaïve T lymphocytes; U memory T lymphocytes.
*P-value < 0.05, **p-value 0.01. 
Table 4. Associations of independent stress-related perinatal factors with absolute numbers of lymphocyte subsets 
in neonates.
Lymphocyte subsets
T B NK
Mode of delivery 
Vaginal Reference Reference Reference
Forceps or vacuum assisted 7 (-4, 18) 12 (-4, 27) 41 (23, 59)**
Caesarean section -5 (-16, 8) -14 (-32, 3) -36 (-56, -16)**
Apgar scores
1-minute 0 (-5, 5) -0 (-8, 8) -4 (-15, 6)
5-minute -7 (-15, 1) -9 (-21, 4) 4 (-12, 19)
pHcord blood -1 (-7, 4) -18 (-27, -10)** -28 (-38, -17)**
T lymphocyte subsets
Helper Cytotoxic Naïve Memory
Mode of delivery 
Vaginal Reference Reference Reference Reference
Forceps or vacuum assisted 6 (-5, 18) 9 (-5, 22) -2 (-17, 14) 45 (13, 77)**
Caesarean section -8 (-21, 5) 4 (-11, 20) -5 (-22, 13) 1 (-4, 4)
Apgar scores
1-minute 1 (-5, 7) 0 (-8, 7) -2 (-10, 7) 16 (-2, 34)
5-minute -8 (-17, 1) -7 (-18, 4) -4 (-16, 8) -13 (-38, 13)
pHcord blood 0 (-6, 6) 1 (-9, 6) 1 (-7, 10) -19 (-36, -1)*
Values are regression coeffi  cients (95% confi dence interval) and refl ect the diff erence in lymphocyte subsets (%) of forceps 
or vacuum assisted and caesarean section delivered infants with vaginal delivered infants and the increase of lymphocyte 
subsets (%) per point increase in Apgar scores and umbilical cord blood pH. All models were adjusted for gestational age, 
birth weight gender, maternal fever and for each of the other stress-related perinatal factors. 
*P-value < 0.05, **p-value 0.01.
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planned due to previously known maternal indication, and a secondary caesarean sec-
tion delivery because of acute fetal or maternal distress. 
Both low Apgar scores and low umbilical cord blood pH can be seen as measures of 
hypoxia and stress of the neonate, implying that the labor-associated stress hypothesis 
could also be applied to these parameters. The eff ects of Apgar scores and umbilical cord 
blood pH were mainly found on the major lymphocyte subset counts, and to a lesser 
extent on T lymphocyte subset counts. The latter might be explained due to the fact that 
all T lymphocyte subsets contributed to an increase of the total T lymphocytes. Studies 
on Apgar scores and eff ects on lymphocyte subset counts are very limited and showed 
that low 1-minute Apgar scores and low 5-minute Apgar scores increase immunoglobu-
lin secreting cell counts and proliferative responses of mononuclear cells in vitro (21, 
22). We found larger eff ect estimates of 5-minute Apgar scores on lymphocyte subset 
counts than 1-minute Apgar scores. Apgar scores 5 minutes after birth probably better 
refl ect the condition of neonates. This is in line with a previous study which observed 
associations of 5-minute Apgar scores and mortality rates (38). Apgar scores at 1 and 5 
minutes after birth are subjective scoring systems for the condition of the neonate. Our 
fully adjusted regression models confi rms this subjectivity of the Apgar scores since the 
independent eff ect of these scores declined severely and the eff ects of umbilical cord 
blood pH, an objective method for hypoxia, remained on most of the major lymphocyte 
subsets. A previous study found an inverse association between the number of leuko-
cytes and umbilical cord blood pH (9). In this study, the eff ects of cord blood pH on the 
various leukocyte subtypes were not explored. One study assessed the relation between 
umbilical cord blood pH and distribution of major lymphocyte subsets and found decreas-
ing percentages of T lymphocytes and increasing percentages of NK lymphocytes with 
decreasing umbilical cord blood pH (20). Diff erences with our study might be explained 
due to their diff erent study population of only vaginal delivered infants with mothers 
frequently receiving labor-inducing medication, spasmolytics, neuroplegic and epidural 
analgesia (7 of 70 mothers received no medication). Unfortunately, data on perinatal 
medication were not available in our study. Another diff erence with our study might be 
that they used percentages of lymphocytes (T+B+NK=100%) instead of absolute values 
of lymphocyte subsets. A low percentage of T lymphocytes automatically provides a high 
percentage of B or NK lymphocytes. Umbilical cord blood pH therefore might lead to an 
opposite eff ect on those lymphocytes. The use of percentages instead of absolute counts 
of the major lymphocyte subsets in our cohort confi rms this hypothesis. An increase of 
0.1 point in umbilical cord blood pH showed an increase of percentual T lymphocytes 
(regression coeffi  cient (95% CI): 5 (3, 6)), a decrease of percentual B lymphocytes (-1 (-2, 
-0.6)) and a decrease of NK lymphocytes (-3 (-4, -2)). For absolute counts of lymphocyte 
subsets, an increase of umbilical cord blood pH led to a decrease of all the major lym-
phocyte subsets (Table 3). Therefore, it is preferable to use absolute counts instead of 
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percentages of lymphocyte subsets to refl ect actual changes of lymphocyte subsets due 
to various factors. 
Some methodological issues should be considered. In our study, excluding participants 
with missing data would lead to selection biased results if the associations of stress-related 
perinatal factors with absolute numbers of lymphocyte subsets diff er between participants 
with and without complete data. Of all participating singleton live births, information about 
mode of delivery was missing in only 5.3%. Of neonates with information of mode of deliv-
ery, neonates with missing data on lymphocyte subsets more often had a caesarean section 
delivery than neonates with data on lymphocyte subsets. Therefore it is likely that due to this 
selective group of missing outcomes the observed eff ects of mode of delivery with absolute 
numbers of lymphocyte subsets may be underestimated. However, caesarean section may 
be performed primary or secondary. Since the associations of primary and secondary cae-
sarean deliveries with lymphocyte subsets counts are expected to be in the opposite direc-
tion, our eff ect estimates may be somewhat biased towards null. Our results are probably 
demonstrating the diff erence between primary caesarean delivery and vaginal delivery. We 
expect to have relatively more missing lymphocyte subset counts among neonates born 
after a secondary caesarean delivery due to logistical constraints in the acute setting.
Information about 1-minute Apgar scores, 5-minute Apgar scores and umbilical cord 
blood pH was missing in 2.6% 1.9% and 50.8% of the neonates, respectively. Measure-
ments of umbilical cord blood pH in the Netherlands is not routinely performed, since 
approximately one-third of the deliveries in the Netherlands is performed at home and 
are at low risk for obstetric complications (39). In line with this, we found that neonates 
without umbilical cord blood pH values more often were vaginally delivered and had 
higher 1- and 5-minute Apgar scores. Neonates without umbilical cord blood pH are 
more frequently from uncomplicated pregnancies with fetal distress. Thus we expect that 
missing values in umbilical cord blood pH did not materially change the eff ect estimated 
but decreased the power of the study.
In our cohort study, information about maternal fever, indicating an underlying infec-
tion, was only available around the third trimester of gestation. It did not materially change 
the eff ect estimates in the associations of stress-related perinatal factors with lymphocyte 
subsets. However, due to the time of maternal fever in pregnancy its confounding eff ect is 
probably underestimated since an acute ongoing maternal infection during delivery might 
show more increasing eff ects on the neonatal lymphocyte subsets.
In conclusion, this population-based cohort study showed that with increasing 
mode of delivery-associated stress lymphocyte subset counts (NK, memory T) increase. 
Furthermore, lower umbilical cord blood pH is associated with an increase of lymphocyte 
subset counts (B, NK, memory T). Therefore, the clinical interpretation of absolute num-
bers of lymphocyte subsets at birth should take the eff ects of stress-and hypoxia related 
perinatal factors into account.
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Abstract 
Objective: Insulin-like growth factor (IGF-I) stimulates growth, development and function 
of lymphocytes. The aim of this study was to examine whether functional variants of the 
IGF-I gene are associated with absolute lymphocyte subset counts in neonates. 
Design: This study was embedded in the Generation R Study, a prospective cohort study 
from fetal life onwards. 
Measurements: IGF-I promoter region polymorphisms were determined in cord blood 
DNA. Lymphocytes (T, B and NK) and T lymphocyte subsets (helper, cytotoxic, naïve 
and memory) in cord blood were immunophenotyped in 380 neonates by 6-color fl ow 
cytometry. 
Results: In total, 39% of the neonates were homozygous for the 192-bp allele (wild-type), 
48% were heterozygous and 13% were non-carrier. No diff erences in absolute lymphocyte 
and T lymphocyte subset counts were observed between the 192-bp allele heterozygous 
and homozygous groups. In non-carriers, we found 13% lower T lymphocyte (p=0.03), 
21% lower B lymphocyte (p=0.04) and 11% lower NK lymphocyte counts (p=0.36) than 
in the 192-bp allele homozygous group. Analyses of T lymphocyte subsets showed 16% 
lower helper T lymphocyte counts (p=0.01) in non-carriers. No signifi cant diff erences 
were found for cytotoxic, naïve and memory T lymphocyte counts. All associations were 
adjusted for gravidity, mode of delivery, gestational age, birth weight, gender, 1- and 
5- minute Apgar scores. 
Conclusions: Our study showed associations between the IGF-I promoter region poly-
morphisms and absolute lymphocyte subset counts in neonates. These results should be 
regarded as hypothesis generating until they have been replicated in other studies. 
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Introduction
Insulin-like growth factor I (IGF-I) is a single chain polypeptide that stimulates bone 
growth, metabolism and cell diff erentiation. IGF-I is synthesized by various tissues and 
has an endocrine, autocrine or paracrine function (1-4). Previous studies suggested 
that IGF-I also stimulates growth, development and function of lymphocytes. Studies in 
animals showed that IGF-I administration leads to an increase of relative and absolute 
counts of T lymphocytes, CD4+ helper T and CD8+ cytotoxic T lymphocytes in thymus and 
peripheral blood (5-10). IGF-I administration resulted also in increased relative and abso-
lute B lymphocyte counts in bone marrow, spleen and blood (5, 6, 8, 10). Furthermore, 
animal studies showed that after allogeneic bone marrow transplantation or dexametha-
son treatment, which usually result in prolonged immunodefi ciency, IGF-I administration 
enhanced lymphoid and myeloid reconstitution (11-15). IGF-I seems not only to lead to 
increased counts of lymphocytes, but also to increased diff erentiation of B lymphocytes 
in bone marrow, a progressed maturation of naïve into memory T lymphocytes and 
increased cytokine production by mononuclear cells in human cord blood (16-19). 
Absence of the 192-bp allele in the IGF-I gene promoter region has shown to be 
associated with circulating IGF-I levels (20-22). Previous studies suggested that this func-
tional polymorphism of the IGF-I gene is also associated with lower birth weight and 
reduced prenatal and postnatal linear growth (23, 24). We hypothesized that absence of 
the common 192-bp allele in the IGF-I gene promoter region is also related to absolute 
counts of lymphocyte subsets. Therefore, we examined in 380 neonates participating in 
a prospective cohort study from fetal life onwards the associations of this IGF-I promoter 
polymorphism with absolute counts of lymphocytes (T, B and NK) and T lymphocyte sub-
sets (helper, cytotoxic, naïve and memory) in cord blood.
Methods
Design
This study was embedded in the Generation R Study, a population-based prospective 
cohort study from fetal life onwards. The Generation R Study is designed to identify early 
environmental and genetic determinants of growth, development and health from fetal 
life until young adulthood and has been described previously in detail (25, 26). Detailed 
assessments of fetal and postnatal growth and development were conducted in a sub-
group of 1,232 Dutch pregnant women and their children, referred to as the Generation 
R Focus Study. This subgroup is ethnic homogeneous to exclude possible confounding or 
eff ect modifi cation by ethnicity. Of all approached pregnant women and their partners, 
79% participated in the Generation R Focus Study. The Medical Ethics Committee of the 
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Erasmus Medical Center, Rotterdam, has approved the study. Written informed consent 
was obtained from all participants. 
Genotyping IGF-I gene
DNA was collected from cord blood samples of the children at birth. Polymerase chain 
reaction (PCR) was performed using oligonucleotide primers designed to amplify the 
polymorphic cytosine-adenine (CA) repeat 1 kb upstream of the human IGF-I gene (27). 
The reaction was carried out in a fi nal volume of 10 ml containing 50 ng of genomic DNA 
obtained from peripheral blood cells, 0.5 nmol/l forward primer (‘5-ACCACTCTGGGA-
GAAGGGTA-3’), 0.5 nmol/l reverse primer (‘5-GCTAGCCAGCTGGTGTTATT-3’), 0.25 mmol/l 
2’-dNTP, 2.2 mmol/l MgCl2, 0.01% W1 (Gibco BRL), and 0.4 Taq DNA polymerase (Gibco 
BRL). PCR was performed in 384 well plates (94˚C 10 min; 35 PCR cycles of 30 s at 94˚C, 30 
s on 55˚C, and 30 s on 72˚C; 72˚C 10 min; 4˚C hold). Forward primers were labelled with 
FAM, HEX or NED to determine the size of PCR products by autosequencer (ABI 3100, 
POP 4, fi lter set D, collecting time array 36 cm 7 s, peak-height between 100 and 2000, 
each lane containing three samples). The size of the PCR products was determined in 
comparison with internal ROX-size standard (Perkin Elmer). Seven diff erent alleles of the 
IGF-I promoter region were identifi ed (Table 1). The genotype frequency was similar to 
those found in previous studies and the frequency distribution did not deviate from the 
Hardy-Weinberg equilibrium (Chi-square = 0.005, P > 0.9) (22, 24). As in previous stud-
Table 1. IGF-I promoter polymorphisms and genotype distributions of the study population.
Neonates 
 (n = 380)
Polymorphism
Allele (base pairs) (CA)n
186 16 2 (0.3)
188 17 20 (2.6)
190 18 36 (4.7)
192 (wild-type) 19 481 (63.3)
194 20 158 (20.8)
196 21 53 (7.0)
198 22 10 (1.3)
Genotype
Homozygous 192-bp 149 (39.2)
Heterozygous 192-bp 183 (48.2)
Non-carriers 192-bp 48 (12.6)
Values are absolute numbers (%). The allele distribution is based on 2 alleles per infant. (CA)n: number of cytosine-adenine 
repeats. Wild type allele refers to the most frequent allele in this population.
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ies, IGF-I genotypes were categorized in the following categories based on their 192-bp 
allele: homozygous (wild-type), heterozygous and non-carrier (23, 24, 28, 29). In our 
study, serum IGF-I levels were not available due to logistic and fi nancial constraints.
Immunophenotyping of lymphocyte subsets 
Heparinized sampling of venous cord blood was carried out by midwifes and obstetri-
cians immediately after delivery and transported to the Immunology laboratory of the 
Erasmus Medical Center within 24 hours. Cord blood samples not received within 24 
hours (weekend days) were excluded since fl ow cytometric analyses of those samples 
showed no reliable results in the pilot phase of the study. Flow cytometric immunophe-
notyping was performed to determine absolute counts of lymphocytes (T, B and NK) and 
T lymphocyte subsets (helper, cytotoxic, naïve and memory T). For this, the monoclonal 
antibodies CD3, CD19, CD16.CD56, CD4, CD8, CD45RA and CD45RO were conjugated 
with the labels fl uorescein isothiocyanate (FITC1), peridin chlorophyll protein (PerCP1), 
peridin chlorophyll protein-cychrome 5.5 (PerCP-Cy5.51), allophycocyanin (APC1), phy-
coerythrin (PE1,3), phycoerythrin-cyanin dye (PE-cy71), allophycocyanin-cyanin dye (APC-
cy71) and rhodamine (RD12) (1Becton Dickinson,2Beckman Coulter and 3Dako). Absolute 
counts of T, B and NK lymphocytes were determined with the lysed whole blood tech-
nique (30). Subsets of the T lymphocytes were determined by 6-color fl ow cytometry. 
Therefore, erythrocytes of 1 ml whole blood were lysed using 50 ml ammoniumchloride. 
After centrifugation, leucocytes were washed twice and suspended in 900 μl PBS/1% 
BSA/0.1% NaAz. Of this cell suspension (5-10*106/ml), 50 μl was incubated for 10 minutes 
at room temperature with combinations of the optimally titrated labelled monoclonal 
antibodies. After incubation the cells were washed and subsequently identifi ed by fl ow 
cytometry. Using a BDTM LSR II fl ow cytometer (Becton Dickinson, San Jose, California, US) 
that had been calibrated with rainbow beads, 10,000 lymphocytes were measured. The 
relative count of helper T lymphocytes, cytotoxic T lymphocytes, naïve T lymphocytes and 
memory T lymphocytes was expressed as the percentage within the total T lymphocyte 
population and calculated by the average of 2-4 independent incubations for each sub-
set. The absolute counts of the T lymphocyte subsets were subsequently calculated from 
the absolute T lymphocyte counts as obtained by the lysed whole blood technique.
Covariates
Information about gravidity, mode of delivery (vaginal, forceps or vacuum assisted, cae-
sarean section), date of birth, birth weight, gender, 1- and 5-minute Apgar scores (assign-
ing a score of 0 to 2 to heart rate, respiratory eff ort, muscle tone, refl ex irritability and 
colour) was obtained from standardized midwives and hospital registries. Gestational 
age was established by the fi rst fetal ultrasound examination after enrolment (26).
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Cohort for analysis 
Of the total of 1,232 women who were enrolled in the Generation R Focus Study, those 
with weekend deliveries (n=202), twin pregnancies (n=24) and pregnancies leading 
to perinatal death (n=2) were excluded from the present analysis. Of the remaining 
singleton 1004 live births, IGF-I was successfully genotyped in DNA form cord blood in 
604 (60%) neonates. Of those neonates, immunophenotyping of lymphocyte subsets 
was performed in 380 (63%). Missing data of immunophenotyped lymphocyte subsets 
was mainly due to constraints in the amount of blood and missing heparinized blood 
samples. 
Data analysis
Diff erences of neonatal characteristics between the IGF-I genotype groups were assessed 
by the independent sample t-test for continuous normal distributed variables, non-
parametric Mann-Whitney test for continuous non-normal distributed variables and the 
chi-square test for categorical variables. 
Table 2. Delivery and neonatal characteristics according to the IGF-I genotype. 
IGF-I genotype groups
Homozygous 
192-bp allele
(n = 149)
Heterozygous 
192-bp allele
(n = 183)
No
192-bp allele
(n = 48)
Gravidity (%)
Primigravid 72 (48.3) 104 (57.5) 26 (54.2)
Multigravid 77(51.7) 77 (42.5) 22 (45.8)
Mode of delivery (%)
Vaginal 104 (73.2) 126 (72.8) 36 (80.0)
Forceps or vacuum assisted 23 (16.2) 33 (19.1) 3 (6.7)
Caesarean section 15 (10.6) 14 (8.1) 6 (13.3)
Gender (%)
Boy 82 (55.0) 82 (44.8) 28 (58.3)
Girl 67 (45.0) 101 (55.2) 20 (41.7)
Gestational age 40.3 (34.1-43.0) 40.4 (36.0-43.4) 40.5 (34.6-42.3)
Birth weight 3558 (472) 3588 (482) 3554 (467)
Apgar scores
1-minute 9 (4-10) 9 (2-10) 9 (7-10)
5-minute 10 (8-10) 10 (5-10) 10 (8-10)
Values are proportions (%), medians (range) or means (sd). 
Diff erences were tested using the independent sample t-test, non-parametric Mann-Whitney test or Chi-square test (all 
p-values > 0.05).
Of the total group, data were missing on gravidity (n=2), mode of delivery (n=20), 1-minute Apgar score (n=8) and 5-minute 
Apgar score (n=7).
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Data on all lymphocyte subset counts were log-transformed to obtain normally dis-
tributed variables. Associations of the IGF-I gene with absolute counts of lymphocyte 
subsets were analyzed using multiple linear regression models. Additionally, regression 
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Figure 1. Associations between IGF-I genotype groups and absolute counts of lymphocyte subsets in neonates.
*P-value < 0.05, **p-value < 0.01 for diff erence with the homozygous 192-bp allele group.
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models were adjusted for the potential confounders gravidity, mode of delivery, gesta-
tional age, birth weight, gender, 1- and 5- minute Apgar scores. Measures of associations 
are presented as geometric medians (range) or as log-transformed mean diff erences 
(95% confi dence interval (CI)), which can be interpreted as percentages after multiply-
ing by 100 (31). The statistical analyses were performed using the Statistical Package of 
Social Sciences version 11.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Birth characteristics for the three genotype groups are shown in Table 2. In total, 149 
(39%) neonates were 192-bp homozygous, 183 (48%) were 192-bp heterozygous and 48 
(13%) neonates were non-carriers. No diff erences in birth characteristics were observed 
between these groups.
Figure 1 shows the geometric medians of absolute counts of lymphocyte and T lym-
phocyte subsets of each IGF-I genotype group. No diff erences in absolute counts of lym-
phocyte and T lymphocyte subsets were observed between the 192-bp allele heterozy-
gous and 192-bp allele homozygous groups. In non-carriers, we found 15% (95% CI: 4%, 
27%) lower T lymphocyte counts, 22% (95% CI: 2%, 41%) lower B lymphocyte counts and 
10% (95% CI: -13%, 33%) lower NK lymphocyte counts than in the 192-bp allele homozy-
gous group, although the latter was not signifi cant. Within the T lymphocyte population, 
the non-carriers had lower absolute counts of helper T (diff erence: -18% (95% CI: -30%, 
-6%)) and naïve T lymphocytes (diff erence: -16% (95% CI: -31%, 0%)) compared to the 
192-bp allele homozygous group. Associations of the IGF-I genotype groups with cyto-
toxic and memory T lymphocyte counts were not observed.
Table 3. Associations between IGF-I genotype groups and absolute counts of lymphocyte subsets in neonates.
Lymphocyte subsets
192-bp allele: T B NK
Homozygous Reference Reference Reference
Heterozygous -1 (-9, 7) 2 (-11, 16) 7 (-8, 22)
Non-carrier -13 (-25, -1)* -21 (-40, -1)* -11 (-33, 12)
T lymphocyte subsets
192-bp allele: Helper Cytotoxic Naïve Memory
Homozygous Reference Reference Reference Reference
Heterozygous 0 (-9, 8) -1 (-12, 9) -3 (-15, 8) 10 (-16, 36)
Non-carrier -16 (-28, -3)** -7 (-22, 9) -14 (-31, 2) 7 (-31, 45)
Values are regression coeffi  cients (95% confi dence interval) and refl ect the percentual diff erence in absolute numbers of 
lymphocyte subsets with the homozygous 192-bp allele reference group (31). Values are adjusted for gravidity, mode of 
delivery, gestational age, birth weight, gender, 1- and 5-minute Apgar scores. 
*P-value < 0.05, **p-value < 0.01. 
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Diff erences in absolute counts of lymphocyte subsets between the genotype groups, 
adjusted for gravidity, mode of delivery, gestational age, birth weight, gender, 1- and 5 
minute Apgar scores, are given in Table 3. These adjustments by multiple regression mod-
els did not materially change the estimated diff erences, except for naïve T lymphocytes. 
No statistically signifi cant diff erence in naïve T lymphocyte counts was found between 
the homozygous and non-carrier 192-bp allele group (diff erence: -14 (95% CI: -31, 2).
Discussion
This study showed that non-carriers of the 192-bp allele in IGF-I promoter region had 
lower absolute counts of T and B lymphocytes compared to 192-bp allele homozygous 
neonates. Within the T lymphocyte population, non-carriers had lower absolute counts of 
helper T lymphocytes. Of the other lymphocyte subsets, absolute counts of NK lympho-
cytes, cytotoxic and naïve T lymphocytes tended to be lower in non-carriers, but memory 
T lymphocytes did not. No diff erences in absolute counts of lymphocyte subsets and T 
lymphocyte subsets were observed between the 192-bp allele homozygous and 192-bp 
allele heterozygous groups.
To our knowledge, this is the fi rst study that examined the associations between 
this IGF-I promoter region polymorphism and absolute counts of lymphocyte subsets 
in neonates. DNA for genotyping was available in 602 neonates (60%). Of all genotyped 
neonates, 63% had immunophenotyped lymphocyte subsets. Frequencies of the 192-bp 
allele homozygous group and non-carriers as well as birth characteristics did not sig-
nifi cantly diff er between those with and without data on counts of lymphocyte subsets. 
Therefore, we do not expect that missing counts of lymphocyte subsets led to biased 
eff ect estimates.
We observed diff erent eff ects of the IGF-I promoter region polymorphisms on the 
various lymphocyte subset counts. Compared with 192-bp allele homozygous neo-
nates, non-carriers had overall lower counts of lymphocytes and T lymphocyte subsets, 
although only a signifi cant eff ect was observed on absolute counts of total T, helper T 
and B lymphocytes. IGF-I binds to the IGF-I receptor of all lymphocytes and stimulates 
growth and development of those cells. Expression of the IGF-I receptor is higher on 
helper T lymphocytes than on cytotoxic T lymphocytes. Since the expression of the IGF-I 
receptor is higher on helper T lymphocytes than on cytotoxic T, it seems plausible that 
the largest eff ects of the IGF-I genotype variants are found for those with the highest 
IGF-I receptor expression (32, 33). 
The present study was initiated because previous studies suggested that IGF-I levels 
aff ect lymphocyte subset counts (5-19). However, studies in IGF-I knockout mice and in 
humans with deletions/mutations in the IGF-I gene or the IGF-I receptor gene did not 
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show defi ciencies in counts of marrow myeloid lymphocytes or thymocyte subpopula-
tions (34). This suggests that IGF-I is not an important thymopoietic or myelopoietic fac-
tor. Furthermore, no associations between IGF-I gene variants and immunodefi ciency 
have been reported. Therefore, our results, suggesting an eff ect of the IGF-I promoter 
region polymorphism on lymphocyte subset counts, do not suggest that variants in the 
IGF-I gene are related to immunodefi ciency syndromes. Observed diff erences between 
genotype groups in our study were all within a normal range and are unlikely to be of any 
clinical importance at birth. Whether and to what extend these diff erences in lymphocyte 
subset counts persist and have clinical consequences at older age should be examined 
in further follow up studies.
We have genotyped a highly polymorphic marker in the regulatory region of IGF-I. 
Due to limited counts of subjects, we were not able to test all alleles, but pooled the 
alleles based on the common allele. Our classifi cation was based on earlier studies, 
which showed associations between IGF-I genotype with serum IGF-I levels as well as 
pathology in our earlier population-based studies (22, 23, 35). Most of these studies were 
focused on growth, anthropometrics or diabetes (22, 23, 29, 36-38). To our knowledge, no 
previous studies have studied the associations between our IGF-I promoter region poly-
morphism and lymphocyte subset counts. In animal studies, it has been suggested that 
the eff ect of IGF-I levels on lymphocyte subset counts is an indirect result of the eff ect 
of IGF-I on body or organ size (5). Due to lack of IGF-I, mice were smaller and counts of 
marrow myeloid cells and thymocyte subpopulations seemed normal when values were 
normalized to the weight of the mice (39, 40). In our study cohort, we did not observe an 
association of the IGF-I promoter region polymorphism with birth weight. Furthermore, 
we found associations between the IGF-I promoter region polymorphism and absolute 
counts of lymphocyte and T lymphocyte subsets that were independent of birth weight. 
These results suggest that the associations of variants in the IGF-I promoter region and 
absolute counts of lymphocyte subsets are not explained by body size.
In IGF-I treated mice, an increase of the absolute counts of marrow myeloid, B and 
T lymphocytes has been reported but the relative frequencies of these lineages seem 
to remain unaff ected by IGF-I (5, 12, 39). We found diff erences in absolute counts, but 
no diff erence in relative counts of T (mean diff erence (95% CI): 0.3% (-3.0%, 3.7%)), B 
(-1.2% (-3.2%, 0.8%), helper T (-1.9% (-4.5%, 0.8%) or naïve T (0.6% (-1.1%, -0.1%) lympho-
cytes between the 192-bp allele homozygous group and non-carriers were observed. In 
humans, total lymphocyte counts per ml of blood are signifi cantly higher in neonates 
than in adults (41). It has been suggested that the use of absolute counts instead of 
percentages of lymphocyte subsets is preferred to show actual changes of lymphocyte 
subsets in neonates (41). 
A major limitation of the current study is that IGF-I levels were not available due 
to logistical and fi nancial constraints. Previous studies showed this polymorphism to be 
Liesbeth BW 16-4.indd   168 24-Apr-08   12:05:36 PM
169Variants of the insulin-like growth factor-I gene and lymphocyte subset counts in neonates
associated with IGF-I levels (20-22). Other IGF-I polymorphisms have also been shown to 
be associated with IGF-I levels and postnatal growth in infants born small size for ges-
tational age (42). Whether these polymorphisms aff ect absolute counts of lymphocyte 
subsets remains to be studied. Several studies suggested that insulin-like growth factor 
II (IGF-II) aff ects growth, development and function of lymphocytes (19, 43). Therefore, it 
might be that polymorphisms of the IGF-II gene also infl uence absolute counts of lym-
phocyte subsets. Growth hormone (GH) or GH gene polymorphisms probably do not 
aff ect counts of lymphocyte subsets in cord blood of neonates. Growth hormone mainly 
aff ects postnatal growth and its eff ects are mostly mediated by IGF-I (7, 44). 
It is found that higher cortisol levels in umbilical cord blood are associated with 
increased lymphocyte subset counts in neonates (45, 46). Unfortunately, for the present 
study, data of cortisol levels in umbilical cord blood were not available due to logistic and 
fi nancial constraints. However, we adjusted our models for mode of delivery and for 1- 
and 5-minute Apgar scores. These variables are strongly associated with stressful events 
for the fetus. We expect that adjusting for mode of delivery and Apgar scores enabled us 
to take account of at least part of the eff ect of fetal stress.
In summary, this study shows an association between IGF-I promoter region poly-
morphisms and absolute counts of lymphocytes subsets in neonates. These results 
should be regarded as hypothesis generating rather than as clinically important. Since 
our study is the fi rst showing these associations, replication studies are urgently needed 
before any conclusions or causal inference can be drawn focused on the role of this IGF-I 
polymorphism. These studies should also assess potential dose-response trends for rela-
tion between IGF-I promoter region polymorphisms, IGF-I levels and lymphocyte subset 
counts. Furthermore, genome-wide approaches may lead to identifi cation of other, more 
specifi c IGF-I related genetic variants associated with counts of lymphocyte subsets. 
References
1. Froesch ER, Hussain MA, Schmid C, Zapf J. Insulin-like growth factor I: physiology, metabolic eff ects 
and clinical uses. Diabetes Metab Rev. 1996 Oct;12(3):195-215.
2. Baxter JB, Blalock JE, Weigent DA. Characterization of immunoreactive insulin-like growth factor-I 
from leukocytes and its regulation by growth hormone. Endocrinology. 1991 Oct;129(4):1727-34.
3. Sabharwal P, Varma S. Growth hormone synthesized and secreted by human thymocytes acts via 
insulin-like growth factor I as an autocrine and paracrine growth factor. J Clin Endocrinol Metab. 
1996 Jul;81(7):2663-9.
4. Robbins K, McCabe S, Scheiner T, Strasser J, Clark R, Jardieu P. Immunological eff ects of insulin-
like growth factor-I--enhancement of immunoglobulin synthesis. Clin Exp Immunol. 1994 
Feb;95(2):337-42.
5. Foster M, Montecino-Rodriguez E, Clark R, Dorshkind K. Regulation of B and T cell development by 
anterior pituitary hormones. Cell Mol Life Sci. 1998 Oct;54(10):1076-82.
Liesbeth BW 16-4.indd   169 24-Apr-08   12:05:36 PM
170
Ch
ap
te
r 4
.4
6. Clark R, Strasser J, McCabe S, Robbins K, Jardieu P. Insulin-like growth factor-1 stimulation of lym-
phopoiesis. J Clin Invest. 1993 Aug;92(2):540-8.
7. Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin-like growth factor-I, and 
thyroid hormones in lymphocyte development and function: insights from genetic models of hor-
mone and hormone receptor defi ciency. Endocr Rev. 2000 Jun;21(3):292-312.
8. LeRoith D, Yanowski J, Kaldjian EP, Jaff e ES, LeRoith T, Purdue K, et al. The eff ects of growth hormone 
and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology. 1996 
Mar;137(3):1071-9.
9. de Mello Coelho V, Villa-Verde DM, Farias-de-Oliveira DA, de Brito JM, Dardenne M, Savino W. Func-
tional insulin-like growth factor-1/insulin-like growth factor-1 receptor-mediated circuit in human 
and murine thymic epithelial cells. Neuroendocrinology. 2002 Feb;75(2):139-50.
10. Tarantal AF, Hunter MK, Gargosky SE. Direct administration of insulin-like growth factor to fetal rhe-
sus monkeys (Macaca mulatta). Endocrinology. 1997 Aug;138(8):3349-58.
11. Alpdogan O, Muriglan SJ, Kappel BJ, Doubrovina E, Schmaltz C, Schiro R, et al. Insulin-like growth 
factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplanta-
tion. Transplantation. 2003 Jun 27;75(12):1977-83.
12. Jardieu P, Clark R, Mortensen D, Dorshkind K. In vivo administration of insulin-like growth factor-I 
stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow trans-
plantation. J Immunol. 1994 May 1;152(9):4320-7.
13. Montecino-Rodriguez E, Clark R, Dorshkind K. Eff ects of insulin-like growth factor administra-
tion and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology. 1998 
Oct;139(10):4120-6.
14. Hinton PS, Hirvonen MD, Ney DM, Keesey RE. Growth hormone, insulin-like growth factor-1, and 
the insulin-like growth factor binding proteins in rats maintaining reduced body protein following 
lesions of the lateral hypothalamus. Physiol Behav. 2000 Mar;68(5):667-72.
15. Hinton PS, Peterson CA, Lo HC, Yang H, McCarthy D, Ney DM. Insulin-like growth factor-I enhances 
immune response in dexamethasone-treated or surgically stressed rats maintained with total paren-
teral nutrition. JPEN J Parenter Enteral Nutr. 1995 Nov-Dec;19(6):444-52.
16. Landreth KS, Narayanan R, Dorshkind K. Insulin-like growth factor-I regulates pro-B cell diff erentia-
tion. Blood. 1992 Sep 1;80(5):1207-12.
17. Tu W, Cheung PT, Lau YL. Insulin-like growth factor 1 promotes cord blood T cell maturation and 
inhibits its spontaneous and phytohemagglutinin-induced apoptosis through diff erent mechanisms. 
J Immunol. 2000 Aug 1;165(3):1331-6.
18. Tu W, Cheung PT, Lau YL. IGF-I increases interferon-gamma and IL-6 mRNA expression and protein 
production in neonatal mononuclear cells. Pediatr Res. 1999 Dec;46(6):748-54.
19. Johnson EW, Jones LA, Kozak RW. Expression and function of insulin-like growth factor receptors on 
anti-CD3-activated human T lymphocytes. J Immunol. 1992 Jan 1;148(1):63-71.
20. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff  PJ, Craig WY, et al. Association between serum 
insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic 
studies of bone mineral density. J Clin Endocrinol Metab. 1998 Jul;83(7):2286-90.
21. Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE, et al. A sequence repeat in the 
insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer. 2002 Jul 20;100(3):332-6.
22. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. A polymorphism in the 
gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes. 
2001 Mar;50(3):637-42.
23. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. Association between 
genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet. 2002 Mar 
23;359(9311):1036-7.
24. Landmann E, Geller F, Schilling J, Rudloff  S, Foeller-Gaudier E, Gortner L. Absence of the wild-type 
allele (192 base pairs) of a polymorphism in the promoter region of the IGF-I gene but not a poly-
Liesbeth BW 16-4.indd   170 24-Apr-08   12:05:36 PM
171Variants of the insulin-like growth factor-I gene and lymphocyte subset counts in neonates
morphism in the insulin gene variable number of tandem repeat locus is associated with accelerated 
weight gain in infancy. Pediatrics. 2006 Dec;118(6):2374-9.
25. Hofman A, Jaddoe VW, Mackenbach JP, Moll HA, Snijders RF, Steegers EA, et al. Growth, develop-
ment and health from early fetal life until young adulthood: the Generation R Study. Paediatr Perinat 
Epidemiol. 2004 Jan;18(1):61-72.
26. Jaddoe VW, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Verhulst FC, et al. The Generation R 
Study: Design and cohort profi le. Eur J Epidemiol. 2006;21(6):475-84.
27. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the 
polymerase chain reaction. Am J Hum Genet. 1989 Mar;44(3):388-96.
28. Allen NE, Davey GK, Key TJ, Zhang S, Narod SA. Serum insulin-like growth factor I (IGF-I) concentra-
tion in men is not associated with the cytosine-adenosine repeat polymorphism of the IGF-I gene. 
Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):319-20.
29. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, et al. A putative functional 
polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose toler-
ance, and fetal growth in U.K. populations. Diabetes. 2002 Jul;51(7):2313-6.
30. de Vries E, de Bruin-Versteeg S, Comans-Bitter WM, de Groot R, Boerma GJ, Lotgering FK, et al. Cor-
rection for erythroid cell contamination in microassay for immunophenotyping of neonatal lympho-
cytes. Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F226-9.
31. Cole TJ. Sympercents: symmetric percentage diff erences on the 100 log(e) scale simplify the presen-
tation of log transformed data. Stat Med. 2000 Nov 30;19(22):3109-25.
32. Kooijman R, Willems M, De Haas CJ, Rijkers GT, Schuurmans AL, Van Buul-Off ers SC, et al. Expression 
of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocri-
nology. 1992 Nov;131(5):2244-50.
33. Xu X, Mardell C, Xian CJ, Zola H, Read LC. Expression of functional insulin-like growth factor-1 recep-
tor on lymphoid cell subsets of rats. Immunology. 1995 Jul;85(3):394-9.
34. Walenkamp MJ, Wit JM. Genetic disorders in the growth hormone - insulin-like growth factor-I axis. 
Horm Res. 2006;66(5):221-30.
35. Rietveld I, Janssen JA, Hofman A, Pols HA, van Duijn CM, Lamberts SW. A polymorphism in the 
IGF-I gene infl uences the age-related decline in circulating total IGF-I levels. Eur J Endocrinol. 2003 
Feb;148(2):171-5.
36. Geelhoed JJ, Mook-Kanamori DO, Witteman JC, Hofman A, van Duijn CM, Moll HA, et al. Variation in 
the IGF1 gene and growth in foetal life and infancy. The Generation R Study. Clin Endocrinol (Oxf ). 
2007 Sep 20.
37. Kajantie E, Fall CH, Seppala M, Koistinen R, Dunkel L, Yliharsila H, et al. Serum insulin-like growth 
factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk 
factors, body composition, size at birth, and childhood growth. J Clin Endocrinol Metab. 2003 
Mar;88(3):1059-65.
38. Rietveld I, Janssen JA, van Rossum EF, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, et al. A poly-
morphic CA repeat in the IGF-I gene is associated with gender-specifi c diff erences in body height, but 
has no eff ect on the secular trend in body height. Clin Endocrinol (Oxf ). 2004 Aug;61(2):195-203.
39. Montecino-Rodriguez E, Clark R, Johnson A, Collins L, Dorshkind K. Defective B cell develop-
ment in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. J Immunol. 1996 Oct 
15;157(8):3334-40.
40. Montecino-Rodriguez E, Clark RG, Powell-Braxton L, Dorshkind K. Primary B cell development is 
impaired in mice with defects of the pituitary/thyroid axis. J Immunol. 1997 Sep 15;159(6):2712-9.
41. de Vries E, de Bruin-Versteeg S, Comans-Bitter WM, de Groot R, Hop WC, Boerma GJ, et al. Neonatal 
blood lymphocyte subpopulations: a diff erent perspective when using absolute counts. Biol Neo-
nate. 2000 May;77(4):230-5.
Liesbeth BW 16-4.indd   171 24-Apr-08   12:05:36 PM
172
Ch
ap
te
r 4
.4
42. Arends N, Johnston L, Hokken-Koelega A, van Duijn C, de Ridder M, Savage M, et al. Polymorphism 
in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). J Clin 
Endocrinol Metab. 2002 Jun;87(6):2720.
43. Rechler MM, Nissley SP. The nature and regulation of the receptors for insulin-like growth factors. 
Annu Rev Physiol. 1985;47:425-42.
44. Isaksson OG, Ohlsson C, Nilsson A, Isgaard J, Lindahl A. Regulation of cartilage growth by growth 
hormone and insulin-like growth factor I. Pediatr Nephrol. 1991 Jul;5(4):451-3.
45. Chirico G, Gasparoni A, Ciardelli L, Martinotti L, Rondini G. Leukocyte counts in relation to the method 
of delivery during the fi rst fi ve days of life. Biol Neonate. 1999 May;75(5):294-9.
46. De Amici D, Gasparoni A, Chirico G, Ceriana P, Bartoli A, Ramajoli I, et al. Natural killer cell activity and 
delivery: possible infl uence of cortisol and anesthetic agents. A study on newborn cord blood. Biol 
Neonate. 1999 Dec;76(6):348-54.
Liesbeth BW 16-4.indd   172 24-Apr-08   12:05:36 PM
Summary and general discussion
5
Liesbeth BW 16-4.indd   173 24-Apr-08   12:05:36 PM
Liesbeth BW 16-4.indd   174 24-Apr-08   12:05:36 PM
175Summary and general discussion
In this chapter, the main fi ndings of the studies are presented. Subsequently, method-
ological considerations are discussed and future perspectives on infectious diseases and 
the adaptive immune system in infants are described.
Main fi ndings
All studies described in this thesis were embedded in the Generation R Study, a popula-
tion-based prospective cohort study from early fetal life until young adulthood among 
9,778 mothers and their children (1, 2). More detailed assessments of fetal and postna-
tal growth and development were conducted in a subgroup of 1,232 Dutch pregnant 
women and their children, referred to as the Generation R Focus Study (1, 2). Studies on 
infectious diseases in pregnancy and infectious diseases in infancy were performed in 
the whole cohort study. Studies on nasopharyngeal carriage of Streptococcus pneumo-
niae and the adaptive immune system in infancy were conducted in the Generation R 
Focus Study.
Infectious diseases in pregnancy
The incidence of low birth weight and premature birth varies from 4.2% to 24.6% and 
5 to 15%, respectively, depending on geographical and demographical features of the 
population studied (3-5). Delivery of low birth weight and premature infants is recog-
nized as a major public health problem, accounting for the majority of neonatal death 
and morbidity in developed countries. In the last decades, there seems to be an upward 
trend in the incidence of premature births in Western societies (6-8).
Chlamydia trachomatis infection during pregnancy may infl uence pregnancy out-
comes leading to adverse conditions, including preterm birth and low birth weight. The 
literature regarding these detrimental eff ects of C. trachomatis infection yields confl ict-
ing conclusions that seem primarily due to diff erences in study design, population and 
microbiological tests employed (9-19). We found evidence that C. trachomatis infection 
was associated with a 6-fold increased risk of preterm delivery before 32 weeks, but not 
with low birth weight (chapter 2.1). Of all preterm deliveries before 32 weeks gestation 
in our region 15.8% was attributable to C. trachomatis infection. The population attribut-
able risk of C. trachomatis infection for preterm delivery before 35 weeks of gestation was 
7.5%. Young age, Antillean and Surinamese ethnicity and single marital status were inde-
pendent risk factors for C. trachomatis infection in pregnant women as were Cape Verd-
ian, Surinamese and Moroccan or Turkish ethnicity and promiscuity of their partners. 
Presence of urogenital tract infections during pregnancy is associated with low 
birth weight, preterm delivery, premature rupture of membranes (PROM) and other 
adverse pregnancy outcomes (10, 15, 20). Not much is known of the eff ects of urogenital 
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symptoms in diff erent periods of pregnancy with pregnancy outcomes. This may be rele-
vant for identifying critical time-periods that could be used for preventive strategies. Our 
study showed that mothers with vaginal bleeding in late pregnancy have an increased 
risk of preterm birth (chapter 2.2). Mothers with urinary tract symptoms present in early 
or multiple periods of pregnancy had an increased risk of low birth weight. 
Infectious diseases in infancy
World wide, respiratory tract infections and gastrointestinal infections are the leading 
cause of morbidity in children (21, 22). In industrialized countries, prospective cohort 
studies in the last decade revealed prevalence’s of 3.4% to 32.1% for respiratory tract 
disease and 1.2% to 26.3% for gastrointestinal disease in infancy (23-28). Various risk fac-
tors for upper respiratory tract infections, lower respiratory tract infections and gastro-
intestinal infections have been identifi ed, including gestational age, birth weight, socio-
economic status, ethnicity, number of siblings, daycare attendance, maternal smoking 
and breastfeeding (23-44). Of these, maternal smoking and breastfeeding are the most 
modifi able infl uencing factors. 
There is extended evidence that breastfeeding protects infants against infections in 
developing countries. In industrialized countries, the eff ect remains controversial mainly 
due to methodological fl aws in various studies performed in the nineties. In our review, 
we described studies performed in industrialized countries from the late nineties until 
present (chapter 3.1). Altogether, it seems that breastfeeding protects infants against 
overall, gastrointestinal and respiratory tract infections in industrialized countries. A 
dose-response eff ect is suggested whereby a longer and more exclusive period of breast-
feeding leads to a better protection against infection diseases. The benefi ts of 4 versus 
6 months of exclusively breastfeeding are not completely clarifi ed, although the World 
Health Organization recommended in 2001 to exclusively breastfeed infants for 6 months 
in all countries (45). We found that infants exclusively breastfed for 4 months had lower 
risks for upper and lower respiratory and gastrointestinal tract infections during the fi rst 
6 months and for lower respiratory tract infections between 7 and 12 months (chapter 
3.2). These eff ects were explained by additional partially breastfeeding for 4 to 6 months. 
Exclusively breastfeeding for 6 months was only associated with upper respiratory tract 
infections from birth to 6 months. 
The independent eff ects of maternal smoking in diff erent periods of pregnancy and 
in the postnatal period on the risks of respiratory tract infections in young infants may 
be relevant for identifying critical periods for the eff ect of exposure of maternal smoking 
on airway and lung development and respiratory tract infections in infants. We observed 
weak evidence for an association of maternal smoking in the early postnatal period with 
lower respiratory tract infections in infants in the fi rst 6 months of life (chapter 3.3). 
No eff ect of maternal smoking of diff erent duration in pregnancy on respiratory tract 
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infections in infants was found. We did not observe dose-response eff ects for maternal 
smoking in diff erent periods on respiratory tract infections.
Nasopharyngeal carriage of S. pneumoniae is mostly asymptomatic, but might lead 
to serious pneumococcal disease when the host-pathogen balance is disturbed (46-49). 
Population-based prospective cohort studies in infants regarding environmental factors, 
dynamics and interference of S. pneumoniae with other pathogens are scarce. Risk factors 
for pneumococcal carriage at 6 weeks of age were low birth weight and siblings (chapter 
3.4). Having siblings was also associated with pneumococcal carriage at 6 months of age 
as was daycare attendance. Attending a daycare center was the only independent risk 
factor for pneumococcal carriage at 14 months of age. Furthermore, we found that pneu-
mococcal carriage at 6 months of age predisposes for subsequent pneumococcal car-
riage at older age. No associations of gestational age, gender, maternal socio-economic 
status, maternal smoking or breastfeeding with pneumococcal carriage in infancy were 
found. 
Immune system in infancy
One of the major reasons for the high rate of recurrent infections in infants might be 
their relative immature immune system. Several studies observed changes in absolute 
numbers of various lymphocyte subsets from birth until adulthood, especially in the fi rst 
two years of life (50-52). The diff erent maturation phases of the lymphocyte subsets in 
infancy are assessed in more detail and described in chapter 4.1. 
Large population-based studies assessing the associations of gestational age, birth 
weight and fetal growth or other infl uencing pre-and perinatal factors with the devel-
opment of the lymphocytes are scarce. We found that with increasing gestational age 
at birth, absolute numbers of T, B, NK lymphocytes and helper, cytotoxic and naïve T 
lymphocytes increase (chapter 4.2). Increased birth weight and fetal growth in late preg-
nancy were associated with higher absolute numbers of B lymphocytes, but not with 
T, NK and T lymphocyte subset counts. Furthermore, we observed that with increasing 
stress-related mode of delivery, absolute NK and T lymphocyte counts as well as several 
subset counts within the T lymphocyte population increased, but B lymphocyte counts 
did not (chapter 4.3). Lower 1-minute Apgar scores showed higher B and NK lymphocyte 
counts. Larger eff ects on these lymphocyte counts were observed for lower 5-minute 
Apgar scores and additionally on total T and cytotoxic T lymphocyte counts. Lower 
umbilical cord blood pH was associated with higher T, B, NK and memory T lymphocyte 
counts. Eff ects of Apgar scores and umbilical cord blood pH on other T lymphocyte sub-
sets were not observed. 
We hypothesized that variants of the promoter region of the IGF-I gene, which are 
associated with circulating IGF-I levels, may be related to an increase of absolute num-
bers of lymphocyte subsets. Our study showed that non-carriers of the 192-bp allele had 
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lower absolute numbers of T and B lymphocytes compared to 192-bp allele homozygous 
neonates (chapter 4.4). Within the T lymphocyte population, non-carriers had lower 
absolute numbers of helper T and naïve T lymphocytes. Of the remaining lymphocyte 
subsets, absolute numbers of NK lymphocytes and cytotoxic T lymphocytes tended to 
be lower in non-carriers, but memory T lymphocytes did not. No diff erences in absolute 
numbers of lymphocyte subsets and T lymphocyte subsets were observed between the 
192-bp allele homozygous and 192-bp allele heterozygous groups.
Methodological considerations
The specifi c methodological considerations of the studies presented in this thesis have 
been discussed in the separate chapters. In this paragraph, selection bias, information 
bias and confounding are discussed in general for our studies perfomed within the Gen-
eration R Study.
Selection bias
Of all eligible children at birth, 61% participated in the Generation R Study. National and 
regional registries do not have subject characteristics in all eligible children and their 
parents that enables detailed non-response analyses (2). However, the percentages of 
mothers from diff erent ethnicity, lower socio-economic status and the percentages of 
mothers or children with medical complications were lower among the participants 
than expected from the population fi gures in Rotterdam (2, 53). This selection towards a 
more affl  uent and healthy study population may be related to some determinants and 
outcomes separately, aff ecting the frequency rates and, as a consequence, the statistical 
power and generalizibility of the results. The prevalence and incidence rates found in the 
study should therefore carefully be interpreted considering the role of potential selec-
Table 1. Main fi ndings of the studies presented in this thesis.
1. Chlamydia trachomatis infection and vaginal bleeding in late pregnancy are associated with increased risks of preterm 
delivery, but not with low birth weight. 
2. In industrialized countries, breastfeeding protects infants against infectious diseases in infancy. Infants who are exclusively 
breastfed for 4 months and partially thereafter have lower risks for respiratory tract and gastrointestinal infections. 
Maternal smoking of diff erent duration in pregnancy not aff ects respiratory tract infections in infants. Main risk factors for 
pneumococcal carriage at 6 weeks of age are low birth weight and siblings.
3. Fetal growth, birth weight, gestational age, stress- and hypoxia associated mode of delivery and a known IGF-I promotor 
region polymorphism are associated with changes in the absolute numbers lymphocytes (T, B and NK) and T lymphocyte 
subsets (helper, cytotoxic, naïve and memory) in neonates. 
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tion mechanisms. This selection leads only to bias in etiological studies if the selection 
mechanisms are both related to the determinant and outcome. 
C. trachomatis could not be tested for 21% of initially enrolled women. However, all 
risk factors were similarly distributed among tested and untested women and no diff er-
ences were found in the median gestational age and mean birth weight (40.1 weeks ver-
sus 40.1 weeks; p=0.33, 3419 grams versus 3418 grams; p=0.99). Also, no diff erences were 
found in the proportion of C. trachomatis infection between women included and not 
included in the analyses of gestational age and birth weight (3.6% versus 4.5%); p=0.57). 
Therefore, selection bias seems unlikely. Our numbers were too small to properly assess 
the association of C. trachomatis infection with abortion, stillbirth or perinatal death. Of 
all women enrolled in the study and with information about C. trachomatis infection, 62 
(1.5%) had an abortion, stillbirth or perinatal death. Data on gestational age and birth 
weight were not available for women with the latter adverse pregnancy outcomes, but 
it is likely that these women delivered prematurely relatively more frequently. None of 
these women had a C. trachomatis infection. Theoretically, our eff ect estimates for the 
associations of chlamydial infection with gestational age and birth weight could be 
biased and exaggerated when these associations would diff er between all fetuses and 
fetal `survivors`. This would be the case when C. trachomatis infection has a `protective` 
eff ect on early fetal death. However, this is most unlikely (12, 18). 
Of all eligible participants of the Generation R Study, questionnaires with data on the 
main determinants were missing for breastfeeding (35%) and maternal smoking (2.9%). 
At the age of 6 months, infectious diseases were more present in those without informa-
tion than those with information about breastfeeding (50.0% and 43.6%). No diff erences 
in prevalences of infectious diseases between those with and without information about 
maternal smoking were found. Selection bias due to non-response seems therefore only 
applicable to the eff ects of breastfeeding on infectious diseases at the age of 6 months, 
which might be underestimated. We do not expect that non-response to breastfeeding 
questions did aff ect the associations between breastfeeding and infectious diseases from 
the age of 7 through 12 months. Of all participants with breastfeeding data, informa-
tion on infectious diseases was missing at the age of 6 in 9.8% and 12 months in 14.2%. 
Selection bias due to loss to follow-up seems therefore unlikely for the association of 
breastfeeding and infectious diseases. However, selection bias due to loss to follow-up 
could be present in our study on maternal smoking and infectious diseases since infants 
lost to follow-up more often had smoking mothers than non-smoking mothers (48.4% 
and 41.9%, respectively).
In our studies on infl uencing factors of absolute numbers of lymphocyte subsets 
in neonates, data were mostly missing for mode of delivery (5.3%) and umbilical cord 
blood pH (50.8%) of the eligible infants. Those with missing data on mode of delivery 
had lower geometric means of absolute numbers of T, B, NK and helper T lymphocytes. 
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The observed eff ects of mode of delivery on numbers of these lymphocytes may there-
fore be underestimated. Measurements of umbilical cord blood pH in the Netherlands 
are not routinely performed and neonates without umbilical cord blood pH were more 
frequently from uncomplicated pregnancies without fetal distress. Thus we expect that 
missing values in umbilical cord blood pH did not materially change the eff ect estimated 
but decreased the power of the study. Participating infants without cord blood samples 
more often had a lower gestational age, lower birth weight, more often were born by 
caesarean section and more often had a 192-bp allele homozygous genotype for IGF-I 
than infants with cord blood samples. These diff erences due to selective loss to follow-up 
might have led to an underestimation of the observed eff ects of the infl uencing factors 
on absolute numbers of the various lymphocyte subsets.
Information bias 
Information about most of the determinants, including maternal urogenital symptoms, 
smoking, ethnicity, education, infants’ feeding habits, siblings and daycare attendance 
were prospectively obtained by postal questionnaires. This information was recorded 
without direct reference to adverse birth outcomes, infectious diseases or pneumococ-
cal carriage in infants. The parents were not aware of the specifi c research questions 
addressed in this thesis. However, misclassifi cation may occur, especially for self-reported 
information about maternal smoking and breastfeeding. Assessment of adverse life style 
habits (i.e. smoking) by questionnaires may lead to underreporting. Random misclas-
sifi cation of the smoking and breastfeeding categories would lead to an underestimation 
of the eff ect estimates. 
To overcome the limitation of underreporting of smoking, other studies have used 
biomarkers of tobacco exposure including cotinine in maternal urine, saliva or blood 
samples or nicotine in indoor air (9, 26, 54, 55). However, so far these studies have dem-
onstrated that these biomarkers are not superior to self-report when studying the eff ect 
of maternal smoking on respiratory tract infections of their off spring (19, 26, 35, 37, 56, 
57). 
Misclassifi cation of breastfeeding habits seems diffi  cult to prevent. A recent review 
of studies performed between 1966 and 2003 showed that maternal report of breast-
feeding is reliable through the age of 3 (58). 
The main outcomes in our study assessed by questionnaires were self-reported doc-
tor-attended upper and lower respiratory tract infections and gastointestinal infections. 
These infections were not compared with data from medical records and could be either 
under- or overreported by the parents. If independent of the determinant, the diff er-
ences in eff ects are usually biased towards the null. It would be ideal to diagnose respira-
tory and gastrointestinal infections by detection of the pathogens in saliva or stools. In 
large cohort studies this is rarely done probably due to logistic and fi nancial constraints. 
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Although assessing infectious diseases by questionnaires is not optimal, questionnaires 
are widely used in large epidemiological studies to obtain diagnoses and reliably refl ect 
the true incidence of respiratory and gastrointestinal infections (28, 59-62) 
Validity of the laboratory tests to detect C. trachomatis, S. Pneumoniae and absolute 
numbers of lymphocyte subsets are described in the relating chapters separately.
Confounding 
Our interest was in the eff ects of maternal infectious diseases in pregnancy on birth out-
comes and in the eff ect of breastfeeding and maternal smoking on infectious diseases 
in infancy. Adjustment for gestational age, birth weight, siblings, daycare attendance, 
gender, maternal ethnicity or education weakened the strengths of the associations. Mis-
classifi cation of these variables seems not likely and probably do not cause a bias of the 
estimated eff ect in either direction. The adjustment for birth weight in the association of 
maternal smoking and infectious diseases in infants could be argued. We hypothesized 
that maternal smoking in pregnancy has its independent eff ect on lung development 
thereby increasing the risk of infectious diseases. However, it has been shown that birth 
weight can also act as an intermediate in the association of maternal smoking in preg-
nancy and symptoms of the respiratory tract (41). Therefore, the intermediating eff ect of 
birth weight on infections of the respiratory tract needs to be further explored.
Our interest was in the eff ect of pre-and perinatal infl uencing factors on absolute 
numbers of lymphocyte subsets in neonates. Regarding the literature and our own data 
analyses, proper adjustment for known and possible confounders was assessed. Howev-
er, we were unable to take acute maternal infections during delivery into account which 
might dilute or exaggerate the observed eff ects. 
Future research
Our study showed that C. trachomatis infection in pregnant women increases the risk of 
preterm delivery, especially early prematurity, such that a signifi cant proportion of pre-
term deliveries can be attributed to this infection. C. trachomatis infection in pregnancy 
should be regarded as a serious public health problem, especially for young women 
belonging to certain socio-economic and ethnic groups at increased risk for C. tracho-
matis infection. Population-based screening on C. trachomatis infection in pregnancy in 
the Netherlands seems indicated. Since the prevalence, risk factors and adverse eff ects 
of a chlamydial infection are clarifi ed, cost-benefi ts strategies for implying a chlamydial 
screening program in high risk pregnant women have to be explored. 
Our studies suggest that dose-duration of maternal smoking and breastfeeding 
infl uences the risk of respiratory and gastrointestinal infections in infancy. Follow-up 
studies are needed to examine whether these eff ects persist at older ages. Furthermore, 
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the dose-duration eff ects on other outcomes including growth, development, asthma 
symptoms and allergy are of interest. 
We examined numbers of lymphocyte subsets to express the developmental status 
of the adaptive immune system. Our studies suggest that fetal growth and development 
as well as perinatal stress and the IGF-1 promoter region polymorphism infl uence abso-
lute numbers of lymphocyte subsets in neonates. These fi ndings underline the impor-
tance of focusing on environmental and genetic factors in the development of the adap-
tive immune system. Whether numbers of lymphocyte subsets are related to function of 
these cells remains to be assessed. 
Further studies are needed to examine whether other infl uencing factors, includ-
ing pre-eclampsia, pregnancy induced hypertension or acute urogenital infections of 
pregnant women during delivery, lead to changes in absolute lymphocyte subset counts 
in neonates. However, prevalences of these diagnoses are low, leading to less power to 
detect diff erences in absolute numbers of lymphocyte subsets in neonates. A nested 
case-control design in a larger cohort might overcome this issue. A lower gestational age 
at birth was associated with lower lymphocyte subset counts in neonates and suggests a 
relative more immature adaptive immune system. To what age these lower counts persist 
is unknown. If ‘catch-up’ growth in absolute numbers of lymphocyte subsets occurs, it is 
interesting to examine whether this might depend on the frequency rate of exposure to 
pathogens or other infl uencing factors including vaccination. Follow-up studies are also 
needed to examine whether the observed prenatal eff ects of stress-associated perina-
tal factors and the IGF-I promoter region polymorphism on lymphocyte subsets counts 
in neonates persist at older ages and have consequences for morbidity in childhood. 
Furthermore, the associations of postnatal factors including infections, vaccinations and 
nutrition with the development of lymphocyte subsets at older ages would be interest-
ing to assess in this large cohort study. Blood samples of infants until adulthood will be 
preferable, although the diffi  culties of obtaining consent for 
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Samenvatting
Het onderzoek beschreven in dit proefschrift is uitgevoerd in het Generation R onderzoek. 
Het Generation R onderzoek is een populatie-gebaseerd prospectief cohort onderzoek 
bij 9778 moeders en kinderen vanaf het vroege foetale leven tot de volwassenheid. Het 
onderzoek gericht op infectieziekten in de zwangerschap en in het eerste jaar is uitge-
voerd in dit gehele cohort. Aanvullende, gedetailleerde metingen zijn uitgevoerd in een 
subgroep van 1232 moeders en kinderen. Dit subgroep onderzoek wordt het Generation 
R Focus onderzoek genoemd. Het onderzoek gericht op dragerschap van Streptococcus 
pneumoniae en het immuunsysteem is uitgevoerd in deze subgroep.
Infectieziekten in de zwangerschap
Het onderzoek beschreven in hoofdstuk 2 is gericht op de eff ecten van een Chlamydia 
trachomatis infectie, éen van de belangrijkste seksueel overdraagbare aandoeningen, en 
subklinische urogenitale symptomen bij moeder in de zwangerschap op het risico voor 
het krijgen van een kind met een laag geboortegewicht of prematuriteit. Laag geboor-
tegewicht en prematuriteit zijn de belangrijkste risicofactoren voor neonatale sterfte en 
morbiditeit in Westerse landen. De afgelopen decennia lijkt er een trend zichtbaar naar 
een toenemende incidentie van prematuriteit in Nederland.
Hoofdstuk 2.1 laat zien dat een C. trachomatis infectie geassocieerd is met een 
6-keer hoger risico op prematuriteit met een zwangerschapsduur korter dan 32 weken. 
Er werd geen relatie met laag geboortegewicht gevonden. Van alle prematuren met een 
zwangerschapsduur korter dan 32 weken, lijkt bijna 16% verklaarbaar door een C. tra-
chomatis infectie. Van alle prematuren met een zwangerschapsduur van korter dan 35 
weken, is dit 7.5%. In ons onderzoek waren bij de moeders een jonge leeftijd, een Antilli-
aanse of Surinaamse etniciteit en ongetrouwd zijn risicofactoren voor een infectie met C. 
trachomatis infectie. Bij de partners waren Kaap Verdiaanse, Surinaamse en Marokkaanse 
of Turkse etniciteit en verschillende sexuele contacten risicofactoren.
De aanwezigheid van urogenitale infecties gedurende de zwangerschap lijkt gere-
lateerd te zijn aan het risico op prematuur gebroken vliezen, prematuriteit en andere 
ongunstige geboorteuitkomsten. In hoofdstuk 2.2 wordt aangetoond dat vaginaal 
bloedverlies in het laatste deel van de zwangerschap leidt tot een hoger risico op prema-
turiteit. Daarnaast blijkt dat moeders met urogenitale symptomen in de vroege zwanger-
schap of in verschillende periodes van de zwangerschap een verhoogd risico hebben op 
het krijgen van een kind met een laag geboortegewicht.
Infectieziekten in het eerste levensjaar
Infectieziekten zijn de belangrijkste oorzaak van morbiditeit in de eerste levensjaren. 
Eerdere studies hebben gesuggereerd dat meer dan 25% van de kinderen luchtweg en 
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gastrointestinale infecties in het eerste levensjaar doormaakt. Bekende risico factoren 
voor luchtweg en gastrointestinale infecties zijn de zwangerschapsduur, het geboorte-
gewicht, de sociaal economische status, de etniciteit, het aantal broers en zussen, bezoek 
aan het kinderdagverblijf, het roken door moeder en het krijgen van borstvoeding. De 
laatste 2 risicofactoren lijken het meest beïnvloedbaar.
Wij concludeerden op basis van eerdere studies dat borstvoeding een beschermend 
eff ect heeft op het krijgen van luchtweg en gastrointestinale infecties in geïndustriali-
seerde landen (hoofdstuk 3.1). Een langere periode van exclusieve borstvoeding lijkt 
het grootste beschermende eff ect te hebben. Uit het Generation R onderzoek blijkt dat 
zuigelingen die minimaal 4 maanden exclusief borstvoeding krijgen en daarna borst-
voeding combineren met fl esvoeding een lager risico hebben op bovenste en onderste 
luchtweginfecties en gastrointestinale infecties in het eerste levensjaar. Het grootste 
eff ect was zichtbaar op infectieziekten in de eerste 6 maanden (hoofdstuk 3.2). 
In hoofdstuk 3.3 worden de relaties bestudeerd tussen enerzijds roken door moe-
der in verschillen perioden in de zwangerschap en in de eerste maanden postnataal 
en anderzijds het risico op luchtweginfecties in het eerste levensjaar. Hiermee kunnen 
specifi eke perioden in het vroege leven die kritiek zijn voor de ontwikkeling van de lucht-
wegen en voor het risico op luchtweg infecties geïdentifi ceerd worden. Wij vonden een 
zwakke relatie tussen roken door moeder in de vroege postnatale periode en het risico 
op onderste luchtweginfecties. Wij vonden geen relatie tussen het roken in verschillende 
perioden in de zwangerschap en het risico op luchtweginfecties. 
Eén van de belangrijkste bacteriële verwekkers van luchtweginfecties is de Strepto-
coccus pneumoniae. Dragerschap van de S. pneumoniae is meestal asymptomatisch maar 
kan leiden tot milde en ernstige luchtweginfecties. Factoren van invloed op dragerschap 
van S. pneumoniae en de interactie met andere bacteriën is niet uitgebreid bestudeerd 
in populatie-gebasseerd prospectief cohort onderzoek. Laag geboortegewicht en het 
hebben van broers of zussen lijken risicofactoren voor dragerschap in de eerste maan-
den (hoofdstuk 3.4). Bezoek aan een kinderdagverblijf is gerelateerd aan S. pneumoniae 
dragerschap op 6 en 14 maanden. 
Het immuunsysteem in het eerste levensjaar
Eén van de belangrijkste redenen voor het hoge aantal infectieziekten in het eerste 
levensjaar is het relatieve onrijpe afweersysteem. In hoofdstuk 4 worden de ontwikke-
ling van het afweer systeem en de factoren van invloed daarop bestudeerd.
In hoofdstuk 4.1 wordt de ontwikkeling en uitrijping van het immuunsysteem 
bestudeerd. Hiervoor zijn T, B, NK lymfocyten en hun verschillende subsets bepaald in 
bloedmonsters die verzameld zijn bij de geboorte en op de leeftijd van 6, 14 en 24 maan-
den. De gepresenteerde gegevens kunnen als normaal waarden voor gezonde kinderen 
gebruikt worden. 
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Hoofdstuk 4.2 laat zien dat een langere zwangerschapsduur positief geassocieerd is 
met de absolute aantallen T, B, NK lymfocyten en helper, cytotoxische and naïeve T lym-
focyten. Een hoger geboortegewicht en snellere foetale groei in de laatste fase van de 
zwangerschap zijn alleen geassocieerd met een hoger aantal B lymfocyten. In hoofdstuk 
4.3 laten we zien dat stress gerelateerde bevallingen geassocieerd zijn met het aantal 
NK and T lymfocyten en met verschillende aantallen lymfocyten binnen de subset van T 
lymfocyten. Er was geen relatie met B lymfocyten. Een lage Apgar score na 1 minuut leidt 
tot een hoger aantal hogere B en NK lymfocyten. Grotere eff ecten op deze en ook de T 
lymfocyten zijn zichtbaar voor de Apgar score na 5 minuten. Een lage pH in het navel-
strengbloed is geassocieerd met een hoger aantal T, B, NK and memory T lymfocyten. 
Er waren geen eff ecten van de Apgar score en van de pH in het navelstreng bloed op 
andere T lymfocyten. 
In hoofdstuk 4.4 hebben we onderzocht of een bekende variant in de promoter 
regio van het insuline-like growth factor-I (IGF-I) gen geassocieerd is met verschillen in 
aantallen lymfocyten. Eerder onderzoek heeft aangetoond dat deze genetische variant 
gerelateerd is aan IGF-1 niveaus in het bloed. Kinderen die geen drager waren van het 
192-bp allel (non-carriers) hadden lagere aantallen T and B lymfocyten in vergelijking 
met 192-bp allel homozygoten. Non-carriers hadden tevens lagere aantallen helper en 
naïeve T lymfocyten. 
In hoofdstuk 5, de algemene discussie, worden de resultaten van dit proefschrift 
beschreven en in een bredere context geplaatst. Bovendien worden relevante methodo-
logische kwesties bediscussieerd en suggesties gegeven voor toekomstig onderzoek.
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‘Wat Jantje is, zal Jan worden’, prof.dr. H.K.A. Visser, 19 mei 1995.
Als eerste promovendus vanuit de afdeling kindergeneeskunde mocht ik mij vlak na de 
start van het Generation R onderzoek bij dit grote avontuur aansluiten. Mijn eerste en 
grootste dank gaat uit naar de vele enthousiaste, kundige, gedreven wetenschappers en 
medewerkers die betrokken zijn bij de groei, ontwikkeling en gezondheid van het Gene-
ration R onderzoek en de duizenden kinderen en hun ouders waarvan wij belangeloos 
unieke gegevens mogen verzamelen!
Henriëtte Moll, van co-promotor tot promotor, nu voor de eerste maal in de grote com-
missie als prof, super! Dank voor de bewogen jaren, de vrijheid die je me gaf en je altijd 
aanwezige optimisme. Ronald de Groot, mijn promotor ‘op afstand’, bedankt voor het 
doorploegen van een heel manuscript in korte tijd.
Bert Hofman, dank dat ik met jouw gedrevenheid, enthousiasme, kennis en kunde de 
wondere wereld van de epidemiologie en het opzetten van een cohort onderzoek mocht 
ontdekken. Herbert Hooijkaas, het immuunsysteem is een beetje zoals de Generation R 
populatie, veel subpopulaties die door verschillende factoren op hun eigen manier matu-
reren, kortom ongelofelijk complex. Je hebt mij, als clinicus, daar op een enorm vriende-
lijke en bereidwillige manier een beetje wegwijs in kunnen maken, bedankt. Johan de 
Jongste, jouw inzet tot het inhoudelijk en taalkundig beter worden van het manuscript 
staat niet in verhouding tot het aantal co-auteurschappen op mijn papers…bedankt.
Bert van der Heijden en Matthijs de Hoog, dank voor de mogelijkheid om wetenschap-
pelijk onderzoek met de opleiding tot kinderarts te combineren. Anja Vaessen-Verberne, 
stimulerend, motiverend en waakzaam om het maximale uit mijn opleiding tot kinderarts 
te halen, je bent een opleider pur sang! De levendigheid en Brabantse gezelligheid van jou 
en de andere Bredaase kinderartsen siert jullie. Muppets i.o., dank voor jullie altijd aanwe-
zige begrip en mogelijkheid tot -tig keer ruilen van diensten deze afgelopen maanden.
Henri Verbrugh, Ingrid Rours, Roel Verkooijen en het lab Medische Microbiologie, dank 
voor jullie bewogen samenwerking en de Chlamydia-substudie. Peter Hermans, Debby 
Bogaert, Marcel Sluijter en laboranten, peumococcen goeroes, bedankt voor de samen-
werking.
Liesbeth B., naam- en schrijfgenoot, ook jij hebt mij veel van de immunologie bijge-
bracht. Dank voor je inzet, elke keer weer. De mooiste immuno-papers zullen nog volgen! 
Romana, Jac, Marja, Ivonne, Anja en Mirjam, immunologie-laboranten, jullie hebben een 
enorme hoeveelheid werk verricht om de grote hoeveelheid bloedmonsters te analyse-
ren. De taart komt echt…
Het Generation R team, de huidige en oud-medewerkers en promovendi zijn er inmid-
dels te veel om persoonlijk te bedanken. Mede dankzij jullie is dit proefschrift tot stand 
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gekomen. Maar bovenal leveren jullie een fantastische ondersteuning aan het Genera-
tion R onderzoek! Het Generation R Focus team, de logistiek en uitvoering zijn helemaal 
vanaf het begin samen met jullie opgezet. Het was spannend, uitdagend en heel gezellig, 
enorm bedankt! Christi en de bloedmonsters, ach, je weet het wel…super bedankt! Het 
Generation R Management team en het ‘Klein MT’, dank voor de samenwerking en de 
vele leermomenten. Claudia, bedankt voor je positiviteit en je altijd snelle reply’s met het 
zoveelste geupdate databestand. Ernst-Jan, Vincent, Mijke, Sabine en Bero, om als eerste 
GR-promovendi vanuit diverse afdelingen een onderzoek mee helpen op te zetten vergt 
gedrevenheid. ‘Never ever give up’ lijkt jullie slogan te zijn. Bedankt voor de mooie herin-
nering en de vele borrels…met bittergarnituur!
Karin, zusje van me, paranimf, ben er trots op dat je naast me staat. Als iemand met passie 
en vuur strijdt voor een doel wat ie voor ogen heeft, dan ben jij het wel! Dank voor je 
steun de afgelopen maanden!
Joost, paranimf, van frequentie-tabelletjes tot confounder-modelling, van ambitieuze 
onderzoeker tot fotomodelletje van GR, van Kluun tot 3000 pagina’s over 1 pneumoc 
(lekker ontspannen lezen, duh!), van puinzooi tot Baukje, van ‘het allermooiste-Thaise-
meisje-wat-ik-ooit-gezien-heb’ (elke hoek weer 1) tot ‘alive and kicking’ Anouk, van 
poepiedoepiesnoepie Vincent tot Vinnie mét dolcegabbanalightblueman, van strak, 
marineblauw-wit gestreept t-shirtje (zó 2007!) tot door stof bedekte smoking, van Joost 
Wilhem Maria Labout tot JLa. We’ve shared it all…X Roomie.
Troetje, toch ook een klein woordje aan jou, zo na dertien jaar vriendschap en periodiek 
collega’s zijn. Het doet me goed je in die jaren te hebben zien groeien van serieuze, nette, 
ambitieuze topstudent tot geinfantiliseerde wetenschapper met kwik-kwek-kwak-gel-
kuifj e met bijpassende, kleurrijke, zeg maar, sokken. Bovendien wist je me altijd weer op 
te vrolijken met je stralende glimlach, gezellige afdelingsroddels, rustige aanwezigheid, 
en het dagelijks netjes op orde houden van mijn op auteur, jaartal en tijdschrift gerang-
schikte artikelen, mappen en boeken. Bedankt!
Van origine Leidse medische studie-vrienden, inmiddels aangevuld met private bankers, 
juristen, managers, verpleegkundigen en veel, heel veel garnalen, dank voor de enorme 
lol die we elke keer weer hebben! Dikke knuff el van T. Lies. Ook groetjes aan de Jaddoe-
tjes. Emy en Theo, dank voor jullie steun tijdens al mijn opleidingsjaren. Indonesië was 
een soort van thuiskomen…
Caroline, Karin en Wouter, zussies en Da Lill’ Bro, zo verschillend en toch zo hetzelfde. We 
zien elkaar weinig, maar dat maakt jullie betekenis voor mij niet minder, integendeel!
Pap en mam, om iets op eigen kracht te kunnen doen moet je wel de nodige basis heb-
ben meegekregen. Jullie hebben ieder op je eigen manier daaraan bijgedragen. Knuf!
Vincent, lieffi  e, partner in science en in nog zo veel meer…bedankt!
‘Wat Liesje was, is Liesbeth geworden’, tijd voor een feestje!
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